BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 605644 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C24H24FN3O2/c1-15-21(17-6-4-5-16(9-17)19-13-30-14-19)11-20(12-27-15)28-23(29)18-7-8-26-22(10-18)24(2,3)25/h4-12,19H,13-14H2,1-3H3,(H,28,29) HRLPVQNNCFFDEE-UHFFFAOYSA-N 313220 2-(2-fluoropropan-2-yl)-N-(6-methyl-5-(3-(oxetan-3-yl)phenyl)pyridin-3-yl)isonicotinamide::US10167279, Example 1 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313220&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609731 383540130 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605645 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C24H20F3NO2/c1-15-8-9-21(28-23(29)18-6-3-7-20(11-18)24(25,26)27)12-22(15)17-5-2-4-16(10-17)19-13-30-14-19/h2-12,19H,13-14H2,1H3,(H,28,29) DXELCDSUXSXDKL-UHFFFAOYSA-N 313225 N-(6-methyl-3′-(oxetan-3-yl)-[1,1′-biphenyl]-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 2 RAF proto-oncogene serine/threonine-protein kinase Human 700 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313225&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118948796 383540135 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605646 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H29FN4O3/c1-6-34-24-21(26(5)14-33-15-26)9-18(12-30-24)20-11-19(13-29-16(20)2)31-23(32)17-7-8-28-22(10-17)25(3,4)27/h7-13H,6,14-15H2,1-5H3,(H,31,32) JKCYWOKOZYYPHI-UHFFFAOYSA-N 313258 N-(6′-ethoxy-2-methyl-5′-(3-methyloxetan-3-yl)-[3,3′-bipyridin]-5-yl)-2-(2-fluoropropan-2-yl)isonicotinamide::US10167279, Example 3 RAF proto-oncogene serine/threonine-protein kinase Human 500 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313258&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609377 383540168 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605647 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cn(C)c(=O)c(n1)C1COC1 InChI=1S/C23H20F3N3O3/c1-13-6-7-17(27-21(30)14-4-3-5-16(8-14)23(24,25)26)9-18(13)19-10-29(2)22(31)20(28-19)15-11-32-12-15/h3-10,15H,11-12H2,1-2H3,(H,27,30) UXBUZPMEWYAGGT-UHFFFAOYSA-N 313260 N-(4-methyl-3-(4-methyl-6-(oxetan-3-yl)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)-3-(trifluoromethyl)benzamide::US10167279, Example 4 RAF proto-oncogene serine/threonine-protein kinase Human 3000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313260 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313260&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609690 383540170 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605648 Cc1ccc(NC(=O)c2ccc(CCl)c(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C25H21ClF3NO2/c1-15-5-8-21(11-22(15)17-4-2-3-16(9-17)20-13-32-14-20)30-24(31)18-6-7-19(12-26)23(10-18)25(27,28)29/h2-11,20H,12-14H2,1H3,(H,30,31) CJDOFLRYZHBZEX-UHFFFAOYSA-N 313261 4-(aminomethyl)-N-(6-methyl-3′-(oxetan-3-yl)-[1,1′-biphenyl]-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 5 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313261&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118948699 383540171 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605649 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(C2COC2)c2nccn2n1 InChI=1S/C24H19F3N4O2/c1-14-5-6-18(29-23(32)15-3-2-4-17(9-15)24(25,26)27)10-19(14)21-11-20(16-12-33-13-16)22-28-7-8-31(22)30-21/h2-11,16H,12-13H2,1H3,(H,29,32) FRHQMEJWOTXICJ-UHFFFAOYSA-N 313263 N-(4-methyl-3-(8-(oxetan-3-yl)imidazo[1,2-b]pyridazin-6-yl)phenyl)-3-(trifluoromethyl)benzamide::US10167279, Example 6 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313263&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118949141 383540173 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605650 Cc1ncc(NC(=O)c2ccc(CO)c(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C24H21F3N2O3/c1-14-21(16-4-2-3-15(7-16)19-12-32-13-19)9-20(10-28-14)29-23(31)17-5-6-18(11-30)22(8-17)24(25,26)27/h2-10,19,30H,11-13H2,1H3,(H,29,31) JVPUDWMUUHFIJM-UHFFFAOYSA-N 313265 4-(hydroxymethyl)-N-(6-methyl-5-(oxetan-3-yl)phenyl)pyridin-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 7 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313265 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313265&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609699 383540175 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605651 Cc1ncc(NC(=O)c2ccc(CCl)c(c2)C(F)(F)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C25H22ClF3N2O2/c1-15-21(16-4-3-5-19(8-16)24(2)13-33-14-24)10-20(12-30-15)31-23(32)17-6-7-18(11-26)22(9-17)25(27,28)29/h3-10,12H,11,13-14H2,1-2H3,(H,31,32) MGIFFMMJXBHPBJ-UHFFFAOYSA-N 313266 4-(aminomethyl-N-(6-methyl-5-(3(3-methyloxetan-3-yl)phenyl)pyridin-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 8 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313266 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313266&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609358 383540176 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605652 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(C2COC2)c2nccn2n1 InChI=1S/C23H18F3N5O2/c1-13-18(20-9-19(15-11-33-12-15)21-27-5-6-31(21)30-20)8-17(10-28-13)29-22(32)14-3-2-4-16(7-14)23(24,25)26/h2-10,15H,11-12H2,1H3,(H,29,32) KPBQQHQQFZWVCC-UHFFFAOYSA-N 313267 N-(6-methyl-5-(8-(oxetan-3-yl)imidazo[1,2-b]pyridazin-6-yl)pyridin-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 9 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313267 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313267&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609454 383540177 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605653 Cc1ncc(NC(=O)c2ccc(CN)c(c2)C(F)(F)F)cc1-c1cc(C2COC2)c2nccn2n1 InChI=1S/C24H21F3N6O2/c1-13-18(21-8-19(16-11-35-12-16)22-29-4-5-33(22)32-21)7-17(10-30-13)31-23(34)14-2-3-15(9-28)20(6-14)24(25,26)27/h2-8,10,16H,9,11-12,28H2,1H3,(H,31,34) WWAWDTTXEXRRSK-UHFFFAOYSA-N 313269 4-(aminomethyl)-N-(6-methyl-5-(8-(oxetan-3-yl)imidazo[1,2-b]pyridazin-6-yl)pyridin-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 10 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313269&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609621 383540179 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605654 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(OC2CCOCC2)nn1)C1(C)COC1 InChI=1S/C27H27F3N4O4/c1-16-21(11-19(13-31-16)32-24(35)17-4-3-5-18(10-17)27(28,29)30)23-12-22(26(2)14-37-15-26)25(34-33-23)38-20-6-8-36-9-7-20/h3-5,10-13,20H,6-9,14-15H2,1-2H3,(H,32,35) FWDLDLNOXSEFPM-UHFFFAOYSA-N 313270 N-(6-methyl-5-(5-(3-methyloxetan-3-yl)-6-((tetrahydro-2H-pyran-4-yl)oxy)pyridazin-3-yl)pyridin-3-yl)-3-(trifluoromethylbenzamide::US10167279, Example 11 RAF proto-oncogene serine/threonine-protein kinase Human 600 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313270 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313270&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609524 383540180 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605655 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc(OS(=O)(=O)C(F)(F)F)c(c1)C1(O)COC1 InChI=1S/C24H20F5N3O6S/c1-13-3-4-16(32-20(33)14-5-6-30-19(8-14)22(2,25)26)9-17(13)15-7-18(23(34)11-37-12-23)21(31-10-15)38-39(35,36)24(27,28)29/h3-10,34H,11-12H2,1-2H3,(H,32,33) QMRUOJNWTRFUPF-UHFFFAOYSA-N 313275 2-(1,1-difluoroethyl)-N-(3-(6-(1,3-dimethyl-1H-pyrazol-4-yl)-5-(3-hydroxyoxetan-3-yl)pyridin-3-yl)-4-methylphenyl)isonicotinamide::US10167279, Example 12 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313275 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313275&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609561 383540183 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605656 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc(OCc2ccccc2)c(c1)C1(O)COC1 InChI=1S/C30H27F2N3O4/c1-19-8-9-23(35-27(36)21-10-11-33-26(13-21)29(2,31)32)14-24(19)22-12-25(30(37)17-38-18-30)28(34-15-22)39-16-20-6-4-3-5-7-20/h3-15,37H,16-18H2,1-2H3,(H,35,36) PHHLVOVOBWQTBL-UHFFFAOYSA-N 313276 2-(1,1-difluoroethyl)-N-(3-(5-(3-hydroxyoxetan-3-yl)-6-oxo-1,6-dihydropyridin-3-yl)-4-methylphenyl)isonicotinamide::US10167279, Example 13 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313276 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313276&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609423 383540184 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605657 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(c(OCCO)nn1)C1(C)COC1 InChI=1S/C24H23F3N4O4/c1-14-3-4-16(29-21(33)15-5-6-28-20(9-15)24(25,26)27)10-17(14)19-11-18(23(2)12-34-13-23)22(31-30-19)35-8-7-32/h3-6,9-11,32H,7-8,12-13H2,1-2H3,(H,29,33) DDXSLYGKJWGWRJ-UHFFFAOYSA-N 313279 N-(3-(6-(2-hydroxyethoxy)-5-(3-methyloxetan-3-yl)pyridazin-3-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide::US10167279, Example 14 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313279&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609705 383540187 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605658 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(Cl)nn1)C1(C)COC1 InChI=1S/C22H18ClF3N4O2/c1-12-16(18-8-17(19(23)30-29-18)21(2)10-32-11-21)7-15(9-27-12)28-20(31)13-4-3-5-14(6-13)22(24,25)26/h3-9H,10-11H2,1-2H3,(H,28,31) ZAVXUAYMDMTPHL-UHFFFAOYSA-N 313280 N-(6-methyl-5-(5-(3-methyloxetan-3-yl)-6-oxo-1,6-dihydropyridazin-3-yl)pyridin-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 15 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313280&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118948785 383540188 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605659 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(OCCO)nn1)C1(C)COC1 InChI=1S/C24H23F3N4O4/c1-14-18(20-10-19(23(2)12-34-13-23)22(31-30-20)35-7-6-32)9-17(11-28-14)29-21(33)15-4-3-5-16(8-15)24(25,26)27/h3-5,8-11,32H,6-7,12-13H2,1-2H3,(H,29,33) BLQNDVARNNJNRY-UHFFFAOYSA-N 313282 N-(5-(6-(2-hydroxyethoxy)-5-(3-methyloxetan-3-yl)pyridazin-3-yl)-6-methylpyridin-3-yl)-3-(trifluoromethyl)benzamide::US10167279, Example 16 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313282&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609394 383540190 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605660 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1ccnc(c1)C(F)(F)F InChI=1S/C23H20F3N3O4/c1-13-3-4-14(20(30)29-16-5-6-27-19(9-16)23(24,25)26)7-17(13)15-8-18(21(32-2)28-10-15)22(31)11-33-12-22/h3-10,31H,11-12H2,1-2H3,(H,27,29,30) YHBNKPYCVWEXJA-UHFFFAOYSA-N 313283 3-(5-(3-hydroxyoxetan-3-yl)-6-methoxypyridin-3-yl)-4-methyl-N-(2-(trifluoromethyl)pyridin-4-yl)benzamide::US10167279, Example 17 RAF proto-oncogene serine/threonine-protein kinase Human 700 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313283&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118948654 383540191 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605661 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1cccc(c1)C(F)F InChI=1S/C24H22F2N2O4/c1-14-6-7-16(22(29)28-18-5-3-4-15(8-18)21(25)26)9-19(14)17-10-20(23(31-2)27-11-17)24(30)12-32-13-24/h3-11,21,30H,12-13H2,1-2H3,(H,28,29) BEEUUPGEUAELJF-UHFFFAOYSA-N 313284 N-(3-(difluoromethyl)phenyl)-3-(5-(3-hydroxyoxetan-3-yl)-6-methoxypyridin-3-yl)-4-methylbenzamide::US10167279, Example 18 RAF proto-oncogene serine/threonine-protein kinase Human 600 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313284&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118948784 383540192 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605662 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(cc(n2)C(C)(C)N)C(F)(F)F)ccc1C InChI=1S/C26H27F3N4O4/c1-14-5-6-17(10-18(14)15-7-19(23(36-4)31-11-15)25(35)12-37-13-25)32-22(34)20-8-16(26(27,28)29)9-21(33-20)24(2,3)30/h5-11,35H,12-13,30H2,1-4H3,(H,32,34) NBWMAYNCBZUBNZ-UHFFFAOYSA-N 313285 6-(2-aminopropan-2-yl)-N-(3-(5-(3-hydroxyoxetan-3-yl)-6-m ethoxypyridin-3-yl)-4-methylphenyl)-4-(trifluoromethyl)picolinamide::US10167279, Example 19 RAF proto-oncogene serine/threonine-protein kinase Human 7000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313285&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609376 383540193 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605663 COc1cc(cc(c1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C)C1COC1 InChI=1S/C24H21F3N2O3/c1-14-22(17-6-16(18-12-32-13-18)8-21(9-17)31-2)10-20(11-28-14)29-23(30)15-4-3-5-19(7-15)24(25,26)27/h3-11,18H,12-13H2,1-2H3,(H,29,30) FGZCWEHMBQEQEG-UHFFFAOYSA-N 313287 N-(5-(3-methoxy-5- (oxetan-3-yl)phenyl)-6- methylpyridin-3-yl)-3- (trifluoromethyl)- benzamide::US10167279, Example 20 RAF proto-oncogene serine/threonine-protein kinase Human 628 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313287&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609595 383540195 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605664 COc1cc(cc(c1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C)C1COC1 InChI=1S/C24H21F3N2O3/c1-14-22(17-6-16(18-12-32-13-18)8-21(9-17)31-2)10-20(11-28-14)29-23(30)15-4-3-5-19(7-15)24(25,26)27/h3-11,18H,12-13H2,1-2H3,(H,29,30) FGZCWEHMBQEQEG-UHFFFAOYSA-N 313287 N-(5-(3-methoxy-5- (oxetan-3-yl)phenyl)-6- methylpyridin-3-yl)-3- (trifluoromethyl)- benzamide::US10167279, Example 20 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 6883 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313287&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609595 383540195 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605665 COc1cc(cc(c1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)ccc1C)C1COC1 InChI=1S/C25H22F3NO3/c1-15-6-7-21(29-24(30)16-4-3-5-20(9-16)25(26,27)28)12-23(15)18-8-17(19-13-32-14-19)10-22(11-18)31-2/h3-12,19H,13-14H2,1-2H3,(H,29,30) LWHMHWZBAZYQLL-UHFFFAOYSA-N 313289 N-(3'-methoxy-6- methyl-5'-(oxetan-3-yl)- [1,1'-biphenyl-3-yl)-3- (trifluoromethyl)- benzamide::US10167279, Example 21 RAF proto-oncogene serine/threonine-protein kinase Human 373 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313289&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133624 383540197 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605666 COc1cc(cc(c1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)ccc1C)C1COC1 InChI=1S/C25H22F3NO3/c1-15-6-7-21(29-24(30)16-4-3-5-20(9-16)25(26,27)28)12-23(15)18-8-17(19-13-32-14-19)10-22(11-18)31-2/h3-12,19H,13-14H2,1-2H3,(H,29,30) LWHMHWZBAZYQLL-UHFFFAOYSA-N 313289 N-(3'-methoxy-6- methyl-5'-(oxetan-3-yl)- [1,1'-biphenyl-3-yl)-3- (trifluoromethyl)- benzamide::US10167279, Example 21 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2728 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313289&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133624 383540197 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605667 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C23H19F3N2O2/c1-14-21(16-5-2-4-15(8-16)18-12-30-13-18)10-20(11-27-14)28-22(29)17-6-3-7-19(9-17)23(24,25)26/h2-11,18H,12-13H2,1H3,(H,28,29) FXNXFVFPIIFJDM-UHFFFAOYSA-N 313290 N-(6-methyl-5-(3- (oxetan-3- yl)phenyl)pyridin-2-yl)- 3-(trifluoromethyl)- benzamide::US10167279, Example 24::US10167279, Example 22 RAF proto-oncogene serine/threonine-protein kinase Human 595 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313290&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133690 383540198 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605668 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C23H19F3N2O2/c1-14-21(16-5-2-4-15(8-16)18-12-30-13-18)10-20(11-27-14)28-22(29)17-6-3-7-19(9-17)23(24,25)26/h2-11,18H,12-13H2,1H3,(H,28,29) FXNXFVFPIIFJDM-UHFFFAOYSA-N 313290 N-(6-methyl-5-(3- (oxetan-3- yl)phenyl)pyridin-2-yl)- 3-(trifluoromethyl)- benzamide::US10167279, Example 24::US10167279, Example 22 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3764 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313290&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133690 383540198 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605669 COc1cc(cc(c1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C)C1COC1 InChI=1S/C27H27N3O3/c1-17-5-6-22(30-26(31)18-7-8-29-25(12-18)27(2,3)16-28)13-24(17)20-9-19(21-14-33-15-21)10-23(11-20)32-4/h5-13,21H,14-15H2,1-4H3,(H,30,31) YEAKSBWYJCTXFP-UHFFFAOYSA-N 313291 2-(2-cyanopropan-2-yl)- N-(3'-methoxy-6- methyl-5'-(oxetan-3-yl)- [1,1'-biphenyl]-3- yl)isonicotinamide::US10167279, Example 23 RAF proto-oncogene serine/threonine-protein kinase Human 25000340 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313291&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609550 383540199 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605670 COc1cc(cc(c1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C)C1COC1 InChI=1S/C27H27N3O3/c1-17-5-6-22(30-26(31)18-7-8-29-25(12-18)27(2,3)16-28)13-24(17)20-9-19(21-14-33-15-21)10-23(11-20)32-4/h5-13,21H,14-15H2,1-4H3,(H,30,31) YEAKSBWYJCTXFP-UHFFFAOYSA-N 313291 2-(2-cyanopropan-2-yl)- N-(3'-methoxy-6- methyl-5'-(oxetan-3-yl)- [1,1'-biphenyl]-3- yl)isonicotinamide::US10167279, Example 23 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 25000340 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313291&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609550 383540199 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605671 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C23H19F3N2O2/c1-14-21(16-5-2-4-15(8-16)18-12-30-13-18)10-20(11-27-14)28-22(29)17-6-3-7-19(9-17)23(24,25)26/h2-11,18H,12-13H2,1H3,(H,28,29) FXNXFVFPIIFJDM-UHFFFAOYSA-N 313290 N-(6-methyl-5-(3- (oxetan-3- yl)phenyl)pyridin-2-yl)- 3-(trifluoromethyl)- benzamide::US10167279, Example 24::US10167279, Example 22 RAF proto-oncogene serine/threonine-protein kinase Human 455 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313290&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133690 383540198 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605672 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C23H19F3N2O2/c1-14-21(16-5-2-4-15(8-16)18-12-30-13-18)10-20(11-27-14)28-22(29)17-6-3-7-19(9-17)23(24,25)26/h2-11,18H,12-13H2,1H3,(H,28,29) FXNXFVFPIIFJDM-UHFFFAOYSA-N 313290 N-(6-methyl-5-(3- (oxetan-3- yl)phenyl)pyridin-2-yl)- 3-(trifluoromethyl)- benzamide::US10167279, Example 24::US10167279, Example 22 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3521 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313290&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133690 383540198 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605673 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C25H22F3NO2/c1-16-9-10-21(29-23(30)18-6-4-8-20(12-18)25(26,27)28)13-22(16)17-5-3-7-19(11-17)24(2)14-31-15-24/h3-13H,14-15H2,1-2H3,(H,29,30) PBZIVNRGIYOENS-UHFFFAOYSA-N 313297 N-(6-methyl-3'-(3- methyloxetan-3-yl)- [1,1'-biphenyl]-3-yl)-3- (trifluoromethyl)benz- amide::US10167279, Example 25 RAF proto-oncogene serine/threonine-protein kinase Human 154 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313297&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609572 383540204 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605674 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C25H22F3NO2/c1-16-9-10-21(29-23(30)18-6-4-8-20(12-18)25(26,27)28)13-22(16)17-5-3-7-19(11-17)24(2)14-31-15-24/h3-13H,14-15H2,1-2H3,(H,29,30) PBZIVNRGIYOENS-UHFFFAOYSA-N 313297 N-(6-methyl-3'-(3- methyloxetan-3-yl)- [1,1'-biphenyl]-3-yl)-3- (trifluoromethyl)benz- amide::US10167279, Example 25 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 870 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313297 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313297&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609572 383540204 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605675 Cc1ccc(cc1-c1cccc(c1)C1(C)COC1)C(=O)Nc1cccc(c1)C(F)(F)F InChI=1S/C25H22F3NO2/c1-16-9-10-18(23(30)29-21-8-4-7-20(13-21)25(26,27)28)12-22(16)17-5-3-6-19(11-17)24(2)14-31-15-24/h3-13H,14-15H2,1-2H3,(H,29,30) LUELUUNUMMYFRK-UHFFFAOYSA-N 313299 6-methyl-3'-(3- methyloxetan-3-yl)-N- (3- (trifluoromethyl)phenyl)- [1,1'-biphenyl]-3- carboxamide::US10167279, Example 26 RAF proto-oncogene serine/threonine-protein kinase Human 372 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313299&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609365 383540206 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605676 Cc1ccc(cc1-c1cccc(c1)C1(C)COC1)C(=O)Nc1cccc(c1)C(F)(F)F InChI=1S/C25H22F3NO2/c1-16-9-10-18(23(30)29-21-8-4-7-20(13-21)25(26,27)28)12-22(16)17-5-3-6-19(11-17)24(2)14-31-15-24/h3-13H,14-15H2,1-2H3,(H,29,30) LUELUUNUMMYFRK-UHFFFAOYSA-N 313299 6-methyl-3'-(3- methyloxetan-3-yl)-N- (3- (trifluoromethyl)phenyl)- [1,1'-biphenyl]-3- carboxamide::US10167279, Example 26 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2298 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313299 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313299&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609365 383540206 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605677 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C27H27N3O2/c1-18-8-9-22(30-25(31)20-10-11-29-24(13-20)26(2,3)15-28)14-23(18)19-6-5-7-21(12-19)27(4)16-32-17-27/h5-14H,16-17H2,1-4H3,(H,30,31) RVARZTCIJZHBPC-UHFFFAOYSA-N 313300 2-(2-cyanopropan-2-yl)- N-(6-methyl-3'-(3- methyloxetan-3-yl)- [1,1'-biphenyl]-3- yl)isonicotinamide::US10167279, Example 27 RAF proto-oncogene serine/threonine-protein kinase Human 262951 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313300&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609580 383540207 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605678 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C27H27N3O2/c1-18-8-9-22(30-25(31)20-10-11-29-24(13-20)26(2,3)15-28)14-23(18)19-6-5-7-21(12-19)27(4)16-32-17-27/h5-14H,16-17H2,1-4H3,(H,30,31) RVARZTCIJZHBPC-UHFFFAOYSA-N 313300 2-(2-cyanopropan-2-yl)- N-(6-methyl-3'-(3- methyloxetan-3-yl)- [1,1'-biphenyl]-3- yl)isonicotinamide::US10167279, Example 27 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1210945 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313300 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313300&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609580 383540207 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605679 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cccc(c1)C1COC1 InChI=1S/C26H25N3O2/c1-17-7-8-22(13-23(17)19-6-4-5-18(11-19)21-14-31-15-21)29-25(30)20-9-10-28-24(12-20)26(2,3)16-27/h4-13,21H,14-15H2,1-3H3,(H,29,30) FCQUZDXKIQUFJI-UHFFFAOYSA-N 313301 2-(2-cyanopropan-2-yl)- N-(6-methyl-3'-(oxetan- 3-yl)-[1,1'-biphenyl]-3- yl)isonicotinamide::US10167279, Example 28 RAF proto-oncogene serine/threonine-protein kinase Human 25000340 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313301&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609551 383540208 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605680 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cccc(c1)C1COC1 InChI=1S/C26H25N3O2/c1-17-7-8-22(13-23(17)19-6-4-5-18(11-19)21-14-31-15-21)29-25(30)20-9-10-28-24(12-20)26(2,3)16-27/h4-13,21H,14-15H2,1-3H3,(H,29,30) FCQUZDXKIQUFJI-UHFFFAOYSA-N 313301 2-(2-cyanopropan-2-yl)- N-(6-methyl-3'-(oxetan- 3-yl)-[1,1'-biphenyl]-3- yl)isonicotinamide::US10167279, Example 28 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 25000340 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313301 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313301&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609551 383540208 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605681 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(c2nccn2n1)C1(C)COC1 InChI=1S/C27H26N6O2/c1-17-5-6-19(31-25(34)18-7-8-29-23(11-18)26(2,3)14-28)12-20(17)22-13-21(27(4)15-35-16-27)24-30-9-10-33(24)32-22/h5-13H,15-16H2,1-4H3,(H,31,34) WAPHUDZFZIETDY-UHFFFAOYSA-N 313302 2-(2-cyanopropan-2-yl)- N-(4-methyl-3-(8-(3- methyloxetan-3- yl)imidazo[1,2- b]pyridazin-6- yl)phenyl)isonicotinamide::US10167279, Example 29 RAF proto-oncogene serine/threonine-protein kinase Human 637 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313302&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609695 383540209 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605682 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(c2nccn2n1)C1(C)COC1 InChI=1S/C27H26N6O2/c1-17-5-6-19(31-25(34)18-7-8-29-23(11-18)26(2,3)14-28)12-20(17)22-13-21(27(4)15-35-16-27)24-30-9-10-33(24)32-22/h5-13H,15-16H2,1-4H3,(H,31,34) WAPHUDZFZIETDY-UHFFFAOYSA-N 313302 2-(2-cyanopropan-2-yl)- N-(4-methyl-3-(8-(3- methyloxetan-3- yl)imidazo[1,2- b]pyridazin-6- yl)phenyl)isonicotinamide::US10167279, Example 29 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 4947 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313302 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313302&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609695 383540209 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605683 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C26H25FN4O3/c1-16-5-6-19(31-23(32)17-7-8-29-22(10-17)25(2,3)13-28)11-20(16)18-9-21(24(33-4)30-12-18)26(27)14-34-15-26/h5-12H,14-15H2,1-4H3,(H,31,32) MUHJLBFFIXVCKK-UHFFFAOYSA-N 313303 2-(2-cyanopropan-2-yl)- N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 30 RAF proto-oncogene serine/threonine-protein kinase Human 229 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313303&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609549 383540210 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605684 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C26H25FN4O3/c1-16-5-6-19(31-23(32)17-7-8-29-22(10-17)25(2,3)13-28)11-20(16)18-9-21(24(33-4)30-12-18)26(27)14-34-15-26/h5-12H,14-15H2,1-4H3,(H,31,32) MUHJLBFFIXVCKK-UHFFFAOYSA-N 313303 2-(2-cyanopropan-2-yl)- N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 30 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1297 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313303 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313303&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609549 383540210 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605685 CCOc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C28H29FN4O3/c1-5-36-26-23(28(14-29)16-35-17-28)10-20(13-32-26)22-12-21(7-6-18(22)2)33-25(34)19-8-9-31-24(11-19)27(3,4)15-30/h6-13H,5,14,16-17H2,1-4H3,(H,33,34) KLYLLRQQDAMWTR-UHFFFAOYSA-N 313307 2-(2-cyanopropan-2-yl)- N-(3-(6-ethoxy-5-(3- (fluoromethyl)oxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 31 RAF proto-oncogene serine/threonine-protein kinase Human 157 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313307 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313307&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133623 383540214 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605686 CCOc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C28H29FN4O3/c1-5-36-26-23(28(14-29)16-35-17-28)10-20(13-32-26)22-12-21(7-6-18(22)2)33-25(34)19-8-9-31-24(11-19)27(3,4)15-30/h6-13H,5,14,16-17H2,1-4H3,(H,33,34) KLYLLRQQDAMWTR-UHFFFAOYSA-N 313307 2-(2-cyanopropan-2-yl)- N-(3-(6-ethoxy-5-(3- (fluoromethyl)oxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 31 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 446 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313307 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313307&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133623 383540214 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605687 CCOc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H28F2N4O3/c1-5-35-24-21(26(13-27)14-34-15-26)8-18(11-31-24)20-10-19(12-30-16(20)2)32-23(33)17-6-7-29-22(9-17)25(3,4)28/h6-12H,5,13-15H2,1-4H3,(H,32,33) UZEWNQQQGQUITO-UHFFFAOYSA-N 313313 N-(6''-ethoxy-5''-(3- (fluoromethyl)oxetan-3- yl)-2-methyl-[3,3''- bipyridin]-5-yl)-2-(2- fluoropropan-2- yl)isonicotinamide::US10167279, Example 131::US10167279, Example 32 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313313&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609619 383540219 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605688 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C30H32N4O5/c1-19-4-5-22(34-27(35)20-6-9-32-26(13-20)29(2,3)16-31)14-24(19)21-12-25(30(36)17-38-18-30)28(33-15-21)39-23-7-10-37-11-8-23/h4-6,9,12-15,23,36H,7-8,10-11,17-18H2,1-3H3,(H,34,35) LXFWRJRUBAPZCY-UHFFFAOYSA-N 313314 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- ((tetrahydro-2H-pyran- 4-yl)oxy)pyridin-3-yl)- 4- methylphenyl)isonicotin- amide::US10167279, Example 33 RAF proto-oncogene serine/threonine-protein kinase Human 804 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313314&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609602 383540220 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605689 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C30H32N4O5/c1-19-4-5-22(34-27(35)20-6-9-32-26(13-20)29(2,3)16-31)14-24(19)21-12-25(30(36)17-38-18-30)28(33-15-21)39-23-7-10-37-11-8-23/h4-6,9,12-15,23,36H,7-8,10-11,17-18H2,1-3H3,(H,34,35) LXFWRJRUBAPZCY-UHFFFAOYSA-N 313314 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- ((tetrahydro-2H-pyran- 4-yl)oxy)pyridin-3-yl)- 4- methylphenyl)isonicotin- amide::US10167279, Example 33 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2136 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313314 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313314&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609602 383540220 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605690 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C29H31N5O5/c1-18-23(12-21(14-32-18)34-26(35)19-4-7-31-25(11-19)28(2,3)15-30)20-10-24(29(36)16-38-17-29)27(33-13-20)39-22-5-8-37-9-6-22/h4,7,10-14,22,36H,5-6,8-9,16-17H2,1-3H3,(H,34,35) DUOKLAQCAJTSSK-UHFFFAOYSA-N 313315 2-(2-cyanopropan-2-yl)- N-(5'-(3-hydroxyoxetan- 3-yl)-2-methyl-6'- ((tetrahydro-2H-pyran- 4-yl)oxy)-[3,3'- bipyridin]-5- yl)isonicotinamide::US10167279, Example 34 RAF proto-oncogene serine/threonine-protein kinase Human 7627 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313315&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609611 383540221 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605691 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C29H31N5O5/c1-18-23(12-21(14-32-18)34-26(35)19-4-7-31-25(11-19)28(2,3)15-30)20-10-24(29(36)16-38-17-29)27(33-13-20)39-22-5-8-37-9-6-22/h4,7,10-14,22,36H,5-6,8-9,16-17H2,1-3H3,(H,34,35) DUOKLAQCAJTSSK-UHFFFAOYSA-N 313315 2-(2-cyanopropan-2-yl)- N-(5'-(3-hydroxyoxetan- 3-yl)-2-methyl-6'- ((tetrahydro-2H-pyran- 4-yl)oxy)-[3,3'- bipyridin]-5- yl)isonicotinamide::US10167279, Example 34 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 20480 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313315&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609611 383540221 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605692 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C27H26F3N3O5/c1-16-2-3-19(33-24(34)17-4-7-31-23(11-17)27(28,29)30)12-21(16)18-10-22(26(35)14-37-15-26)25(32-13-18)38-20-5-8-36-9-6-20/h2-4,7,10-13,20,35H,5-6,8-9,14-15H2,1H3,(H,33,34) YJYPRLFGAJUDER-UHFFFAOYSA-N 313317 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- ((tetrahydro-2H-pyran- 4-yl)oxy)pyridin-3-yl)- 4-methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 35 RAF proto-oncogene serine/threonine-protein kinase Human 297 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313317 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313317&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609647 383540223 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605693 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C27H26F3N3O5/c1-16-2-3-19(33-24(34)17-4-7-31-23(11-17)27(28,29)30)12-21(16)18-10-22(26(35)14-37-15-26)25(32-13-18)38-20-5-8-36-9-6-20/h2-4,7,10-13,20,35H,5-6,8-9,14-15H2,1H3,(H,33,34) YJYPRLFGAJUDER-UHFFFAOYSA-N 313317 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- ((tetrahydro-2H-pyran- 4-yl)oxy)pyridin-3-yl)- 4-methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 35 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 966 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313317 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313317&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609647 383540223 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605694 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OCCO)c(c1)C1(O)COC1 InChI=1S/C24H22F3N3O5/c1-14-19(16-8-20(23(33)12-34-13-23)22(29-10-16)35-6-5-31)9-18(11-28-14)30-21(32)15-3-2-4-17(7-15)24(25,26)27/h2-4,7-11,31,33H,5-6,12-13H2,1H3,(H,30,32) PIILVYHHFKHLER-UHFFFAOYSA-N 313318 N-(6'-(2- hydroxyethoxy)-5'-(3- hydroxyoxetan-3-yl)-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 36 RAF proto-oncogene serine/threonine-protein kinase Human 1838 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313318 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313318&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609388 383540224 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605695 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OCCO)c(c1)C1(O)COC1 InChI=1S/C24H22F3N3O5/c1-14-19(16-8-20(23(33)12-34-13-23)22(29-10-16)35-6-5-31)9-18(11-28-14)30-21(32)15-3-2-4-17(7-15)24(25,26)27/h2-4,7-11,31,33H,5-6,12-13H2,1H3,(H,30,32) PIILVYHHFKHLER-UHFFFAOYSA-N 313318 N-(6'-(2- hydroxyethoxy)-5'-(3- hydroxyoxetan-3-yl)-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 36 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 11992 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313318 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313318&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609388 383540224 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605696 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C24H21F4N3O4/c1-14-19(16-8-20(23(25)12-34-13-23)22(30-10-16)35-6-5-32)9-18(11-29-14)31-21(33)15-3-2-4-17(7-15)24(26,27)28/h2-4,7-11,32H,5-6,12-13H2,1H3,(H,31,33) BCRITNOMXRPKQD-UHFFFAOYSA-N 313319 N-(5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 37 RAF proto-oncogene serine/threonine-protein kinase Human 354 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313319&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609730 383540225 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605697 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C24H21F4N3O4/c1-14-19(16-8-20(23(25)12-34-13-23)22(30-10-16)35-6-5-32)9-18(11-29-14)31-21(33)15-3-2-4-17(7-15)24(26,27)28/h2-4,7-11,32H,5-6,12-13H2,1H3,(H,31,33) BCRITNOMXRPKQD-UHFFFAOYSA-N 313319 N-(5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 37 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1851 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313319&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609730 383540225 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605698 Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C23H20F4N4O4/c1-13-17(15-6-18(22(24)11-34-12-22)21(30-9-15)35-5-4-32)8-16(10-29-13)31-20(33)14-2-3-28-19(7-14)23(25,26)27/h2-3,6-10,32H,4-5,11-12H2,1H3,(H,31,33) BAOHJEZOMBIUDX-UHFFFAOYSA-N 313320 N-(5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 38 RAF proto-oncogene serine/threonine-protein kinase Human 729 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313320 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313320&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609721 383540226 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605699 Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C23H20F4N4O4/c1-13-17(15-6-18(22(24)11-34-12-22)21(30-9-15)35-5-4-32)8-16(10-29-13)31-20(33)14-2-3-28-19(7-14)23(25,26)27/h2-3,6-10,32H,4-5,11-12H2,1H3,(H,31,33) BAOHJEZOMBIUDX-UHFFFAOYSA-N 313320 N-(5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 38 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 4838 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313320 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313320&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609721 383540226 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605700 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C24H23F3N4O4/c1-14-18(16-7-19(24(27)12-34-13-24)22(30-10-16)35-6-5-32)9-17(11-29-14)31-21(33)15-3-4-28-20(8-15)23(2,25)26/h3-4,7-11,32H,5-6,12-13H2,1-2H3,(H,31,33) NFNDDLQHGULDGM-UHFFFAOYSA-N 313321 7-(1,1-difluoroethyl)-N- (5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)isonotinamide::US10167279, Example 39 RAF proto-oncogene serine/threonine-protein kinase Human 1174 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313321 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313321&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133708 383540227 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605701 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C24H23F3N4O4/c1-14-18(16-7-19(24(27)12-34-13-24)22(30-10-16)35-6-5-32)9-17(11-29-14)31-21(33)15-3-4-28-20(8-15)23(2,25)26/h3-4,7-11,32H,5-6,12-13H2,1-2H3,(H,31,33) NFNDDLQHGULDGM-UHFFFAOYSA-N 313321 7-(1,1-difluoroethyl)-N- (5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)isonotinamide::US10167279, Example 39 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 5900 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313321 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313321&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133708 383540227 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605702 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C25H26F2N4O4/c1-15-19(17-8-20(25(27)13-34-14-25)23(30-11-17)35-7-6-32)10-18(12-29-15)31-22(33)16-4-5-28-21(9-16)24(2,3)26/h4-5,8-12,32H,6-7,13-14H2,1-3H3,(H,31,33) XKKQDSSFPIARNV-UHFFFAOYSA-N 313322 N-(5'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 40 RAF proto-oncogene serine/threonine-protein kinase Human 3472 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313322 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313322&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609442 383540228 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605703 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cnc(OCCO)c(c1)C1(F)COC1 InChI=1S/C26H27F2N3O4/c1-16-4-5-19(31-23(33)17-6-7-29-22(11-17)25(2,3)27)12-20(16)18-10-21(26(28)14-34-15-26)24(30-13-18)35-9-8-32/h4-7,10-13,32H,8-9,14-15H2,1-3H3,(H,31,33) TXKYMVOKGCIMRU-UHFFFAOYSA-N 313323 N-(3-(5-(3-fluorooxetan- 3-yl)-6-(2- hydroxyethoxy)pyridin- 3-yl)-4-methylphenyl)- 2-(2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 41 RAF proto-oncogene serine/threonine-protein kinase Human 245 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313323 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313323&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609355 383540229 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605704 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C25H25F3N4O3/c1-14-18(16-7-19(22(34-4)31-10-16)25(23(26)27)12-35-13-25)9-17(11-30-14)32-21(33)15-5-6-29-20(8-15)24(2,3)28/h5-11,23H,12-13H2,1-4H3,(H,32,33) IEVVIZVQENGLAX-UHFFFAOYSA-N 313324 N-(5'-(3- (difluoromethyl)oxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 42 RAF proto-oncogene serine/threonine-protein kinase Human 243 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313324 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313324&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609584 383540230 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605705 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C25H25F3N4O3/c1-14-18(16-7-19(22(34-4)31-10-16)25(23(26)27)12-35-13-25)9-17(11-30-14)32-21(33)15-5-6-29-20(8-15)24(2,3)28/h5-11,23H,12-13H2,1-4H3,(H,32,33) IEVVIZVQENGLAX-UHFFFAOYSA-N 313324 N-(5'-(3- (difluoromethyl)oxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 42 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1421 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313324 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313324&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609584 383540230 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605706 COc1ncc(cc1C1(COC1)C=O)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C27H26N4O4/c1-17-5-6-20(31-24(33)18-7-8-29-23(10-18)26(2,3)13-28)11-21(17)19-9-22(25(34-4)30-12-19)27(14-32)15-35-16-27/h5-12,14H,15-16H2,1-4H3,(H,31,33) LZLXCWZZYYKQQM-UHFFFAOYSA-N 313325 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- formyloxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 43 RAF proto-oncogene serine/threonine-protein kinase Human 2672 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313325&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609379 383540231 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605707 COc1ncc(cc1C1(COC1)C=O)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C27H26N4O4/c1-17-5-6-20(31-24(33)18-7-8-29-23(10-18)26(2,3)13-28)11-21(17)19-9-22(25(34-4)30-12-19)27(14-32)15-35-16-27/h5-12,14H,15-16H2,1-4H3,(H,31,33) LZLXCWZZYYKQQM-UHFFFAOYSA-N 313325 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- formyloxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 43 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 10228 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313325&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609379 383540231 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605708 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(=O)n(CCCO)c1)C1(F)COC1 InChI=1S/C25H23F4N3O4/c1-15-20(17-9-21(24(26)13-36-14-24)23(35)32(12-17)6-3-7-33)10-19(11-30-15)31-22(34)16-4-2-5-18(8-16)25(27,28)29/h2,4-5,8-12,33H,3,6-7,13-14H2,1H3,(H,31,34) FRKSLJSPQVGZID-UHFFFAOYSA-N 313326 N-(5'-(3-fluorooxetan-3- yl)-1'-(3- hydroxypropyl)-2- methyl-6'-oxo-1',6'- dihydro-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 44 RAF proto-oncogene serine/threonine-protein kinase Human 8628 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313326 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313326&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609531 383540232 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605709 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(=O)n(CCCO)c1)C1(F)COC1 InChI=1S/C25H23F4N3O4/c1-15-20(17-9-21(24(26)13-36-14-24)23(35)32(12-17)6-3-7-33)10-19(11-30-15)31-22(34)16-4-2-5-18(8-16)25(27,28)29/h2,4-5,8-12,33H,3,6-7,13-14H2,1H3,(H,31,34) FRKSLJSPQVGZID-UHFFFAOYSA-N 313326 N-(5'-(3-fluorooxetan-3- yl)-1'-(3- hydroxypropyl)-2- methyl-6'-oxo-1',6'- dihydro-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 44 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 67935 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313326 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313326&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609531 383540232 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605710 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(=O)n(CC(O)CO)c1)C1(F)COC1 InChI=1S/C25H23F4N3O5/c1-14-20(7-18(8-30-14)31-22(35)15-3-2-4-17(5-15)25(27,28)29)16-6-21(24(26)12-37-13-24)23(36)32(9-16)10-19(34)11-33/h2-9,19,33-34H,10-13H2,1H3,(H,31,35) IUXCLFXBQANTMZ-UHFFFAOYSA-N 313327 N-(1'-(2,3- dihydroxypropyl)-5'-(3- fluorooxetan-3-yl)-2- methyl-6'-oxo-1',6'- dihydro-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 45 RAF proto-oncogene serine/threonine-protein kinase Human 120579 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313327 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313327&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609562 383540233 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605711 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(=O)n(CC(O)CO)c1)C1(F)COC1 InChI=1S/C25H23F4N3O5/c1-14-20(7-18(8-30-14)31-22(35)15-3-2-4-17(5-15)25(27,28)29)16-6-21(24(26)12-37-13-24)23(36)32(9-16)10-19(34)11-33/h2-9,19,33-34H,10-13H2,1H3,(H,31,35) IUXCLFXBQANTMZ-UHFFFAOYSA-N 313327 N-(1'-(2,3- dihydroxypropyl)-5'-(3- fluorooxetan-3-yl)-2- methyl-6'-oxo-1',6'- dihydro-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 45 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1178656 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313327 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313327&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609562 383540233 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605712 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(c(=O)n(CCO)c1)C1(F)COC1 InChI=1S/C24H21F4N3O4/c1-14-19(16-8-20(23(25)12-35-13-23)22(34)31(11-16)5-6-32)9-18(10-29-14)30-21(33)15-3-2-4-17(7-15)24(26,27)28/h2-4,7-11,32H,5-6,12-13H2,1H3,(H,30,33) QXYPNSBHPKVVNE-UHFFFAOYSA-N 313328 N-(5'-(3-fluorooxetan-3- yl)-1'-(2-hydroxyethyl)- 2-methyl-6'-oxo-1',6'- dihydro-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 46 RAF proto-oncogene serine/threonine-protein kinase Human 51538 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313328 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313328&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609366 383540234 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605713 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(cc(OCCO)n1)C1(F)COC1 InChI=1S/C24H21F4N3O4/c1-14-2-3-17(30-22(33)15-4-5-29-20(8-15)24(26,27)28)11-18(14)19-9-16(23(25)12-34-13-23)10-21(31-19)35-7-6-32/h2-5,8-11,32H,6-7,12-13H2,1H3,(H,30,33) IMIRKBJHNZXUEP-UHFFFAOYSA-N 313329 N-(3-(4-(3-fluorooxetan- 3-yl)-6-(2- hydroxyethoxy)pyridin- 2-yl)-4-methylphenyl)- 2- (trifluoromethyl)isonicotin- amide::US10167279, Example 47 RAF proto-oncogene serine/threonine-protein kinase Human 4348 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313329&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609680 383540235 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605714 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(cc(OCCO)n1)C1(F)COC1 InChI=1S/C25H26F2N4O4/c1-15-19(20-9-17(25(27)13-34-14-25)10-22(31-20)35-7-6-32)11-18(12-29-15)30-23(33)16-4-5-28-21(8-16)24(2,3)26/h4-5,8-12,32H,6-7,13-14H2,1-3H3,(H,30,33) OQDYHDSBBSXUQO-UHFFFAOYSA-N 313330 N-(4-(3-fluorooxetan-3- yl)-6-(2- hydroxyethoxy)-2'- methyl-[2,3'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 48 RAF proto-oncogene serine/threonine-protein kinase Human 7527 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313330 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313330&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133739 383540236 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605715 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C24H21F4N3O3/c1-14-19(16-7-20(22(33-2)30-9-16)23(11-25)12-34-13-23)8-18(10-29-14)31-21(32)15-4-3-5-17(6-15)24(26,27)28/h3-10H,11-13H2,1-2H3,(H,31,32) DQCYVISJQPXSEI-UHFFFAOYSA-N 313333 N-(5'-(3- (fluoromethyl)oxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 49 RAF proto-oncogene serine/threonine-protein kinase Human 118 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313333&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609711 383540239 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605716 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C24H21F4N3O3/c1-14-19(16-7-20(22(33-2)30-9-16)23(11-25)12-34-13-23)8-18(10-29-14)31-21(32)15-4-3-5-17(6-15)24(26,27)28/h3-10H,11-13H2,1-2H3,(H,31,32) DQCYVISJQPXSEI-UHFFFAOYSA-N 313333 N-(5'-(3- (fluoromethyl)oxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 49 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 469 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313333&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609711 383540239 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605717 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(OCCO)nc(c1)C1(F)COC1 InChI=1S/C25H26F2N4O4/c1-15-19(17-9-21(25(27)13-34-14-25)31-22(10-17)35-7-6-32)11-18(12-29-15)30-23(33)16-4-5-28-20(8-16)24(2,3)26/h4-5,8-12,32H,6-7,13-14H2,1-3H3,(H,30,33) UGVPDRNMMXUHTG-UHFFFAOYSA-N 313334 N-(2'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,4'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 50 RAF proto-oncogene serine/threonine-protein kinase Human 3290 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313334&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609727 383540240 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605718 Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(F)COC1 InChI=1S/C23H20F4N4O4/c1-13-17(15-7-18(22(24)11-34-12-22)31-20(8-15)35-5-4-32)9-16(10-29-13)30-21(33)14-2-3-28-19(6-14)23(25,26)27/h2-3,6-10,32H,4-5,11-12H2,1H3,(H,30,33) UIXLOJHDNRFIHI-UHFFFAOYSA-N 313380 N-(2'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,4'-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 51 RAF proto-oncogene serine/threonine-protein kinase Human 2792 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313380&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609527 383540281 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605719 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(F)COC1 InChI=1S/C24H21F4N3O4/c1-14-19(16-8-20(23(25)12-34-13-23)31-21(9-16)35-6-5-32)10-18(11-29-14)30-22(33)15-3-2-4-17(7-15)24(26,27)28/h2-4,7-11,32H,5-6,12-13H2,1H3,(H,30,33) XCROZBZESLEWRE-UHFFFAOYSA-N 313381 N-(2'-(3-fluorooxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,4'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 52 RAF proto-oncogene serine/threonine-protein kinase Human 2148 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313381&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609723 383540282 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605720 Cc1ccc(NC(=O)c2ccnc(c2)C(F)F)cc1-c1cc(OCCO)nc(c1)C1(F)COC1 InChI=1S/C24H22F3N3O4/c1-14-2-3-17(29-23(32)15-4-5-28-19(8-15)22(25)26)11-18(14)16-9-20(24(27)12-33-13-24)30-21(10-16)34-7-6-31/h2-5,8-11,22,31H,6-7,12-13H2,1H3,(H,29,32) WAADUDOSFDBOKG-UHFFFAOYSA-N 313382 2-(difluoromethyl-N- (3-(2-(3-fluorooxetan-3- yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 53 RAF proto-oncogene serine/threonine-protein kinase Human 624 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313382 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313382&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133232 383540283 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605721 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1(F)COC1 InChI=1S/C25H24F3N3O4/c1-15-3-4-18(30-23(33)16-5-6-29-20(9-16)24(2,26)27)12-19(15)17-10-21(25(28)13-34-14-25)31-22(11-17)35-8-7-32/h3-6,9-12,32H,7-8,13-14H2,1-2H3,(H,30,33) BVHCPVUTKBHOMO-UHFFFAOYSA-N 313383 2-(1,1-difluoroethyl)-N- (3-(2-(3-fluorooxetan-3- yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 54 RAF proto-oncogene serine/threonine-protein kinase Human 211 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313383&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609523 383540284 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605722 Cc1ccc(NC(=O)c2ccnc(c2)C(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)COC1 InChI=1S/C25H24F3N3O4/c1-15-2-3-18(30-24(33)16-4-5-29-20(8-16)23(27)28)11-19(15)17-9-21(25(12-26)13-34-14-25)31-22(10-17)35-7-6-32/h2-5,8-11,23,32H,6-7,12-14H2,1H3,(H,30,33) DJQBPSLTIVOVQZ-UHFFFAOYSA-N 313387 2-(difluoromethyl)-N- (3-(2-(3- (fluoromethyl)oxetan-3- yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 55 RAF proto-oncogene serine/threonine-protein kinase Human 74.7 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313387 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313387&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609406 383540288 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605723 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)COC1 InChI=1S/C26H26F3N3O4/c1-16-3-4-19(31-24(34)17-5-6-30-21(9-17)25(2,28)29)12-20(16)18-10-22(26(13-27)14-35-15-26)32-23(11-18)36-8-7-33/h3-6,9-12,33H,7-8,13-15H2,1-2H3,(H,31,34) TZSDYUDZOVMBIV-UHFFFAOYSA-N 313388 2-(1,1-difluoroethyl)-N- (3-(2-(3- (fluoromethyl)oxetan-3- yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 56 RAF proto-oncogene serine/threonine-protein kinase Human 281 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313388 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313388&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609437 383540289 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605724 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)COC1 InChI=1S/C25H23F4N3O4/c1-15-2-3-18(31-23(34)16-4-5-30-21(8-16)25(27,28)29)11-19(15)17-9-20(24(12-26)13-35-14-24)32-22(10-17)36-7-6-33/h2-5,8-11,33H,6-7,12-14H2,1H3,(H,31,34) UNSUFJMKRLXMBT-UHFFFAOYSA-N 313389 N-(3-(2-(3- (fluoromethyl)oxetan-3- yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4-methylphenyl)- 2- (trifluoromethyl)isonicotin- amide::US10167279, Example 57 RAF proto-oncogene serine/threonine-protein kinase Human 149 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313389 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313389&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609712 383540290 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605725 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(COC1)C(F)F InChI=1S/C25H22F5N3O4/c1-14-2-3-17(32-22(35)15-4-5-31-20(8-15)25(28,29)30)11-18(14)16-9-19(24(23(26)27)12-36-13-24)33-21(10-16)37-7-6-34/h2-5,8-11,23,34H,6-7,12-13H2,1H3,(H,32,35) DVXAFYDKYYTGPH-UHFFFAOYSA-N 313390 N-(3-(2-(3- (difluoromethyl)oxetan- 3-yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4-methylphenyl)- 2- (trifluoromethyl)isonicotin- amide::US10167279, Example 58 RAF proto-oncogene serine/threonine-protein kinase Human 15.5 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313390&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609601 383540291 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605726 COC1(COC1)c1cc(cnc1OCCO)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C25H24F3N3O5/c1-15-3-4-18(31-22(33)16-5-6-29-21(10-16)25(26,27)28)11-19(15)17-9-20(24(34-2)13-35-14-24)23(30-12-17)36-8-7-32/h3-6,9-12,32H,7-8,13-14H2,1-2H3,(H,31,33) XQWHABXRIJEOOS-UHFFFAOYSA-N 313391 N-(3-(6-(2- hydroxyethoxy)-5-(3- methoxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 59 RAF proto-oncogene serine/threonine-protein kinase Human 103 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313391&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609375 383540292 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605727 COC1(COC1)c1cc(cnc1OCCO)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C26H27F2N3O5/c1-16-4-5-19(31-23(33)17-6-7-29-22(11-17)25(2,27)28)12-20(16)18-10-21(26(34-3)14-35-15-26)24(30-13-18)36-9-8-32/h4-7,10-13,32H,8-9,14-15H2,1-3H3,(H,31,33) YDSOGYKCCFRHJW-UHFFFAOYSA-N 313392 2-(1,1-difluoroethyl)-N- (3-(6-(2- hydroxyethoxy)-5-(3- methoxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 60 RAF proto-oncogene serine/threonine-protein kinase Human 203 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313392&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609625 383540293 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605728 COC1(COC1)c1cc(cnc1OCCO)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H29FN4O5/c1-16-20(18-9-21(26(34-4)14-35-15-26)24(30-12-18)36-8-7-32)11-19(13-29-16)31-23(33)17-5-6-28-22(10-17)25(2,3)27/h5-6,9-13,32H,7-8,14-15H2,1-4H3,(H,31,33) XKQNZCMHYWYDMY-UHFFFAOYSA-N 313393 2-(2-fluoropropan-2-yl)- N-(6'-(2- hydroxyethoxy)-5'-(3- methoxyoxetan-3-yl)-2- methyl-[3,3'-bipyridin]- 5-yl)isonicotinamide::US10167279, Example 61 RAF proto-oncogene serine/threonine-protein kinase Human 1321 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313393&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609371 383540294 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605729 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)O)cc1-c1cc(c2nccn2n1)C1(C)COC1 InChI=1S/C26H27N5O3/c1-16-5-6-18(29-24(32)17-7-8-27-22(11-17)25(2,3)33)12-19(16)21-13-20(26(4)14-34-15-26)23-28-9-10-31(23)30-21/h5-13,33H,14-15H2,1-4H3,(H,29,32) MBNRXSKCDPORSY-UHFFFAOYSA-N 313395 2-(2-hydroxypropan-2- yl)-N-(4-methyl-3-(8-(3- methyloxetan-3- yl)imidazo[1,2- b]pyridazin-6- yl)phenyl)isonicotinamide::US10167279, Example 62 RAF proto-oncogene serine/threonine-protein kinase Human 707 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313395&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609563 383540296 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605730 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)O)cc1-c1cc(c2nccn2n1)C1(C)COC1 InChI=1S/C26H27N5O3/c1-16-5-6-18(29-24(32)17-7-8-27-22(11-17)25(2,3)33)12-19(16)21-13-20(26(4)14-34-15-26)23-28-9-10-31(23)30-21/h5-13,33H,14-15H2,1-4H3,(H,29,32) MBNRXSKCDPORSY-UHFFFAOYSA-N 313395 2-(2-hydroxypropan-2- yl)-N-(4-methyl-3-(8-(3- methyloxetan-3- yl)imidazo[1,2- b]pyridazin-6- yl)phenyl)isonicotinamide::US10167279, Example 62 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3774 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313395&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609563 383540296 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605731 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C24H23F3N4O3/c1-4-34-22-19(23(3)12-33-13-23)7-16(10-30-22)18-9-17(11-29-14(18)2)31-21(32)15-5-6-28-20(8-15)24(25,26)27/h5-11H,4,12-13H2,1-3H3,(H,31,32) MLGNXKIPPIXQET-UHFFFAOYSA-N 313396 N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 63 RAF proto-oncogene serine/threonine-protein kinase Human 183 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313396&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609708 383540297 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605732 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C24H23F3N4O3/c1-4-34-22-19(23(3)12-33-13-23)7-16(10-30-22)18-9-17(11-29-14(18)2)31-21(32)15-5-6-28-20(8-15)24(25,26)27/h5-11H,4,12-13H2,1-3H3,(H,31,32) MLGNXKIPPIXQET-UHFFFAOYSA-N 313396 N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 63 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 613 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313396&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609708 383540297 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605733 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C27H29N5O3/c1-6-35-25-22(27(5)15-34-16-27)9-19(12-31-25)21-11-20(13-30-17(21)2)32-24(33)18-7-8-29-23(10-18)26(3,4)14-28/h7-13H,6,15-16H2,1-5H3,(H,32,33) NBIYSUCYKGZDKD-UHFFFAOYSA-N 313397 2-(2-cyanopropan-2-yl)- N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)isonicotinamide::US10167279, Example 64 RAF proto-oncogene serine/threonine-protein kinase Human 1180 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313397&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609516 383540298 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605734 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C27H29N5O3/c1-6-35-25-22(27(5)15-34-16-27)9-19(12-31-25)21-11-20(13-30-17(21)2)32-24(33)18-7-8-29-23(10-18)26(3,4)14-28/h7-13H,6,15-16H2,1-5H3,(H,32,33) NBIYSUCYKGZDKD-UHFFFAOYSA-N 313397 2-(2-cyanopropan-2-yl)- N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)isonicotinamide::US10167279, Example 64 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 7124 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313397&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609516 383540298 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605735 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2cnnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C26H28N6O3/c1-6-35-24-21(26(5)14-34-15-26)7-17(10-29-24)20-9-19(12-28-16(20)2)31-23(33)18-8-22(32-30-11-18)25(3,4)13-27/h7-12H,6,14-15H2,1-5H3,(H,31,33) YFRNBQDGZXGYJM-UHFFFAOYSA-N 313398 6-(2-cyanopropan-2-yl)- N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)pyridazine-4- carboxamide::US10167279, Example 65 RAF proto-oncogene serine/threonine-protein kinase Human 1135 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313398&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609677 383540299 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605736 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2cnnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C26H28N6O3/c1-6-35-24-21(26(5)14-34-15-26)7-17(10-29-24)20-9-19(12-28-16(20)2)31-23(33)18-8-22(32-30-11-18)25(3,4)13-27/h7-12H,6,14-15H2,1-5H3,(H,31,33) YFRNBQDGZXGYJM-UHFFFAOYSA-N 313398 6-(2-cyanopropan-2-yl)- N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)pyridazine-4- carboxamide::US10167279, Example 65 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 7133 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313398&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609677 383540299 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605737 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2cnnc(c2)C(F)(F)F)cnc1C InChI=1S/C23H22F3N5O3/c1-4-34-21-18(22(3)11-33-12-22)5-14(8-28-21)17-7-16(10-27-13(17)2)30-20(32)15-6-19(23(24,25)26)31-29-9-15/h5-10H,4,11-12H2,1-3H3,(H,30,32) GHZXICDTBSELRS-UHFFFAOYSA-N 313399 N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)-6- (trifluoromethyl)pyridazine- 4-carboxamide::US10167279, Example 66 RAF proto-oncogene serine/threonine-protein kinase Human 258 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313399&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609400 383540300 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605738 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2cnnc(c2)C(F)(F)F)cnc1C InChI=1S/C23H22F3N5O3/c1-4-34-21-18(22(3)11-33-12-22)5-14(8-28-21)17-7-16(10-27-13(17)2)30-20(32)15-6-19(23(24,25)26)31-29-9-15/h5-10H,4,11-12H2,1-3H3,(H,30,32) GHZXICDTBSELRS-UHFFFAOYSA-N 313399 N-(6'-ethoxy-2-methyl- 5'-(3-methyloxetan-3- yl)-[3,3'-bipyridin]-5- yl)-6- (trifluoromethyl)pyridazine- 4-carboxamide::US10167279, Example 66 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1451 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313399&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609400 383540300 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605739 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2cnnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H23F3N4O3/c1-4-34-22-19(23(3)12-33-13-23)7-15(10-28-22)18-9-17(6-5-14(18)2)30-21(32)16-8-20(24(25,26)27)31-29-11-16/h5-11H,4,12-13H2,1-3H3,(H,30,32) BYRIYFLSQKIKLG-UHFFFAOYSA-N 313400 N-(3-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-6- (trifluoromethyl)pyridazine- 4-carboxamide::US10167279, Example 67 RAF proto-oncogene serine/threonine-protein kinase Human 78.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313400&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609597 383540301 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605740 CCOc1ncc(cc1C1(C)COC1)-c1cc(NC(=O)c2cnnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H23F3N4O3/c1-4-34-22-19(23(3)12-33-13-23)7-15(10-28-22)18-9-17(6-5-14(18)2)30-21(32)16-8-20(24(25,26)27)31-29-11-16/h5-11H,4,12-13H2,1-3H3,(H,30,32) BYRIYFLSQKIKLG-UHFFFAOYSA-N 313400 N-(3-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-6- (trifluoromethyl)pyridazine- 4-carboxamide::US10167279, Example 67 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 304 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313400&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609597 383540301 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605741 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C24H23F2N3O2/c1-15-20(16-5-4-6-18(9-16)23(2)13-31-14-23)11-19(12-28-15)29-22(30)17-7-8-27-21(10-17)24(3,25)26/h4-12H,13-14H2,1-3H3,(H,29,30) ZXQIHHCPZPSOKN-UHFFFAOYSA-N 313403 2-(1,1-difluoroethyl)-N- (6-methyl-5-(3-(3- methyloxetan-3- yl)phenyl)pyridin-3- yl)isonicotinamide::US10167279, Example 68 RAF proto-oncogene serine/threonine-protein kinase Human 618 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313403&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609590 383540304 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605742 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C24H23F2N3O2/c1-15-20(16-5-4-6-18(9-16)23(2)13-31-14-23)11-19(12-28-15)29-22(30)17-7-8-27-21(10-17)24(3,25)26/h4-12H,13-14H2,1-3H3,(H,29,30) ZXQIHHCPZPSOKN-UHFFFAOYSA-N 313403 2-(1,1-difluoroethyl)-N- (6-methyl-5-(3-(3- methyloxetan-3- yl)phenyl)pyridin-3- yl)isonicotinamide::US10167279, Example 68 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3707 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313403&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609590 383540304 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605743 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C25H26FN3O2/c1-16-21(17-6-5-7-19(10-17)25(4)14-31-15-25)12-20(13-28-16)29-23(30)18-8-9-27-22(11-18)24(2,3)26/h5-13H,14-15H2,1-4H3,(H,29,30) BGQKVLUTZWWNRF-UHFFFAOYSA-N 313404 2-(2-fluoropropan-2-yl)- N-(6-methyl-5-(3-(3- methyloxetan-3- yl)phenyl)pyridin-3- yl)isonicotinamide::US10167279, Example 69 RAF proto-oncogene serine/threonine-protein kinase Human 895 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313404&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609631 383540305 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605744 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C25H26FN3O2/c1-16-21(17-6-5-7-19(10-17)25(4)14-31-15-25)12-20(13-28-16)29-23(30)18-8-9-27-22(11-18)24(2,3)26/h5-13H,14-15H2,1-4H3,(H,29,30) BGQKVLUTZWWNRF-UHFFFAOYSA-N 313404 2-(2-fluoropropan-2-yl)- N-(6-methyl-5-(3-(3- methyloxetan-3- yl)phenyl)pyridin-3- yl)isonicotinamide::US10167279, Example 69 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 5102 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313404&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609631 383540305 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605745 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C23H21F2N3O2/c1-14-20(16-5-3-4-15(8-16)18-12-30-13-18)10-19(11-27-14)28-22(29)17-6-7-26-21(9-17)23(2,24)25/h3-11,18H,12-13H2,1-2H3,(H,28,29) RQNQXSNNUFTUHR-UHFFFAOYSA-N 313405 2-(1,1-difluoroethyl)-N- (6-methyl-5-(3-(oxetan- 3-yl)phenyl)pyridin-3- yl)isonicotinamide::US10167279, Example 70 RAF proto-oncogene serine/threonine-protein kinase Human 1591 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313405&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609374 383540306 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605746 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cccc(c1)C1COC1 InChI=1S/C23H21F2N3O2/c1-14-20(16-5-3-4-15(8-16)18-12-30-13-18)10-19(11-27-14)28-22(29)17-6-7-26-21(9-17)23(2,24)25/h3-11,18H,12-13H2,1-2H3,(H,28,29) RQNQXSNNUFTUHR-UHFFFAOYSA-N 313405 2-(1,1-difluoroethyl)-N- (6-methyl-5-(3-(oxetan- 3-yl)phenyl)pyridin-3- yl)isonicotinamide::US10167279, Example 70 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 12935 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313405&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609374 383540306 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605747 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C23H20F3N3O4/c1-13-3-4-16(29-20(30)14-5-6-27-19(8-14)23(24,25)26)9-17(13)15-7-18(21(32-2)28-10-15)22(31)11-33-12-22/h3-10,31H,11-12H2,1-2H3,(H,29,30) LHKCIZXDNRINFK-UHFFFAOYSA-N 313408 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 71 RAF proto-oncogene serine/threonine-protein kinase Human 351 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313408&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609540 383540308 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605748 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C23H20F3N3O4/c1-13-3-4-16(29-20(30)14-5-6-27-19(8-14)23(24,25)26)9-17(13)15-7-18(21(32-2)28-10-15)22(31)11-33-12-22/h3-10,31H,11-12H2,1-2H3,(H,29,30) LHKCIZXDNRINFK-UHFFFAOYSA-N 313408 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 71 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2838 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313408&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609540 383540308 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605749 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C26H26N4O4/c1-16-5-6-19(30-23(31)17-7-8-28-22(10-17)25(2,3)13-27)11-20(16)18-9-21(24(33-4)29-12-18)26(32)14-34-15-26/h5-12,32H,14-15H2,1-4H3,(H,30,31) JZJGSPWYNOKXEA-UHFFFAOYSA-N 313409 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 72 RAF proto-oncogene serine/threonine-protein kinase Human 1035 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313409 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313409&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609546 383540309 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605750 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C26H26N4O4/c1-16-5-6-19(30-23(31)17-7-8-28-22(10-17)25(2,3)13-27)11-20(16)18-9-21(24(33-4)29-12-18)26(32)14-34-15-26/h5-12,32H,14-15H2,1-4H3,(H,30,31) JZJGSPWYNOKXEA-UHFFFAOYSA-N 313409 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 72 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 4196 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313409 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313409&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609546 383540309 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605751 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)O)ccc1C InChI=1S/C25H27N3O5/c1-15-5-6-18(28-22(29)16-7-8-26-21(10-16)24(2,3)30)11-19(15)17-9-20(23(32-4)27-12-17)25(31)13-33-14-25/h5-12,30-31H,13-14H2,1-4H3,(H,28,29) WSLCVLHLAXIALB-UHFFFAOYSA-N 313454 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-2-(2- hydroxypropan-2- yl)isonicotinamide::US10167279, Example 73 RAF proto-oncogene serine/threonine-protein kinase Human 3093 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313454&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609567 383540354 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605752 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)O)ccc1C InChI=1S/C25H27N3O5/c1-15-5-6-18(28-22(29)16-7-8-26-21(10-16)24(2,3)30)11-19(15)17-9-20(23(32-4)27-12-17)25(31)13-33-14-25/h5-12,30-31H,13-14H2,1-4H3,(H,28,29) WSLCVLHLAXIALB-UHFFFAOYSA-N 313454 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-2-(2- hydroxypropan-2- yl)isonicotinamide::US10167279, Example 73 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 23382 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313454&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609567 383540354 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605753 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C24H23F2N3O4/c1-14-4-5-17(29-21(30)15-6-7-27-20(9-15)23(2,25)26)10-18(14)16-8-19(22(32-3)28-11-16)24(31)12-33-13-24/h4-11,31H,12-13H2,1-3H3,(H,29,30) AGCCJFPZNFFNKB-UHFFFAOYSA-N 313455 2-(1,1-difluoroethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 74 RAF proto-oncogene serine/threonine-protein kinase Human 360 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313455&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609710 383540355 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605754 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C24H23F2N3O4/c1-14-4-5-17(29-21(30)15-6-7-27-20(9-15)23(2,25)26)10-18(14)16-8-19(22(32-3)28-11-16)24(31)12-33-13-24/h4-11,31H,12-13H2,1-3H3,(H,29,30) AGCCJFPZNFFNKB-UHFFFAOYSA-N 313455 2-(1,1-difluoroethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 74 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2066 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313455&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609710 383540355 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605755 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C22H19F3N4O4/c1-12-16(14-5-17(20(32-2)28-8-14)21(31)10-33-11-21)7-15(9-27-12)29-19(30)13-3-4-26-18(6-13)22(23,24)25/h3-9,31H,10-11H2,1-2H3,(H,29,30) UPDCRFMSKQBTEF-UHFFFAOYSA-N 313456 US10167279, Example 79::N-(5''-(3-hydroxyoxetan- 3-yl)-6''-methoxy-2- methyl-[3,3''-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 75 RAF proto-oncogene serine/threonine-protein kinase Human 6364 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313456&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609440 383540356 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605756 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C22H19F3N4O4/c1-12-16(14-5-17(20(32-2)28-8-14)21(31)10-33-11-21)7-15(9-27-12)29-19(30)13-3-4-26-18(6-13)22(23,24)25/h3-9,31H,10-11H2,1-2H3,(H,29,30) UPDCRFMSKQBTEF-UHFFFAOYSA-N 313456 US10167279, Example 79::N-(5''-(3-hydroxyoxetan- 3-yl)-6''-methoxy-2- methyl-[3,3''-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 75 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 76561 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313456&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609440 383540356 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605757 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C24H25FN4O4/c1-14-18(16-7-19(22(32-4)28-10-16)24(31)12-33-13-24)9-17(11-27-14)29-21(30)15-5-6-26-20(8-15)23(2,3)25/h5-11,31H,12-13H2,1-4H3,(H,29,30) AWIPUFCUNGXHQE-UHFFFAOYSA-N 313457 2-(2-fluoropropan-2-yl)- N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)isonicotinamide::US10167279, Example 76 RAF proto-oncogene serine/threonine-protein kinase Human 3926 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313457&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609537 383540357 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605758 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C24H25FN4O4/c1-14-18(16-7-19(22(32-4)28-10-16)24(31)12-33-13-24)9-17(11-27-14)29-21(30)15-5-6-26-20(8-15)23(2,3)25/h5-11,31H,12-13H2,1-4H3,(H,29,30) AWIPUFCUNGXHQE-UHFFFAOYSA-N 313457 2-(2-fluoropropan-2-yl)- N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)isonicotinamide::US10167279, Example 76 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 22782 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313457&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609537 383540357 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605759 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)cnc1C InChI=1S/C23H22F2N4O4/c1-13-17(15-6-18(21(32-3)28-9-15)23(31)11-33-12-23)8-16(10-27-13)29-20(30)14-4-5-26-19(7-14)22(2,24)25/h4-10,31H,11-12H2,1-3H3,(H,29,30) MFZWFQKVLJPDPP-UHFFFAOYSA-N 313458 2-(1,1-difluoroethyl)-N- (5'-(3-hydroxyoxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)isonicotinamide::US10167279, Example 77 RAF proto-oncogene serine/threonine-protein kinase Human 3569 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313458&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609620 383540358 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605760 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)cnc1C InChI=1S/C23H22F2N4O4/c1-13-17(15-6-18(21(32-3)28-9-15)23(31)11-33-12-23)8-16(10-27-13)29-20(30)14-4-5-26-19(7-14)22(2,24)25/h4-10,31H,11-12H2,1-3H3,(H,29,30) MFZWFQKVLJPDPP-UHFFFAOYSA-N 313458 2-(1,1-difluoroethyl)-N- (5'-(3-hydroxyoxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)isonicotinamide::US10167279, Example 77 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 24010 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313458&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609620 383540358 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605761 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)cnc1C InChI=1S/C22H19F3N4O4/c1-12-16(13-5-17(20(32-2)28-8-13)21(31)10-33-11-21)7-15(9-27-12)29-19(30)18-6-14(3-4-26-18)22(23,24)25/h3-9,31H,10-11H2,1-2H3,(H,29,30) MNFHDOUSIFYSPG-UHFFFAOYSA-N 313459 N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 78 RAF proto-oncogene serine/threonine-protein kinase Human 3231 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313459&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609703 383540359 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605762 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)cnc1C InChI=1S/C22H19F3N4O4/c1-12-16(13-5-17(20(32-2)28-8-13)21(31)10-33-11-21)7-15(9-27-12)29-19(30)18-6-14(3-4-26-18)22(23,24)25/h3-9,31H,10-11H2,1-2H3,(H,29,30) MNFHDOUSIFYSPG-UHFFFAOYSA-N 313459 N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 78 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 23498 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313459&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609703 383540359 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605763 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C22H19F3N4O4/c1-12-16(14-5-17(20(32-2)28-8-14)21(31)10-33-11-21)7-15(9-27-12)29-19(30)13-3-4-26-18(6-13)22(23,24)25/h3-9,31H,10-11H2,1-2H3,(H,29,30) UPDCRFMSKQBTEF-UHFFFAOYSA-N 313456 US10167279, Example 79::N-(5''-(3-hydroxyoxetan- 3-yl)-6''-methoxy-2- methyl-[3,3''-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 75 RAF proto-oncogene serine/threonine-protein kinase Human 493 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313456&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609440 383540356 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605764 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C22H19F3N4O4/c1-12-16(14-5-17(20(32-2)28-8-14)21(31)10-33-11-21)7-15(9-27-12)29-19(30)13-3-4-26-18(6-13)22(23,24)25/h3-9,31H,10-11H2,1-2H3,(H,29,30) UPDCRFMSKQBTEF-UHFFFAOYSA-N 313456 US10167279, Example 79::N-(5''-(3-hydroxyoxetan- 3-yl)-6''-methoxy-2- methyl-[3,3''-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 75 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3999 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313456&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609440 383540356 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605765 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C25H24FN5O3/c1-15-19(17-7-20(23(33-4)30-10-17)25(26)13-34-14-25)9-18(11-29-15)31-22(32)16-5-6-28-21(8-16)24(2,3)12-27/h5-11H,13-14H2,1-4H3,(H,31,32) DTORPAFWVVQTHZ-UHFFFAOYSA-N 313461 2-(2-cyanopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)isonicotinamide::US10167279, Example 80 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313461&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609676 383540360 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605766 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)O)cnc1C InChI=1S/C24H25FN4O4/c1-14-18(16-7-19(22(32-4)28-10-16)24(25)12-33-13-24)9-17(11-27-14)29-21(30)15-5-6-26-20(8-15)23(2,3)31/h5-11,31H,12-13H2,1-4H3,(H,29,30) CWUCZXKZRSAFRS-UHFFFAOYSA-N 313462 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2- hydroxypropan-2- yl)isonicotinamide::US10167279, Example 81 RAF proto-oncogene serine/threonine-protein kinase Human 4849 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313462&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609583 383540361 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605767 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)O)cnc1C InChI=1S/C24H25FN4O4/c1-14-18(16-7-19(22(32-4)28-10-16)24(25)12-33-13-24)9-17(11-27-14)29-21(30)15-5-6-26-20(8-15)23(2,3)31/h5-11,31H,12-13H2,1-4H3,(H,29,30) CWUCZXKZRSAFRS-UHFFFAOYSA-N 313462 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2- hydroxypropan-2- yl)isonicotinamide::US10167279, Example 81 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 34902 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313462&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609583 383540361 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605768 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C24H24F2N4O3/c1-14-18(16-7-19(22(32-4)29-10-16)24(26)12-33-13-24)9-17(11-28-14)30-21(31)15-5-6-27-20(8-15)23(2,3)25/h5-11H,12-13H2,1-4H3,(H,30,31) NFORJBGLNHLYCX-UHFFFAOYSA-N 313463 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 82 RAF proto-oncogene serine/threonine-protein kinase Human 1134 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313463&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609450 383540362 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605769 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C24H24F2N4O3/c1-14-18(16-7-19(22(32-4)29-10-16)24(26)12-33-13-24)9-17(11-28-14)30-21(31)15-5-6-27-20(8-15)23(2,3)25/h5-11H,12-13H2,1-4H3,(H,30,31) NFORJBGLNHLYCX-UHFFFAOYSA-N 313463 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 82 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3732 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313463&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609450 383540362 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605770 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)cnc1C InChI=1S/C22H18F4N4O3/c1-12-16(13-5-17(20(32-2)29-8-13)21(23)10-33-11-21)7-15(9-28-12)30-19(31)18-6-14(3-4-27-18)22(24,25)26/h3-9H,10-11H2,1-2H3,(H,30,31) BRSPICUFRBRJOE-UHFFFAOYSA-N 313464 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 83 RAF proto-oncogene serine/threonine-protein kinase Human 13.6 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313464&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609698 383540363 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605771 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)cnc1C InChI=1S/C22H18F4N4O3/c1-12-16(13-5-17(20(32-2)29-8-13)21(23)10-33-11-21)7-15(9-28-12)30-19(31)18-6-14(3-4-27-18)22(24,25)26/h3-9H,10-11H2,1-2H3,(H,30,31) BRSPICUFRBRJOE-UHFFFAOYSA-N 313464 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 83 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 59.3 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313464&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609698 383540363 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605772 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)ccc1C InChI=1S/C23H20F3N3O4/c1-13-3-4-16(29-20(30)19-8-15(5-6-27-19)23(24,25)26)9-17(13)14-7-18(21(32-2)28-10-14)22(31)11-33-12-22/h3-10,31H,11-12H2,1-2H3,(H,29,30) QVSDCOARSBZIJX-UHFFFAOYSA-N 313465 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 84 RAF proto-oncogene serine/threonine-protein kinase Human 351 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313465&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609381 383540364 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605773 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)ccc1C InChI=1S/C23H20F3N3O4/c1-13-3-4-16(29-20(30)19-8-15(5-6-27-19)23(24,25)26)9-17(13)14-7-18(21(32-2)28-10-14)22(31)11-33-12-22/h3-10,31H,11-12H2,1-2H3,(H,29,30) QVSDCOARSBZIJX-UHFFFAOYSA-N 313465 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 84 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2206 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313465&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609381 383540364 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605774 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)C#N)ccc1C InChI=1S/C26H26N4O4/c1-16-5-6-19(30-23(31)22-10-18(7-8-28-22)25(2,3)13-27)11-20(16)17-9-21(24(33-4)29-12-17)26(32)14-34-15-26/h5-12,32H,14-15H2,1-4H3,(H,30,31) OWTCWJBOPKHMAD-UHFFFAOYSA-N 313466 4-(2-cyanopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)picolinamide::US10167279, Example 85 RAF proto-oncogene serine/threonine-protein kinase Human 1174 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313466&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609616 383540365 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605775 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)C#N)ccc1C InChI=1S/C26H26N4O4/c1-16-5-6-19(30-23(31)22-10-18(7-8-28-22)25(2,3)13-27)11-20(16)17-9-21(24(33-4)29-12-17)26(32)14-34-15-26/h5-12,32H,14-15H2,1-4H3,(H,30,31) OWTCWJBOPKHMAD-UHFFFAOYSA-N 313466 4-(2-cyanopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)picolinamide::US10167279, Example 85 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 6473 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313466&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609616 383540365 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605776 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)C#N)cnc1C InChI=1S/C25H24FN5O3/c1-15-19(16-7-20(23(33-4)30-10-16)25(26)13-34-14-25)9-18(11-29-15)31-22(32)21-8-17(5-6-28-21)24(2,3)12-27/h5-11H,13-14H2,1-4H3,(H,31,32) KCDSCGODCUASFM-UHFFFAOYSA-N 313467 4-(2-cyanopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 86 RAF proto-oncogene serine/threonine-protein kinase Human 2328 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313467&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609669 383540366 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605777 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)C#N)cnc1C InChI=1S/C25H24FN5O3/c1-15-19(16-7-20(23(33-4)30-10-16)25(26)13-34-14-25)9-18(11-29-15)31-22(32)21-8-17(5-6-28-21)24(2,3)12-27/h5-11H,13-14H2,1-4H3,(H,31,32) KCDSCGODCUASFM-UHFFFAOYSA-N 313467 4-(2-cyanopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 86 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 14709 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313467&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609669 383540366 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605778 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)C#N)ccc1C InChI=1S/C26H25FN4O3/c1-16-5-6-19(31-23(32)22-10-18(7-8-29-22)25(2,3)13-28)11-20(16)17-9-21(24(33-4)30-12-17)26(27)14-34-15-26/h5-12H,14-15H2,1-4H3,(H,31,32) AYCYIDDBWCDKFJ-UHFFFAOYSA-N 313468 4-(2-cyanopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2-4-(2- cyanopropan-2-yl)-N-(3- (5-(3-fluorooxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)picolinamide::US10167279, Example 87 RAF proto-oncogene serine/threonine-protein kinase Human 622 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313468&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133441 383540367 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605779 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)C#N)ccc1C InChI=1S/C26H25FN4O3/c1-16-5-6-19(31-23(32)22-10-18(7-8-29-22)25(2,3)13-28)11-20(16)17-9-21(24(33-4)30-12-17)26(27)14-34-15-26/h5-12H,14-15H2,1-4H3,(H,31,32) AYCYIDDBWCDKFJ-UHFFFAOYSA-N 313468 4-(2-cyanopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2-4-(2- cyanopropan-2-yl)-N-(3- (5-(3-fluorooxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)picolinamide::US10167279, Example 87 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3565 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313468&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133441 383540367 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605780 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)ccc1C InChI=1S/C23H19F4N3O3/c1-13-3-4-16(30-20(31)19-8-15(5-6-28-19)23(25,26)27)9-17(13)14-7-18(21(32-2)29-10-14)22(24)11-33-12-22/h3-10H,11-12H2,1-2H3,(H,30,31) AAKGHBVKMSAASI-UHFFFAOYSA-N 313469 N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 4- (trifluoromethyl)picolin- amide::US10167279, Example 88 RAF proto-oncogene serine/threonine-protein kinase Human 303 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313469&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609594 383540368 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605781 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)ccc1C InChI=1S/C23H19F4N3O3/c1-13-3-4-16(30-20(31)19-8-15(5-6-28-19)23(25,26)27)9-17(13)14-7-18(21(32-2)29-10-14)22(24)11-33-12-22/h3-10H,11-12H2,1-2H3,(H,30,31) AAKGHBVKMSAASI-UHFFFAOYSA-N 313469 N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 4- (trifluoromethyl)picolin- amide::US10167279, Example 88 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 934 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313469&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609594 383540368 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605782 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)ccc1C InChI=1S/C24H22F3N3O3/c1-14-4-5-17(30-21(31)20-9-16(6-7-28-20)23(2,25)26)10-18(14)15-8-19(22(32-3)29-11-15)24(27)12-33-13-24/h4-11H,12-13H2,1-3H3,(H,30,31) ACSMNOOMQYUAMF-UHFFFAOYSA-N 313470 4-(1,1-difluoroethyl)-N- (3-(5-(3-fluorooxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)picolinamide::US10167279, Example 89 RAF proto-oncogene serine/threonine-protein kinase Human 239 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313470&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609688 383540369 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605783 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)ccc1C InChI=1S/C24H22F3N3O3/c1-14-4-5-17(30-21(31)20-9-16(6-7-28-20)23(2,25)26)10-18(14)15-8-19(22(32-3)29-11-15)24(27)12-33-13-24/h4-11H,12-13H2,1-3H3,(H,30,31) ACSMNOOMQYUAMF-UHFFFAOYSA-N 313470 4-(1,1-difluoroethyl)-N- (3-(5-(3-fluorooxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)picolinamide::US10167279, Example 89 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1188 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313470&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609688 383540369 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605784 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)cnc1C InChI=1S/C23H21F3N4O3/c1-13-17(14-6-18(21(32-3)29-9-14)23(26)11-33-12-23)8-16(10-28-13)30-20(31)19-7-15(4-5-27-19)22(2,24)25/h4-10H,11-12H2,1-3H3,(H,30,31) YMYSJZZYDPEHJZ-UHFFFAOYSA-N 313471 4-(1,1-difluoroethyl)-N- (5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 90 RAF proto-oncogene serine/threonine-protein kinase Human 386 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313471&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609608 383540370 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605785 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)cnc1C InChI=1S/C23H21F3N4O3/c1-13-17(14-6-18(21(32-3)29-9-14)23(26)11-33-12-23)8-16(10-28-13)30-20(31)19-7-15(4-5-27-19)22(2,24)25/h4-10H,11-12H2,1-3H3,(H,30,31) YMYSJZZYDPEHJZ-UHFFFAOYSA-N 313471 4-(1,1-difluoroethyl)-N- (5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 90 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3612 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313471&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609608 383540370 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605786 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)cnc1C InChI=1S/C23H22F2N4O4/c1-13-17(14-6-18(21(32-3)28-9-14)23(31)11-33-12-23)8-16(10-27-13)29-20(30)19-7-15(4-5-26-19)22(2,24)25/h4-10,31H,11-12H2,1-3H3,(H,29,30) QKVMMEWDQXSJMV-UHFFFAOYSA-N 313472 4-(1,1-difluoroethyl)-N- (5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 91 RAF proto-oncogene serine/threonine-protein kinase Human 2391 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313472&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133442 383540371 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605787 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)cnc1C InChI=1S/C23H22F2N4O4/c1-13-17(14-6-18(21(32-3)28-9-14)23(31)11-33-12-23)8-16(10-27-13)29-20(30)19-7-15(4-5-26-19)22(2,24)25/h4-10,31H,11-12H2,1-3H3,(H,29,30) QKVMMEWDQXSJMV-UHFFFAOYSA-N 313472 4-(1,1-difluoroethyl)-N- (5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 91 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 13035 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313472&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133442 383540371 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605788 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)ccc1C InChI=1S/C24H23F2N3O4/c1-14-4-5-17(29-21(30)20-9-16(6-7-27-20)23(2,25)26)10-18(14)15-8-19(22(32-3)28-11-15)24(31)12-33-13-24/h4-11,31H,12-13H2,1-3H3,(H,29,30) TUCQSTFLMJPOCC-UHFFFAOYSA-N 313473 4-(1,1-difluoroethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)picolinamide::US10167279, Example 92 RAF proto-oncogene serine/threonine-protein kinase Human 333 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313473&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609495 383540372 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605789 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(F)F)ccc1C InChI=1S/C24H23F2N3O4/c1-14-4-5-17(29-21(30)20-9-16(6-7-27-20)23(2,25)26)10-18(14)15-8-19(22(32-3)28-11-15)24(31)12-33-13-24/h4-11,31H,12-13H2,1-3H3,(H,29,30) TUCQSTFLMJPOCC-UHFFFAOYSA-N 313473 4-(1,1-difluoroethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)picolinamide::US10167279, Example 92 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2202 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313473&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609495 383540372 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605790 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)F)cnc1C InChI=1S/C24H24F2N4O3/c1-14-18(15-7-19(22(32-4)29-10-15)24(26)12-33-13-24)9-17(11-28-14)30-21(31)20-8-16(5-6-27-20)23(2,3)25/h5-11H,12-13H2,1-4H3,(H,30,31) VXLXCMJQNCUFEL-UHFFFAOYSA-N 313474 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4-(2-fluoropropan- 2-yl)picolinamide::US10167279, Example 93 RAF proto-oncogene serine/threonine-protein kinase Human 1012 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313474&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609513 383540373 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605791 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)F)cnc1C InChI=1S/C24H24F2N4O3/c1-14-18(15-7-19(22(32-4)29-10-15)24(26)12-33-13-24)9-17(11-28-14)30-21(31)20-8-16(5-6-27-20)23(2,3)25/h5-11H,12-13H2,1-4H3,(H,30,31) VXLXCMJQNCUFEL-UHFFFAOYSA-N 313474 N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4-(2-fluoropropan- 2-yl)picolinamide::US10167279, Example 93 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 8029 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313474&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609513 383540373 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605792 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)F)cnc1C InChI=1S/C24H25FN4O4/c1-14-18(15-7-19(22(32-4)28-10-15)24(31)12-33-13-24)9-17(11-27-14)29-21(30)20-8-16(5-6-26-20)23(2,3)25/h5-11,31H,12-13H2,1-4H3,(H,29,30) UJGYJLAAYBJTKC-UHFFFAOYSA-N 313475 4-(2-fluoropropan-2-yl)- N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 94 RAF proto-oncogene serine/threonine-protein kinase Human 4236 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313475&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609471 383540374 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605793 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)F)cnc1C InChI=1S/C24H25FN4O4/c1-14-18(15-7-19(22(32-4)28-10-15)24(31)12-33-13-24)9-17(11-27-14)29-21(30)20-8-16(5-6-26-20)23(2,3)25/h5-11,31H,12-13H2,1-4H3,(H,29,30) UJGYJLAAYBJTKC-UHFFFAOYSA-N 313475 4-(2-fluoropropan-2-yl)- N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)picolinamide::US10167279, Example 94 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 31774 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313475&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609471 383540374 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605794 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)F)ccc1C InChI=1S/C25H26FN3O4/c1-15-5-6-18(29-22(30)21-10-17(7-8-27-21)24(2,3)26)11-19(15)16-9-20(23(32-4)28-12-16)25(31)13-33-14-25/h5-12,31H,13-14H2,1-4H3,(H,29,30) PYKKNAWZJVQWFB-UHFFFAOYSA-N 313476 4-(2-fluoropropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)picolinamide::US10167279, Example 95 RAF proto-oncogene serine/threonine-protein kinase Human 514 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313476&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609639 383540375 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605795 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)F)ccc1C InChI=1S/C25H26FN3O4/c1-15-5-6-18(29-22(30)21-10-17(7-8-27-21)24(2,3)26)11-19(15)16-9-20(23(32-4)28-12-16)25(31)13-33-14-25/h5-12,31H,13-14H2,1-4H3,(H,29,30) PYKKNAWZJVQWFB-UHFFFAOYSA-N 313476 4-(2-fluoropropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)picolinamide::US10167279, Example 95 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3921 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313476&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609639 383540375 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605796 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)O)ccc1C InChI=1S/C25H26FN3O4/c1-15-5-6-18(29-22(30)21-10-17(7-8-27-21)24(2,3)31)11-19(15)16-9-20(23(32-4)28-12-16)25(26)13-33-14-25/h5-12,31H,13-14H2,1-4H3,(H,29,30) SZWQBOLNPPTGES-UHFFFAOYSA-N 313477 N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 4-(2-hydroxypropan-2- yl)picolinamide::US10167279, Example 96 RAF proto-oncogene serine/threonine-protein kinase Human 482 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313477&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609477 383540376 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605797 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(ccn2)C(C)(C)O)ccc1C InChI=1S/C25H26FN3O4/c1-15-5-6-18(29-22(30)21-10-17(7-8-27-21)24(2,3)31)11-19(15)16-9-20(23(32-4)28-12-16)25(26)13-33-14-25/h5-12,31H,13-14H2,1-4H3,(H,29,30) SZWQBOLNPPTGES-UHFFFAOYSA-N 313477 N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 4-(2-hydroxypropan-2- yl)picolinamide::US10167279, Example 96 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 4165 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313477&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609477 383540376 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605798 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C23H20F3N3O4/c1-13-18(15-7-19(21(32-2)28-9-15)22(31)11-33-12-22)8-17(10-27-13)29-20(30)14-4-3-5-16(6-14)23(24,25)26/h3-10,31H,11-12H2,1-2H3,(H,29,30) VCHVZERTLFYLKM-UHFFFAOYSA-N 313478 N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 97 RAF proto-oncogene serine/threonine-protein kinase Human 1410 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313478&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609628 383540377 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605799 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C23H20F3N3O4/c1-13-18(15-7-19(21(32-2)28-9-15)22(31)11-33-12-22)8-17(10-27-13)29-20(30)14-4-3-5-16(6-14)23(24,25)26/h3-10,31H,11-12H2,1-2H3,(H,29,30) VCHVZERTLFYLKM-UHFFFAOYSA-N 313478 N-(5'-(3-hydroxyoxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 97 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 10362 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313478&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609628 383540377 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605800 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)F)ccc1C InChI=1S/C23H21F2N3O4/c1-13-3-4-16(28-21(29)14-5-6-26-19(8-14)20(24)25)9-17(13)15-7-18(22(31-2)27-10-15)23(30)11-32-12-23/h3-10,20,30H,11-12H2,1-2H3,(H,28,29) DGJMDWKZTNMASV-UHFFFAOYSA-N 313479 2-(difluoromethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 98 RAF proto-oncogene serine/threonine-protein kinase Human 1106 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313479&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609505 383540378 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605801 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)F)ccc1C InChI=1S/C23H21F2N3O4/c1-13-3-4-16(28-21(29)14-5-6-26-19(8-14)20(24)25)9-17(13)15-7-18(22(31-2)27-10-15)23(30)11-32-12-23/h3-10,20,30H,11-12H2,1-2H3,(H,28,29) DGJMDWKZTNMASV-UHFFFAOYSA-N 313479 2-(difluoromethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 98 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 13061 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313479&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609505 383540378 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605802 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C25H26FN3O4/c1-15-5-6-18(29-22(30)16-7-8-27-21(10-16)24(2,3)26)11-19(15)17-9-20(23(32-4)28-12-17)25(31)13-33-14-25/h5-12,31H,13-14H2,1-4H3,(H,29,30) HPAGLHMPDMJRFL-UHFFFAOYSA-N 313480 2-(2-fluoropropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 99 RAF proto-oncogene serine/threonine-protein kinase Human 415 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313480&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609604 383540379 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605803 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C25H26FN3O4/c1-15-5-6-18(29-22(30)16-7-8-27-21(10-16)24(2,3)26)11-19(15)17-9-20(23(32-4)28-12-17)25(31)13-33-14-25/h5-12,31H,13-14H2,1-4H3,(H,29,30) HPAGLHMPDMJRFL-UHFFFAOYSA-N 313480 2-(2-fluoropropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 99 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2665 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313480&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609604 383540379 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605804 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C2(CC2)C#N)ccc1C InChI=1S/C26H24N4O4/c1-16-3-4-19(30-23(31)17-5-8-28-22(10-17)25(13-27)6-7-25)11-20(16)18-9-21(24(33-2)29-12-18)26(32)14-34-15-26/h3-5,8-12,32H,6-7,14-15H2,1-2H3,(H,30,31) YAYPKMUVDJEOHO-UHFFFAOYSA-N 313481 2-(1-cyanocyclopropyl- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 100 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313481&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133233 383540380 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605805 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C2(CC2)C#N)ccc1C InChI=1S/C26H24N4O4/c1-16-3-4-19(30-23(31)17-5-8-28-22(10-17)25(13-27)6-7-25)11-20(16)18-9-21(24(33-2)29-12-18)26(32)14-34-15-26/h3-5,8-12,32H,6-7,14-15H2,1-2H3,(H,30,31) YAYPKMUVDJEOHO-UHFFFAOYSA-N 313481 2-(1-cyanocyclopropyl- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 100 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2203 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313481&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 135133233 383540380 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605806 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C27H28F3N3O4/c1-15-5-6-20(11-21(15)17-9-22(24(36-4)32-12-17)26(35)13-37-14-26)33-23(34)16-7-18(25(2,3)31)10-19(8-16)27(28,29)30/h5-12,35H,13-14,31H2,1-4H3,(H,33,34) ZSGVRAZOFCAXHQ-UHFFFAOYSA-N 313482 3-(2-aminopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-5- (trifluoromethyl)benzamide::US10167279, Example 101 RAF proto-oncogene serine/threonine-protein kinase Human 1453 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313482&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609682 383540381 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605807 COc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C27H28F3N3O4/c1-15-5-6-20(11-21(15)17-9-22(24(36-4)32-12-17)26(35)13-37-14-26)33-23(34)16-7-18(25(2,3)31)10-19(8-16)27(28,29)30/h5-12,35H,13-14,31H2,1-4H3,(H,33,34) ZSGVRAZOFCAXHQ-UHFFFAOYSA-N 313482 3-(2-aminopropan-2-yl)- N-(3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylphenyl)-5- (trifluoromethyl)benzamide::US10167279, Example 101 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 6391 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313482&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609682 383540381 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605808 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C26H26F4N4O3/c1-14-20(16-7-21(23(36-4)33-10-16)25(27)12-37-13-25)9-19(11-32-14)34-22(35)15-5-17(24(2,3)31)8-18(6-15)26(28,29)30/h5-11H,12-13,31H2,1-4H3,(H,34,35) MNOYMAISEXOXQM-UHFFFAOYSA-N 313483 3-(2-aminopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 102 RAF proto-oncogene serine/threonine-protein kinase Human 2678 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313483&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609499 383540382 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605809 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C26H26F4N4O3/c1-14-20(16-7-21(23(36-4)33-10-16)25(27)12-37-13-25)9-19(11-32-14)34-22(35)15-5-17(24(2,3)31)8-18(6-15)26(28,29)30/h5-11H,12-13,31H2,1-4H3,(H,34,35) MNOYMAISEXOXQM-UHFFFAOYSA-N 313483 3-(2-aminopropan-2-yl)- N-(5'-(3-fluorooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 102 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 13153 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313483&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609499 383540382 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605810 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C25H24F3N3O3/c1-15-4-5-18(31-22(32)16-6-7-29-21(9-16)24(2,27)28)10-19(15)17-8-20(23(33-3)30-11-17)25(12-26)13-34-14-25/h4-11H,12-14H2,1-3H3,(H,31,32) CLECSWNROFFXBH-UHFFFAOYSA-N 313484 2-(1,1-difluoroethyl)-N- (3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 103 RAF proto-oncogene serine/threonine-protein kinase Human 84.4 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313484&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609424 383540383 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605811 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C25H24F3N3O3/c1-15-4-5-18(31-22(32)16-6-7-29-21(9-16)24(2,27)28)10-19(15)17-8-20(23(33-3)30-11-17)25(12-26)13-34-14-25/h4-11H,12-14H2,1-3H3,(H,31,32) CLECSWNROFFXBH-UHFFFAOYSA-N 313484 2-(1,1-difluoroethyl)-N- (3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 103 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 293 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313484&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609424 383540383 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605812 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C26H27F2N3O3/c1-16-5-6-19(31-23(32)17-7-8-29-22(10-17)25(2,3)28)11-20(16)18-9-21(24(33-4)30-12-18)26(13-27)14-34-15-26/h5-12H,13-15H2,1-4H3,(H,31,32) HJEKGKRDJAZOEN-UHFFFAOYSA-N 313485 N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4-methylphenyl)-2- (2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 104 RAF proto-oncogene serine/threonine-protein kinase Human 128 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313485&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609481 383540384 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605813 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C26H27F2N3O3/c1-16-5-6-19(31-23(32)17-7-8-29-22(10-17)25(2,3)28)11-20(16)18-9-21(24(33-4)30-12-18)26(13-27)14-34-15-26/h5-12H,13-15H2,1-4H3,(H,31,32) HJEKGKRDJAZOEN-UHFFFAOYSA-N 313485 N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4-methylphenyl)-2- (2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 104 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 417 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313485&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609481 383540384 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605814 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H21F4N3O3/c1-14-3-4-17(31-21(32)15-5-6-29-20(8-15)24(26,27)28)9-18(14)16-7-19(22(33-2)30-10-16)23(11-25)12-34-13-23/h3-10H,11-13H2,1-2H3,(H,31,32) LMKSNXQADYFDKA-UHFFFAOYSA-N 313486 N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4-methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 105 RAF proto-oncogene serine/threonine-protein kinase Human 91.5 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313486&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609461 383540385 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605815 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H21F4N3O3/c1-14-3-4-17(31-21(32)15-5-6-29-20(8-15)24(26,27)28)9-18(14)16-7-19(22(33-2)30-10-16)23(11-25)12-34-13-23/h3-10H,11-13H2,1-2H3,(H,31,32) LMKSNXQADYFDKA-UHFFFAOYSA-N 313486 N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4-methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 105 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 323 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313486&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609461 383540385 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605816 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C27H27FN4O3/c1-17-5-6-20(32-24(33)18-7-8-30-23(10-18)26(2,3)14-29)11-21(17)19-9-22(25(34-4)31-12-19)27(13-28)15-35-16-27/h5-12H,13,15-16H2,1-4H3,(H,32,33) NRJWTGFPQAYOOI-UHFFFAOYSA-N 313487 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 106 RAF proto-oncogene serine/threonine-protein kinase Human 146 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313487&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609363 383540386 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605817 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C27H27FN4O3/c1-17-5-6-20(32-24(33)18-7-8-30-23(10-18)26(2,3)14-29)11-21(17)19-9-22(25(34-4)31-12-19)27(13-28)15-35-16-27/h5-12H,13,15-16H2,1-4H3,(H,32,33) NRJWTGFPQAYOOI-UHFFFAOYSA-N 313487 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 106 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 580 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313487&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609363 383540386 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605818 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C27H27F4N3O3/c1-15-5-6-20(11-21(15)17-9-22(24(36-4)33-12-17)26(28)13-37-14-26)34-23(35)16-7-18(25(2,3)32)10-19(8-16)27(29,30)31/h5-12H,13-14,32H2,1-4H3,(H,34,35) ASLQDTFKZBAPRS-UHFFFAOYSA-N 313488 3-(2-aminopropan-2-yl)- N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 5- (trifluoromethyl)benzamide::US10167279, Example 107 RAF proto-oncogene serine/threonine-protein kinase Human 725 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313488&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609574 383540387 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605819 COc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C27H27F4N3O3/c1-15-5-6-20(11-21(15)17-9-22(24(36-4)33-12-17)26(28)13-37-14-26)34-23(35)16-7-18(25(2,3)32)10-19(8-16)27(29,30)31/h5-12H,13-14,32H2,1-4H3,(H,34,35) ASLQDTFKZBAPRS-UHFFFAOYSA-N 313488 3-(2-aminopropan-2-yl)- N-(3-(5-(3-fluorooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 5- (trifluoromethyl)benzamide::US10167279, Example 107 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2964 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313488&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609574 383540387 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605820 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C28H29F4N3O3/c1-16-5-6-21(35-24(36)17-7-19(26(2,3)33)10-20(8-17)28(30,31)32)11-22(16)18-9-23(25(37-4)34-12-18)27(13-29)14-38-15-27/h5-12H,13-15,33H2,1-4H3,(H,35,36) HGEBNPDXFQZTJE-UHFFFAOYSA-N 313489 3-(2-aminopropan-2-yl)- N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4-methylphenyl)-5- (trifluoromethyl)benzamide::US10167279, Example 108 RAF proto-oncogene serine/threonine-protein kinase Human 424 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313489&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609438 383540388 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605821 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C28H29F4N3O3/c1-16-5-6-21(35-24(36)17-7-19(26(2,3)33)10-20(8-17)28(30,31)32)11-22(16)18-9-23(25(37-4)34-12-18)27(13-29)14-38-15-27/h5-12H,13-15,33H2,1-4H3,(H,35,36) HGEBNPDXFQZTJE-UHFFFAOYSA-N 313489 3-(2-aminopropan-2-yl)- N-(3-(5-(3- (fluoromethyl)oxetan-3- yl)-6-methoxypyridin-3- yl)-4-methylphenyl)-5- (trifluoromethyl)benzamide::US10167279, Example 108 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1803 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313489&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609438 383540388 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605822 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H28F4N4O3/c1-15-21(17-7-22(24(37-4)34-10-17)26(12-28)13-38-14-26)9-20(11-33-15)35-23(36)16-5-18(25(2,3)32)8-19(6-16)27(29,30)31/h5-11H,12-14,32H2,1-4H3,(H,35,36) FALXLNHGHAFSJB-UHFFFAOYSA-N 313490 3-(2-aminopropan-2-yl)- N-(5'-(3- (fluoromethyl)oxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 109 RAF proto-oncogene serine/threonine-protein kinase Human 2244 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313490&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609582 383540389 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605823 COc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H28F4N4O3/c1-15-21(17-7-22(24(37-4)34-10-17)26(12-28)13-38-14-26)9-20(11-33-15)35-23(36)16-5-18(25(2,3)32)8-19(6-16)27(29,30)31/h5-11H,12-14,32H2,1-4H3,(H,35,36) FALXLNHGHAFSJB-UHFFFAOYSA-N 313490 3-(2-aminopropan-2-yl)- N-(5'-(3- (fluoromethyl)oxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 109 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 9500 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313490&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609582 383540389 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605824 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(C2COC2)c(=O)n(C)c1 InChI=1S/C25H26FN3O3/c1-15-5-6-19(28-23(30)16-7-8-27-22(10-16)25(2,3)26)11-20(15)17-9-21(18-13-32-14-18)24(31)29(4)12-17/h5-12,18H,13-14H2,1-4H3,(H,28,30) FMOONJCYRNTRNH-UHFFFAOYSA-N 313491 2-(2-fluoropropan-2-yl)- N-(4-methyl-3-(1- methyl-5-(oxetan-3-yl)- 6-oxo-1,6- dihydropyridin-3- yl)phenyl)isonicotinamide::US10167279, Example 110 RAF proto-oncogene serine/threonine-protein kinase Human 1519 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313491&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609630 383540390 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605825 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(C2COC2)c(=O)n(C)c1 InChI=1S/C25H26FN3O3/c1-15-5-6-19(28-23(30)16-7-8-27-22(10-16)25(2,3)26)11-20(15)17-9-21(18-13-32-14-18)24(31)29(4)12-17/h5-12,18H,13-14H2,1-4H3,(H,28,30) FMOONJCYRNTRNH-UHFFFAOYSA-N 313491 2-(2-fluoropropan-2-yl)- N-(4-methyl-3-(1- methyl-5-(oxetan-3-yl)- 6-oxo-1,6- dihydropyridin-3- yl)phenyl)isonicotinamide::US10167279, Example 110 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 9983 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313491&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609630 383540390 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605826 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C26H25FN4O3/c1-16-5-6-19(31-23(32)17-7-8-29-22(10-17)25(2,3)27)11-20(16)18-9-21(24(33-4)30-12-18)26(13-28)14-34-15-26/h5-12H,14-15H2,1-4H3,(H,31,32) JDJLGKPEAWQOID-UHFFFAOYSA-N 313492 N-(3-(5-(3-cyanooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 2-(2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 111 RAF proto-oncogene serine/threonine-protein kinase Human 716 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313492&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609658 383540391 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605827 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C26H25FN4O3/c1-16-5-6-19(31-23(32)17-7-8-29-22(10-17)25(2,3)27)11-20(16)18-9-21(24(33-4)30-12-18)26(13-28)14-34-15-26/h5-12H,14-15H2,1-4H3,(H,31,32) JDJLGKPEAWQOID-UHFFFAOYSA-N 313492 N-(3-(5-(3-cyanooxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 2-(2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 111 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2746 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313492&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609658 383540391 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605828 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C28H28F5N3O3/c1-15-5-6-20(36-23(37)16-7-18(26(2,3)34)10-19(8-16)28(31,32)33)11-21(15)17-9-22(24(38-4)35-12-17)27(25(29)30)13-39-14-27/h5-12,25H,13-14,34H2,1-4H3,(H,36,37) AUFQIWVZZBGQIN-UHFFFAOYSA-N 313493 3-(2-aminopropan-2-yl)- N-(3-(5-(3- (difluoromethyl)oxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 5- (trifluoromethyl)benzamide::US10167279, Example 112 RAF proto-oncogene serine/threonine-protein kinase Human 225 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313493&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609613 383540392 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605829 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C28H28F5N3O3/c1-15-5-6-20(36-23(37)16-7-18(26(2,3)34)10-19(8-16)28(31,32)33)11-21(15)17-9-22(24(38-4)35-12-17)27(25(29)30)13-39-14-27/h5-12,25H,13-14,34H2,1-4H3,(H,36,37) AUFQIWVZZBGQIN-UHFFFAOYSA-N 313493 3-(2-aminopropan-2-yl)- N-(3-(5-(3- (difluoromethyl)oxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 5- (trifluoromethyl)benzamide::US10167279, Example 112 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1214 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313493&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609613 383540392 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605830 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H27F5N4O3/c1-14-20(16-7-21(23(38-4)35-10-16)26(24(28)29)12-39-13-26)9-19(11-34-14)36-22(37)15-5-17(25(2,3)33)8-18(6-15)27(30,31)32/h5-11,24H,12-13,33H2,1-4H3,(H,36,37) VDBNXKMAAFNVJU-UHFFFAOYSA-N 313494 3-(2-aminopropan-2-yl)- N-(5'-(3- (difluoromethyl)oxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 113 RAF proto-oncogene serine/threonine-protein kinase Human 900 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313494&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609664 383540393 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605831 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H27F5N4O3/c1-14-20(16-7-21(23(38-4)35-10-16)26(24(28)29)12-39-13-26)9-19(11-34-14)36-22(37)15-5-17(25(2,3)33)8-18(6-15)27(30,31)32/h5-11,24H,12-13,33H2,1-4H3,(H,36,37) VDBNXKMAAFNVJU-UHFFFAOYSA-N 313494 3-(2-aminopropan-2-yl)- N-(5'-(3- (difluoromethyl)oxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 113 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 4745 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313494&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609664 383540393 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605832 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H26F3N5O3/c1-15-21(17-7-22(24(37-4)34-10-17)26(12-31)13-38-14-26)9-20(11-33-15)35-23(36)16-5-18(25(2,3)32)8-19(6-16)27(28,29)30/h5-11H,13-14,32H2,1-4H3,(H,35,36) LCFZPXOAPFVJKB-UHFFFAOYSA-N 313495 3-(2-aminopropan-2-yl)- N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 114 RAF proto-oncogene serine/threonine-protein kinase Human 3255 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313495&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609368 383540394 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605833 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H26F3N5O3/c1-15-21(17-7-22(24(37-4)34-10-17)26(12-31)13-38-14-26)9-20(11-33-15)35-23(36)16-5-18(25(2,3)32)8-19(6-16)27(28,29)30/h5-11H,13-14,32H2,1-4H3,(H,35,36) LCFZPXOAPFVJKB-UHFFFAOYSA-N 313495 3-(2-aminopropan-2-yl)- N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 114 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 17518 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313495&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609368 383540394 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605834 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C23H18F3N5O3/c1-13-17(15-5-18(21(33-2)30-8-15)22(10-27)11-34-12-22)7-16(9-29-13)31-20(32)14-3-4-28-19(6-14)23(24,25)26/h3-9H,11-12H2,1-2H3,(H,31,32) RYNRDXPCVVFUEQ-UHFFFAOYSA-N 313496 N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 115 RAF proto-oncogene serine/threonine-protein kinase Human 1055 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313496&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609507 383540395 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605835 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C23H18F3N5O3/c1-13-17(15-5-18(21(33-2)30-8-15)22(10-27)11-34-12-22)7-16(9-29-13)31-20(32)14-3-4-28-19(6-14)23(24,25)26/h3-9H,11-12H2,1-2H3,(H,31,32) RYNRDXPCVVFUEQ-UHFFFAOYSA-N 313496 N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 115 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 7008 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313496&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609507 383540395 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605836 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)cnc1C InChI=1S/C24H21F2N5O3/c1-14-18(16-6-19(22(33-3)30-9-16)24(11-27)12-34-13-24)8-17(10-29-14)31-21(32)15-4-5-28-20(7-15)23(2,25)26/h4-10H,12-13H2,1-3H3,(H,31,32) MMCBOZOQHXYGBR-UHFFFAOYSA-N 313497 N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(1,1- difluoroethyl)isonicotin- amide::US10167279, Example 116 RAF proto-oncogene serine/threonine-protein kinase Human 1248 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313497&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609645 383540396 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605837 COc1ncc(cc1C1(COC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)cnc1C InChI=1S/C24H21F2N5O3/c1-14-18(16-6-19(22(33-3)30-9-16)24(11-27)12-34-13-24)8-17(10-29-14)31-21(32)15-4-5-28-20(7-15)23(2,25)26/h4-10H,12-13H2,1-3H3,(H,31,32) MMCBOZOQHXYGBR-UHFFFAOYSA-N 313497 N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(1,1- difluoroethyl)isonicotin- amide::US10167279, Example 116 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 6218 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313497&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609645 383540396 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605838 CCC(F)(F)c1cc(ccn1)C(=O)Nc1cnc(C)c(c1)-c1cnc(OC)c(c1)C1(COC1)C#N InChI=1S/C25H23F2N5O3/c1-4-25(26,27)21-8-16(5-6-29-21)22(33)32-18-9-19(15(2)30-11-18)17-7-20(23(34-3)31-10-17)24(12-28)13-35-14-24/h5-11H,4,13-14H2,1-3H3,(H,32,33) VHXLEJDYHCFOLN-UHFFFAOYSA-N 313498 N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(1,1- difluoropropyl)isonicotin- amide::US10167279, Example 117 RAF proto-oncogene serine/threonine-protein kinase Human 1426 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313498&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609428 383540397 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605839 CCC(F)(F)c1cc(ccn1)C(=O)Nc1cnc(C)c(c1)-c1cnc(OC)c(c1)C1(COC1)C#N InChI=1S/C25H23F2N5O3/c1-4-25(26,27)21-8-16(5-6-29-21)22(33)32-18-9-19(15(2)30-11-18)17-7-20(23(34-3)31-10-17)24(12-28)13-35-14-24/h5-11H,4,13-14H2,1-3H3,(H,32,33) VHXLEJDYHCFOLN-UHFFFAOYSA-N 313498 N-(5'-(3-cyanooxetan-3- yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-2-(1,1- difluoropropyl)isonicotin- amide::US10167279, Example 117 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 7191 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313498 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313498&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609428 383540397 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605840 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C27H26F3N3O5/c1-16-22(11-20(13-31-16)33-24(34)17-3-2-4-19(9-17)27(28,29)30)18-10-23(26(35)14-37-15-26)25(32-12-18)38-21-5-7-36-8-6-21/h2-4,9-13,21,35H,5-8,14-15H2,1H3,(H,33,34) DVAKMKMLSJUNTG-UHFFFAOYSA-N 313499 N-(5'-(3-hydroxyoxetan- 3-yl)-2-methyl-6'- ((tetrahydro-2H-pyran- 4-yl)oxy)-[3,3'- bipyridin]-5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 118 RAF proto-oncogene serine/threonine-protein kinase Human 562 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313499&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609612 383540398 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605841 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C27H26F3N3O5/c1-16-22(11-20(13-31-16)33-24(34)17-3-2-4-19(9-17)27(28,29)30)18-10-23(26(35)14-37-15-26)25(32-12-18)38-21-5-7-36-8-6-21/h2-4,9-13,21,35H,5-8,14-15H2,1H3,(H,33,34) DVAKMKMLSJUNTG-UHFFFAOYSA-N 313499 N-(5'-(3-hydroxyoxetan- 3-yl)-2-methyl-6'- ((tetrahydro-2H-pyran- 4-yl)oxy)-[3,3'- bipyridin]-5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 118 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3894 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313499 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313499&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609612 383540398 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605842 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C28H27F3N2O5/c1-17-5-6-21(33-25(34)18-3-2-4-20(11-18)28(29,30)31)13-23(17)19-12-24(27(35)15-37-16-27)26(32-14-19)38-22-7-9-36-10-8-22/h2-6,11-14,22,35H,7-10,15-16H2,1H3,(H,33,34) DTHMVQCNWFKXRR-UHFFFAOYSA-N 313500 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- ((tetrahydro-2H-pyran- 4-yl)oxy)pyridin-3-yl)- 4-methylphenyl)-3- (trifluoromethyl)benzamide::US10167279, Example 119 RAF proto-oncogene serine/threonine-protein kinase Human 176 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313500&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609456 383540399 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605843 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cnc(OC2CCOCC2)c(c1)C1(O)COC1 InChI=1S/C28H27F3N2O5/c1-17-5-6-21(33-25(34)18-3-2-4-20(11-18)28(29,30)31)13-23(17)19-12-24(27(35)15-37-16-27)26(32-14-19)38-22-7-9-36-10-8-22/h2-6,11-14,22,35H,7-10,15-16H2,1H3,(H,33,34) DTHMVQCNWFKXRR-UHFFFAOYSA-N 313500 N-(3-(5-(3- hydroxyoxetan-3-yl)-6- ((tetrahydro-2H-pyran- 4-yl)oxy)pyridin-3-yl)- 4-methylphenyl)-3- (trifluoromethyl)benzamide::US10167279, Example 119 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 808 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313500&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609456 383540399 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605844 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C28H30F3N3O4/c1-5-38-25-23(27(36)14-37-15-27)10-18(13-33-25)22-12-21(7-6-16(22)2)34-24(35)17-8-19(26(3,4)32)11-20(9-17)28(29,30)31/h6-13,36H,5,14-15,32H2,1-4H3,(H,34,35) ALXANPICAYVDLF-UHFFFAOYSA-N 313501 3-(2-aminopropan-2-yl)- N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-5- (trifluoromethyl)benzamide::US10167279, Example 120 RAF proto-oncogene serine/threonine-protein kinase Human 2197 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313501&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609362 383540400 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605845 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)ccc1C InChI=1S/C28H30F3N3O4/c1-5-38-25-23(27(36)14-37-15-27)10-18(13-33-25)22-12-21(7-6-16(22)2)34-24(35)17-8-19(26(3,4)32)11-20(9-17)28(29,30)31/h6-13,36H,5,14-15,32H2,1-4H3,(H,34,35) ALXANPICAYVDLF-UHFFFAOYSA-N 313501 3-(2-aminopropan-2-yl)- N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-5- (trifluoromethyl)benzamide::US10167279, Example 120 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 10017 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313501&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609362 383540400 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605846 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C27H28N4O4/c1-5-35-25-22(27(33)15-34-16-27)10-19(13-30-25)21-12-20(7-6-17(21)2)31-24(32)18-8-9-29-23(11-18)26(3,4)14-28/h6-13,33H,5,15-16H2,1-4H3,(H,31,32) OYJLVSPDFAHQND-UHFFFAOYSA-N 313502 2-(2-cyanopropan-2-yl)- N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 121 RAF proto-oncogene serine/threonine-protein kinase Human 975 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313502&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609474 383540401 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605847 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C27H28N4O4/c1-5-35-25-22(27(33)15-34-16-27)10-19(13-30-25)21-12-20(7-6-17(21)2)31-24(32)18-8-9-29-23(11-18)26(3,4)14-28/h6-13,33H,5,15-16H2,1-4H3,(H,31,32) OYJLVSPDFAHQND-UHFFFAOYSA-N 313502 2-(2-cyanopropan-2-yl)- N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 121 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 4930 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313502&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609474 383540401 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605848 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C26H28FN3O4/c1-5-34-24-21(26(32)14-33-15-26)10-18(13-29-24)20-12-19(7-6-16(20)2)30-23(31)17-8-9-28-22(11-17)25(3,4)27/h6-13,32H,5,14-15H2,1-4H3,(H,30,31) JLCYWYQVCUUVPR-UHFFFAOYSA-N 313503 N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-2-(2- fluoropropan-2- yl)isonicotinamide::US10167279, Example 122 RAF proto-oncogene serine/threonine-protein kinase Human 321 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313503&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609596 383540402 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605849 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C26H28FN3O4/c1-5-34-24-21(26(32)14-33-15-26)10-18(13-29-24)20-12-19(7-6-16(20)2)30-23(31)17-8-9-28-22(11-17)25(3,4)27/h6-13,32H,5,14-15H2,1-4H3,(H,30,31) JLCYWYQVCUUVPR-UHFFFAOYSA-N 313503 N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-2-(2- fluoropropan-2- yl)isonicotinamide::US10167279, Example 122 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1786 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313503&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609596 383540402 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605850 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C25H25F2N3O4/c1-4-34-23-20(25(32)13-33-14-25)9-17(12-29-23)19-11-18(6-5-15(19)2)30-22(31)16-7-8-28-21(10-16)24(3,26)27/h5-12,32H,4,13-14H2,1-3H3,(H,30,31) HPSMLWQYKYTEBX-UHFFFAOYSA-N 313504 2-(1,1-difluoroethyl)-N- (3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 123 RAF proto-oncogene serine/threonine-protein kinase Human 165 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313504&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609600 383540403 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605851 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C25H25F2N3O4/c1-4-34-23-20(25(32)13-33-14-25)9-17(12-29-23)19-11-18(6-5-15(19)2)30-22(31)16-7-8-28-21(10-16)24(3,26)27/h5-12,32H,4,13-14H2,1-3H3,(H,30,31) HPSMLWQYKYTEBX-UHFFFAOYSA-N 313504 2-(1,1-difluoroethyl)-N- (3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 123 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1217 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313504&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609600 383540403 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605852 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H22F3N3O4/c1-3-34-22-19(23(32)12-33-13-23)8-16(11-29-22)18-10-17(5-4-14(18)2)30-21(31)15-6-7-28-20(9-15)24(25,26)27/h4-11,32H,3,12-13H2,1-2H3,(H,30,31) DKCXDMLQBAHOEY-UHFFFAOYSA-N 313505 N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 124 RAF proto-oncogene serine/threonine-protein kinase Human 372 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313505&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609397 383540404 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605853 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H22F3N3O4/c1-3-34-22-19(23(32)12-33-13-23)8-16(11-29-22)18-10-17(5-4-14(18)2)30-21(31)15-6-7-28-20(9-15)24(25,26)27/h4-11,32H,3,12-13H2,1-2H3,(H,30,31) DKCXDMLQBAHOEY-UHFFFAOYSA-N 313505 N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 124 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2282 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313505&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609397 383540404 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605854 Cc1ncc(NC(=O)c2cc(ccn2)C(C)(C)C#N)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C26H26N4O2/c1-17-22(18-6-5-7-20(10-18)26(4)15-32-16-26)12-21(13-29-17)30-24(31)23-11-19(8-9-28-23)25(2,3)14-27/h5-13H,15-16H2,1-4H3,(H,30,31) WLJNMTIZJUJAPS-UHFFFAOYSA-N 313506 4-(2-cyanopropan-2-yl)- N-(6-methyl-5-(3-(3- methyloxetan-3- yl)phenyl)pyridin-3- yl)picolinamide::US10167279, Example 126 RAF proto-oncogene serine/threonine-protein kinase Human 1965 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313506&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609598 383540405 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605855 Cc1ncc(NC(=O)c2cc(ccn2)C(C)(C)C#N)cc1-c1cccc(c1)C1(C)COC1 InChI=1S/C26H26N4O2/c1-17-22(18-6-5-7-20(10-18)26(4)15-32-16-26)12-21(13-29-17)30-24(31)23-11-19(8-9-28-23)25(2,3)14-27/h5-13H,15-16H2,1-4H3,(H,30,31) WLJNMTIZJUJAPS-UHFFFAOYSA-N 313506 4-(2-cyanopropan-2-yl)- N-(6-methyl-5-(3-(3- methyloxetan-3- yl)phenyl)pyridin-3- yl)picolinamide::US10167279, Example 126 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 7736 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313506&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609598 383540405 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605856 CCOc1nnc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)cnc1C InChI=1S/C24H25F2N5O3/c1-5-34-22-18(23(3)12-33-13-23)10-19(30-31-22)17-9-16(11-28-14(17)2)29-21(32)15-6-7-27-20(8-15)24(4,25)26/h6-11H,5,12-13H2,1-4H3,(H,29,32) OQXATZCVEBFCLS-UHFFFAOYSA-N 313507 2-(1,1-difluoroethyl)-N- (5-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridazin-3-yl)-6- methylpyridin-3- yl)isonicotinamide::US10167279, Example 127 RAF proto-oncogene serine/threonine-protein kinase Human 987 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313507&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609458 383540406 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605857 CCOc1nnc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)cnc1C InChI=1S/C24H25F2N5O3/c1-5-34-22-18(23(3)12-33-13-23)10-19(30-31-22)17-9-16(11-28-14(17)2)29-21(32)15-6-7-27-20(8-15)24(4,25)26/h6-11H,5,12-13H2,1-4H3,(H,29,32) OQXATZCVEBFCLS-UHFFFAOYSA-N 313507 2-(1,1-difluoroethyl)-N- (5-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridazin-3-yl)-6- methylpyridin-3- yl)isonicotinamide::US10167279, Example 127 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3152 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313507&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609458 383540406 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605858 CCOc1nnc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C25H28FN5O3/c1-6-34-23-19(25(5)13-33-14-25)11-20(30-31-23)18-10-17(12-28-15(18)2)29-22(32)16-7-8-27-21(9-16)24(3,4)26/h7-12H,6,13-14H2,1-5H3,(H,29,32) YTWZCJWFFFAMFJ-UHFFFAOYSA-N 313508 N-(5-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-2- (2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 128 RAF proto-oncogene serine/threonine-protein kinase Human 633 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313508&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609661 383540407 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605859 CCOc1nnc(cc1C1(C)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C25H28FN5O3/c1-6-34-23-19(25(5)13-33-14-25)11-20(30-31-23)18-10-17(12-28-15(18)2)29-22(32)16-7-8-27-21(9-16)24(3,4)26/h7-12H,6,13-14H2,1-5H3,(H,29,32) YTWZCJWFFFAMFJ-UHFFFAOYSA-N 313508 N-(5-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-2- (2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 128 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 2146 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313508&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609661 383540407 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605860 CCOc1nnc(cc1C1(C)COC1)-c1cc(NC(=O)c2cc(CN(C)C)cc(c2)C(F)(F)F)cnc1C InChI=1S/C27H30F3N5O3/c1-6-38-25-22(26(3)14-37-15-26)11-23(33-34-25)21-10-20(12-31-16(21)2)32-24(36)18-7-17(13-35(4)5)8-19(9-18)27(28,29)30/h7-12H,6,13-15H2,1-5H3,(H,32,36) TWDDTYCQVMBBCA-UHFFFAOYSA-N 313509 3- ((dimethylamino)methyl)- N-(5-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 129 RAF proto-oncogene serine/threonine-protein kinase Human 3536 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313509&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609665 383540408 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605861 CCOc1nnc(cc1C1(C)COC1)-c1cc(NC(=O)c2cc(CN(C)C)cc(c2)C(F)(F)F)cnc1C InChI=1S/C27H30F3N5O3/c1-6-38-25-22(26(3)14-37-15-26)11-23(33-34-25)21-10-20(12-31-16(21)2)32-24(36)18-7-17(13-35(4)5)8-19(9-18)27(28,29)30/h7-12H,6,13-15H2,1-5H3,(H,32,36) TWDDTYCQVMBBCA-UHFFFAOYSA-N 313509 3- ((dimethylamino)methyl)- N-(5-(6-ethoxy-5-(3- methyloxetan-3- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 129 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 23364 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313509&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609665 383540408 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605862 CCOc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H28F4N4O3/c1-5-38-24-22(26(28)13-37-14-26)8-17(11-34-24)21-10-20(12-33-15(21)2)35-23(36)16-6-18(25(3,4)32)9-19(7-16)27(29,30)31/h6-12H,5,13-14,32H2,1-4H3,(H,35,36) NCKPRAQCCHITBM-UHFFFAOYSA-N 313510 3-(2-aminopropan-2-yl)- N-(6'-ethoxy-5'-(3- fluorooxetan-3-yl)-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 130 RAF proto-oncogene serine/threonine-protein kinase Human 3088 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313510&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609607 383540409 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605863 CCOc1ncc(cc1C1(F)COC1)-c1cc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(C)(C)N)cnc1C InChI=1S/C27H28F4N4O3/c1-5-38-24-22(26(28)13-37-14-26)8-17(11-34-24)21-10-20(12-33-15(21)2)35-23(36)16-6-18(25(3,4)32)9-19(7-16)27(29,30)31/h6-12H,5,13-14,32H2,1-4H3,(H,35,36) NCKPRAQCCHITBM-UHFFFAOYSA-N 313510 3-(2-aminopropan-2-yl)- N-(6'-ethoxy-5'-(3- fluorooxetan-3-yl)-2- methyl-[3,3'-bipyridin]- 5-yl)-5- (trifluoromethyl)benzamide::US10167279, Example 130 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 20064 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313510&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609607 383540409 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605864 CCOc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H28F2N4O3/c1-5-35-24-21(26(13-27)14-34-15-26)8-18(11-31-24)20-10-19(12-30-16(20)2)32-23(33)17-6-7-29-22(9-17)25(3,4)28/h6-12H,5,13-15H2,1-4H3,(H,32,33) UZEWNQQQGQUITO-UHFFFAOYSA-N 313313 N-(6''-ethoxy-5''-(3- (fluoromethyl)oxetan-3- yl)-2-methyl-[3,3''- bipyridin]-5-yl)-2-(2- fluoropropan-2- yl)isonicotinamide::US10167279, Example 131::US10167279, Example 32 RAF proto-oncogene serine/threonine-protein kinase Human 310 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313313&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609619 383540219 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605865 CCOc1ncc(cc1C1(CF)COC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H28F2N4O3/c1-5-35-24-21(26(13-27)14-34-15-26)8-18(11-31-24)20-10-19(12-30-16(20)2)32-23(33)17-6-7-29-22(9-17)25(3,4)28/h6-12H,5,13-15H2,1-4H3,(H,32,33) UZEWNQQQGQUITO-UHFFFAOYSA-N 313313 N-(6''-ethoxy-5''-(3- (fluoromethyl)oxetan-3- yl)-2-methyl-[3,3''- bipyridin]-5-yl)-2-(2- fluoropropan-2- yl)isonicotinamide::US10167279, Example 131::US10167279, Example 32 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1299 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313313&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609619 383540219 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605866 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)COC1 InChI=1S/C25H23F4N3O4/c1-15-20(17-8-21(24(12-26)13-35-14-24)32-22(9-17)36-6-5-33)10-19(11-30-15)31-23(34)16-3-2-4-18(7-16)25(27,28)29/h2-4,7-11,33H,5-6,12-14H2,1H3,(H,31,34) JTBKTXQEPCCZFG-UHFFFAOYSA-N 313512 N-(2'-(3- (fluoromethyl)oxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,4'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 132 RAF proto-oncogene serine/threonine-protein kinase Human 85.3 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313512&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609557 383540410 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605867 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(OCCO)nc(c1)C1(CF)COC1 InChI=1S/C26H28F2N4O4/c1-16-20(18-9-22(26(13-27)14-35-15-26)32-23(10-18)36-7-6-33)11-19(12-30-16)31-24(34)17-4-5-29-21(8-17)25(2,3)28/h4-5,8-12,33H,6-7,13-15H2,1-3H3,(H,31,34) AGOXUTAYUGZEIV-UHFFFAOYSA-N 313513 N-(2'-(3- (fluoromethyl)oxetan-3- yl)-6'-(2- hydroxyethoxy)-2- methyl-[3,4'-bipyridin]- 5-yl)-2-(2-fluoropropan- 2-yl)isonicotinamide::US10167279, Example 133 RAF proto-oncogene serine/threonine-protein kinase Human 1282 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313513&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609634 383540411 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605868 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C27H23F4NO4/c1-16-5-6-22(32-24(33)17-3-2-4-19(7-17)27(29,30)31)11-23(16)18-8-20(25(28)12-35-13-25)10-21(9-18)26(34)14-36-15-26/h2-11,34H,12-15H2,1H3,(H,32,33) GHBRBCZIIRPLBG-UHFFFAOYSA-N 313514 N-(3'-(3-fluorooxetan-3- yl)-5'-(3-hydroxyoxetan- 3-yl)-6-methyl-[1,1'- biphenyl]-3-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 134 RAF proto-oncogene serine/threonine-protein kinase Human 566 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313514&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609659 383540412 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605869 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C26H22F4N2O4/c1-15-2-3-20(32-23(33)16-4-5-31-22(8-16)26(28,29)30)10-21(15)17-6-18(24(27)11-35-12-24)9-19(7-17)25(34)13-36-14-25/h2-10,34H,11-14H2,1H3,(H,32,33) LBAIDCWGSUTHAK-UHFFFAOYSA-N 313515 N-(3'-(3-fluorooxetan-3- yl)-5'-(3-hydroxyoxetan- 3-yl)-6-methyl-[1,1'- biphenyl]-3-yl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 135 RAF proto-oncogene serine/threonine-protein kinase Human 605 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313515&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609643 383540413 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605870 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C27H25F3N2O4/c1-16-3-4-21(32-24(33)17-5-6-31-23(9-17)25(2,28)29)11-22(16)18-7-19(26(30)12-35-13-26)10-20(8-18)27(34)14-36-15-27/h3-11,34H,12-15H2,1-2H3,(H,32,33) GVUYCFJZBKKCKQ-UHFFFAOYSA-N 313516 2-(1,1-difluoroethyl)-N- (3'-(3-fluorooxetan-3- yl)-5'-(3-hydroxyoxetan- 3-yl)-6-methyl-[1,1'- biphenyl]-3- yl)isonicotinamide::US10167279, Example 136 RAF proto-oncogene serine/threonine-protein kinase Human 177 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313516&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609413 383540414 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605871 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C28H28F2N2O4/c1-17-4-5-22(32-25(33)18-6-7-31-24(10-18)26(2,3)29)12-23(17)19-8-20(27(30)13-35-14-27)11-21(9-19)28(34)15-36-16-28/h4-12,34H,13-16H2,1-3H3,(H,32,33) FNWMEWMEKNQGPN-UHFFFAOYSA-N 313517 N-(3'-(3-fluorooxetan-3- yl)-5'-(3-hydroxyoxetan- 3-yl)-6-methyl-[1,1'- biphenyl]-3-yl)-2-(2- fluoropropan-2- yl)isonicotinamide::US10167279, Example 137 RAF proto-oncogene serine/threonine-protein kinase Human 3319 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313517&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609370 383540415 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605872 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C29H28FN3O4/c1-18-4-5-23(33-26(34)19-6-7-32-25(10-19)27(2,3)13-31)12-24(18)20-8-21(28(30)14-36-15-28)11-22(9-20)29(35)16-37-17-29/h4-12,35H,14-17H2,1-3H3,(H,33,34) XUTPNQCCUPMLOT-UHFFFAOYSA-N 313518 2-(2-cyanopropan-2-yl)- N-(3'-(3-fluorooxetan-3- yl)-5'-(3-hydroxyoxetan- 3-yl)-6-methyl-[1,1'- biphenyl]-3- yl)isonicotinamide::US10167279, Example 138 RAF proto-oncogene serine/threonine-protein kinase Human 2187 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313518&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609615 383540416 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605873 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C26H22F4N2O4/c1-15-22(9-21(10-31-15)32-23(33)16-3-2-4-18(5-16)26(28,29)30)17-6-19(24(27)11-35-12-24)8-20(7-17)25(34)13-36-14-25/h2-10,34H,11-14H2,1H3,(H,32,33) VCQJQJJPKADVNJ-UHFFFAOYSA-N 313519 N-(5-(3-(3-fluorooxetan- 3-yl)-5-(3- hydroxyoxetan-3- yl)phenyl)-6- methylpyridin-3-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 139 RAF proto-oncogene serine/threonine-protein kinase Human 1182 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313519&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609418 383540417 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605874 Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C25H21F4N3O4/c1-14-20(8-19(9-31-14)32-22(33)15-2-3-30-21(6-15)25(27,28)29)16-4-17(23(26)10-35-11-23)7-18(5-16)24(34)12-36-13-24/h2-9,34H,10-13H2,1H3,(H,32,33) BLVUYQXNJLDKJB-UHFFFAOYSA-N 313520 N-(5-(3-(3-fluorooxetan- 3-yl)-5-(3- hydroxyoxetan-3- yl)phenyl)-6- methylpyridin-3-yl)-3- (trifluoromethyl)isonicotin- amide::US10167279, Example 140 RAF proto-oncogene serine/threonine-protein kinase Human 8088 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313520&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133629 383540418 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605875 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C26H24F3N3O4/c1-15-21(9-20(10-31-15)32-23(33)16-3-4-30-22(7-16)24(2,27)28)17-5-18(25(29)11-35-12-25)8-19(6-17)26(34)13-36-14-26/h3-10,34H,11-14H2,1-2H3,(H,32,33) DTNRMUFBUVKLNW-UHFFFAOYSA-N 313521 2-(1,1-difluoroethyl)-N- (5-(3-(3-fluorooxetan-3- yl)-5-(3-hydroxyoxetan- 3-yl)phenyl)-6- methylpyridin-3- yl)isonicotinamide::US10167279, Example 141 RAF proto-oncogene serine/threonine-protein kinase Human 5899 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313521&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609369 383540419 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605876 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C27H27F2N3O4/c1-16-22(10-21(11-31-16)32-24(33)17-4-5-30-23(8-17)25(2,3)28)18-6-19(26(29)12-35-13-26)9-20(7-18)27(34)14-36-15-27/h4-11,34H,12-15H2,1-3H3,(H,32,33) CGDYDOWVZTXJCZ-UHFFFAOYSA-N 313522 N-(5-(3-(3-fluorooxetan- 3-yl)-5-(3- hydroxyoxetan-3- yl)phenyl)-6- methylpyridin-3-yl)-2- (2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 142 RAF proto-oncogene serine/threonine-protein kinase Human 11196 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313522 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313522&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609522 383540420 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605877 Cc1ncc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(cc(c1)C1(F)COC1)C1(O)COC1 InChI=1S/C28H27FN4O4/c1-17-23(19-6-20(27(29)13-36-14-27)9-21(7-19)28(35)15-37-16-28)10-22(11-32-17)33-25(34)18-4-5-31-24(8-18)26(2,3)12-30/h4-11,35H,13-16H2,1-3H3,(H,33,34) RNGMJPFWMOXMFH-UHFFFAOYSA-N 313523 2-(2-cyanopropan-2-yl)- N-(5-(3-(3-fluorooxetan- 3-yl)-5-(3- hydroxyoxetan-3- yl)phenyl)-6- methylpyridin-3- yl)isonicotinamide::US10167279, Example 143 RAF proto-oncogene serine/threonine-protein kinase Human 4362 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313523 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313523&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609696 383540421 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605878 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc(-c2cnn(C)c2)c(c1)C1(O)COC1 InChI=1S/C27H25F2N5O3/c1-16-4-5-20(33-25(35)17-6-7-30-23(9-17)26(2,28)29)10-21(16)18-8-22(27(36)14-37-15-27)24(31-11-18)19-12-32-34(3)13-19/h4-13,36H,14-15H2,1-3H3,(H,33,35) JCRUGRFRGGGUKL-UHFFFAOYSA-N 313524 2-(1,1-difluoroethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-(1-methyl-1H- pyrazol-4-yl)pyridin-3- yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 144 RAF proto-oncogene serine/threonine-protein kinase Human 364 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313524&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609408 383540422 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605879 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc(-c2cnn(C)c2)c(c1)C1(O)COC1 InChI=1S/C27H25F2N5O3/c1-16-4-5-20(33-25(35)17-6-7-30-23(9-17)26(2,28)29)10-21(16)18-8-22(27(36)14-37-15-27)24(31-11-18)19-12-32-34(3)13-19/h4-13,36H,14-15H2,1-3H3,(H,33,35) JCRUGRFRGGGUKL-UHFFFAOYSA-N 313524 2-(1,1-difluoroethyl)-N- (3-(5-(3-hydroxyoxetan- 3-yl)-6-(1-methyl-1H- pyrazol-4-yl)pyridin-3- yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 144 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 1670 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313524 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313524&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609408 383540422 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605880 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1ccnc(c1)S(C)(=O)=O InChI=1S/C23H23N3O6S/c1-14-4-5-15(21(27)26-17-6-7-24-20(10-17)33(3,29)30)8-18(14)16-9-19(22(31-2)25-11-16)23(28)12-32-13-23/h4-11,28H,12-13H2,1-3H3,(H,24,26,27) MTPVDZHGAJLHOQ-UHFFFAOYSA-N 313525 3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methyl-N-(2- (methylsulfonyl)pyridin- 4-yl)benzamide::US10167279, Example 145 RAF proto-oncogene serine/threonine-protein kinase Human 7291 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313525&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609691 383540423 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605881 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1ccnc(c1)S(C)(=O)=O InChI=1S/C23H23N3O6S/c1-14-4-5-15(21(27)26-17-6-7-24-20(10-17)33(3,29)30)8-18(14)16-9-19(22(31-2)25-11-16)23(28)12-32-13-23/h4-11,28H,12-13H2,1-3H3,(H,24,26,27) MTPVDZHGAJLHOQ-UHFFFAOYSA-N 313525 3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methyl-N-(2- (methylsulfonyl)pyridin- 4-yl)benzamide::US10167279, Example 145 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 49260 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313525 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313525&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609691 383540423 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605882 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1cccc(c1)C(C)(C)C#N InChI=1S/C27H27N3O4/c1-17-8-9-18(24(31)30-21-7-5-6-20(12-21)26(2,3)14-28)10-22(17)19-11-23(25(33-4)29-13-19)27(32)15-34-16-27/h5-13,32H,15-16H2,1-4H3,(H,30,31) MPBGECWPUIBRGT-UHFFFAOYSA-N 313526 N-(3-(2-cyanopropan-2- yl)phenyl)-3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylbenzamide::US10167279, Example 146 RAF proto-oncogene serine/threonine-protein kinase Human 801 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313526&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609650 383540424 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605883 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1cccc(c1)C(C)(C)C#N InChI=1S/C27H27N3O4/c1-17-8-9-18(24(31)30-21-7-5-6-20(12-21)26(2,3)14-28)10-22(17)19-11-23(25(33-4)29-13-19)27(32)15-34-16-27/h5-13,32H,15-16H2,1-4H3,(H,30,31) MPBGECWPUIBRGT-UHFFFAOYSA-N 313526 N-(3-(2-cyanopropan-2- yl)phenyl)-3-(5-(3- hydroxyoxetan-3-yl)-6- methoxypyridin-3-yl)-4- methylbenzamide::US10167279, Example 146 Serine/threonine-protein kinase B-raf [416-766,V600E] Human 3311 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313526 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=387&target=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313526&enzyme=Serine%2Fthreonine-protein+kinase+B-raf+%5B416-766%2CV600E%5D&column=ki&startPg=0&Increment=50&submit=Search 134609650 383540424 1 LQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH 8VYR,8VYP,7ZR6,7ZR5,7ZR0,4MNF,5C9C,4G9R,4EHG,1UWJ,6N0P,8F7P,8F7O Serine/threonine-protein kinase B-raf BRAF_HUMAN P15056 A4D1T4 B6HY61 B6HY62 B6HY63 B6HY64 B6HY65 B6HY66 Q13878 Q3MIN6 Q9UDP8 Q9Y6T3 605884 CCOc1ncc(cc1C1(O)COC1)-c1cc(NC(=O)c2cc(cc(n2)C(C)(C)N)C(F)(F)F)ccc1C InChI=1S/C27H29F3N4O4/c1-5-38-24-20(26(36)13-37-14-26)8-16(12-32-24)19-11-18(7-6-15(19)2)33-23(35)21-9-17(27(28,29)30)10-22(34-21)25(3,4)31/h6-12,36H,5,13-14,31H2,1-4H3,(H,33,35) KWVFWGQILDSEBY-UHFFFAOYSA-N 313527 6-(2-aminopropan-2-yl)- N-(3-(6-ethoxy-5-(3- hydroxyoxetan-3- yl)pyridin-3-yl)-4- methylphenyl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 147 RAF proto-oncogene serine/threonine-protein kinase Human 4507 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313527 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313527&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609624 383540425 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605885 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2cc(cc(n2)C(C)(C)N)C(F)(F)F)cnc1C InChI=1S/C26H26F5N5O3/c1-13-17(14-5-18(22(38-4)34-9-14)25(23(27)28)11-39-12-25)8-16(10-33-13)35-21(37)19-6-15(26(29,30)31)7-20(36-19)24(2,3)32/h5-10,23H,11-12,32H2,1-4H3,(H,35,37) LHSOISYUBZVEFJ-UHFFFAOYSA-N 313528 6-(2-aminopropan-2-yl)- N-(5'-(3- (difluoromethyl)oxetan- 3-yl)-6'-methoxy-2- methyl-[3,3'-bipyridin]- 5-yl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 148 RAF proto-oncogene serine/threonine-protein kinase Human 9201 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313528 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313528&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609568 383540426 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605886 COc1ncc(cc1C1(COC1)C(F)F)-c1cc(NC(=O)c2cc(cc(n2)C(C)(C)N)C(F)(F)F)ccc1C InChI=1S/C27H27F5N4O3/c1-14-5-6-17(35-22(37)20-8-16(27(30,31)32)9-21(36-20)25(2,3)33)10-18(14)15-7-19(23(38-4)34-11-15)26(24(28)29)12-39-13-26/h5-11,24H,12-13,33H2,1-4H3,(H,35,37) NSWQQXYRIBJKKH-UHFFFAOYSA-N 313529 6-(2-aminopropan-2-yl)- N-(3-(5-(3- (difluoromethyl)oxetan- 3-yl)-6-methoxypyridin- 3-yl)-4-methylphenyl)- 4- (trifluoromethyl)picolin- amide::US10167279, Example 149 RAF proto-oncogene serine/threonine-protein kinase Human 871 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313529 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313529&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609556 383540427 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605887 COc1ncc(cc1C1(O)COC1)-c1cc(ccc1C)C(=O)Nc1cc(cc(c1)C(F)(F)F)C(C)(C)N InChI=1S/C27H28F3N3O4/c1-15-5-6-16(7-21(15)17-8-22(24(36-4)32-12-17)26(35)13-37-14-26)23(34)33-20-10-18(25(2,3)31)9-19(11-20)27(28,29)30/h5-12,35H,13-14,31H2,1-4H3,(H,33,34) SOFHDPONURJURV-UHFFFAOYSA-N 313530 N-(3-(2-aminopropan-2- yl)-5- (trifluoromethyl)phenyl)- 3-(5-(3-hydroxyoxetan- 3-yl)-6-methoxypyridin- 3-yl)-4- methylbenzamide::US10167279, Example 150 RAF proto-oncogene serine/threonine-protein kinase Human 3000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313530 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313530&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609465 383540428 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605888 COC1(COC1)c1cc(cc(NCCO)n1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C25H25F3N4O4/c1-15-20(17-9-21(24(35-2)13-36-14-24)32-22(10-17)29-6-7-33)11-19(12-30-15)31-23(34)16-4-3-5-18(8-16)25(26,27)28/h3-5,8-12,33H,6-7,13-14H2,1-2H3,(H,29,32)(H,31,34) GYKSESLNXQUMKK-UHFFFAOYSA-N 313531 N-(2'-((2- hydroxyethyl)amino)-6'- (3-methoxyoxetan-3-yl)- 2-methyl-[3,4'- bipyridin]-5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 152 RAF proto-oncogene serine/threonine-protein kinase Human 80.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313531 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313531&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609533 383540429 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605889 COC1(COC1)c1cc(cc(NCCO)n1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)ccc1C InChI=1S/C26H26F3N3O4/c1-16-6-7-20(31-24(34)17-4-3-5-19(10-17)26(27,28)29)13-21(16)18-11-22(25(35-2)14-36-15-25)32-23(12-18)30-8-9-33/h3-7,10-13,33H,8-9,14-15H2,1-2H3,(H,30,32)(H,31,34) HHYBGGHNCKGCTI-UHFFFAOYSA-N 313532 N-(3-(2-((2- hydroxyethyl)amino)-6- (3-methoxyoxetan-3- yl)pyridin-4-yl)-4- methylphenyl)-3- (trifluoromethyl)benzamide::US10167279, Example 153 RAF proto-oncogene serine/threonine-protein kinase Human 40.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313532 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313532&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609553 383540430 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605890 COC1(COC1)c1cc(cc(NCCO)n1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)ccc1C InChI=1S/C25H25F3N4O4/c1-15-3-4-18(31-23(34)20-11-17(5-6-29-20)25(26,27)28)12-19(15)16-9-21(24(35-2)13-36-14-24)32-22(10-16)30-7-8-33/h3-6,9-12,33H,7-8,13-14H2,1-2H3,(H,30,32)(H,31,34) GEKOHQGSTMYGTB-UHFFFAOYSA-N 313533 N-(3-(2-((2- hydroxyethyl)amino)-6- (3-methoxyoxetan-3- yl)pyridin-4-yl)-4- methylphenyl)-4- (trifluoromethyl)picolin- amide::US10167279, Example 154 RAF proto-oncogene serine/threonine-protein kinase Human 40.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313533 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313533&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609462 383540431 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605891 COC1(COC1)c1cc(cc(OCCO)n1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C25H24F3N3O5/c1-15-3-4-18(30-23(33)16-5-6-29-21(9-16)25(26,27)28)12-19(15)17-10-20(24(34-2)13-35-14-24)31-22(11-17)36-8-7-32/h3-6,9-12,32H,7-8,13-14H2,1-2H3,(H,30,33) AIHPQERPNVZGJJ-UHFFFAOYSA-N 313534 N-(3-(2-(2- hydroxyethoxy)-6-(3- methoxyoxetan-3- yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl)isonicotin- amide::US10167279, Example 157 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313534 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313534&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609627 383540432 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605892 COC1(COC1)c1cc(cc(OCCO)n1)-c1cc(NC(=O)c2ccnc(c2)C(F)F)ccc1C InChI=1S/C25H25F2N3O5/c1-15-3-4-18(29-24(32)16-5-6-28-20(9-16)23(26)27)12-19(15)17-10-21(25(33-2)13-34-14-25)30-22(11-17)35-8-7-31/h3-6,9-12,23,31H,7-8,13-14H2,1-2H3,(H,29,32) DIRNAOPQVFONMT-UHFFFAOYSA-N 313535 2-(difluoromethyl)-N- (3-(2-(2- hydroxyethoxy)-6-(3- methoxyoxetan-3- yl)pyridin-4-yl)-4- methylphenyl)isonicotin- amide::US10167279, Example 158 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313535 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313535&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609541 383540433 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605893 COC1(COC1)c1cc(cc(OCCO)n1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C25H24F3N3O5/c1-15-20(17-9-21(24(34-2)13-35-14-24)31-22(10-17)36-7-6-32)11-19(12-29-15)30-23(33)16-4-3-5-18(8-16)25(26,27)28/h3-5,8-12,32H,6-7,13-14H2,1-2H3,(H,30,33) NJTZCEUYZBMQHN-UHFFFAOYSA-N 313536 N-(2'-(2- hydroxyethoxy)-6'-(3- methoxyoxetan-3-yl)-2- methyl-[3,4'-bipyridin]- 5-yl)-3- (trifluoromethyl)benzamide::US10167279, Example 160 RAF proto-oncogene serine/threonine-protein kinase Human 700 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313536 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313536&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609361 383540434 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605894 CCOc1ncc(cc1C1CCOCC1)-c1cc(NC(=O)c2cnnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C27H30N6O3/c1-5-36-26-23(18-6-8-35-9-7-18)10-19(13-30-26)22-12-21(15-29-17(22)2)32-25(34)20-11-24(33-31-14-20)27(3,4)16-28/h10-15,18H,5-9H2,1-4H3,(H,32,34) YYPOSKLIXGYYGS-UHFFFAOYSA-N 313537 6-(2-cyanopropan-2-yl)-N-(6-ethoxy-2-methyl-5′-tetrahydro-2H-pyran-4-yl)-[3,3-′bipyridin]-5-yl)pyridazine-4-carboxamide::US10167279, Example 161 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313537 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313537&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118949105 383540435 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605895 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C26H26F3N3O5/c1-15-2-3-18(31-25(35)16-4-6-30-23(11-16)26(27,28)29)13-20(15)17-10-21(19-5-8-36-14-22(19)34)32-24(12-17)37-9-7-33/h2-4,6,10-13,19,22,33-34H,5,7-9,14H2,1H3,(H,31,35) FWJIIHAZGHCLGJ-UHFFFAOYSA-N 313538 US10167279, Example 251::US10167279, Example 250::N-(3-(2-(2-hydroxyethoxy)-6-(3-hydroxytetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide::US10167279, Example 162 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313538&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609482 383540436 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605896 CCOc1ncc(cc1C1CCOCC1)-c1cc(NC(=O)c2cnnc(c2)C(F)(F)F)cnc1C InChI=1S/C24H24F3N5O3/c1-3-35-23-20(15-4-6-34-7-5-15)8-16(11-29-23)19-10-18(13-28-14(19)2)31-22(33)17-9-21(24(25,26)27)32-30-12-17/h8-13,15H,3-7H2,1-2H3,(H,31,33) XPLCJCINVSLPKA-UHFFFAOYSA-N 313539 N-(6'-ethoxy-2-methyl- 5'-(tetrahydro-2H-pyran- 4-yl)-[3,3'-bipyridin]-5- yl)-6-(trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 163 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313539 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313539&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609578 383540437 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605897 CCOc1ncc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C28H31N5O3/c1-5-36-27-24(19-7-10-35-11-8-19)12-21(15-32-27)23-14-22(16-31-18(23)2)33-26(34)20-6-9-30-25(13-20)28(3,4)17-29/h6,9,12-16,19H,5,7-8,10-11H2,1-4H3,(H,33,34) UHOAEPOPOAWGFR-UHFFFAOYSA-N 313540 2-(2-cyanopropan-2-yl)- N-(6'-ethoxy-2-methyl- 5'-(tetrahydro-2H-pyran- 4-yl)-[3,3'-bipyridin]-5- yl)isonicotinamide::US10167279, Example 164 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313540 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313540&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609398 383540438 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605898 CCOc1ncc(cc1C1(CF)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C27H30F2N4O3/c1-5-36-25-22(27(15-28)7-9-35-16-27)10-19(13-32-25)21-12-20(14-31-17(21)2)33-24(34)18-6-8-30-23(11-18)26(3,4)29/h6,8,10-14H,5,7,9,15-16H2,1-4H3,(H,33,34) DBFCZZIRKSCGOJ-UHFFFAOYSA-N 313541 N-(6'-ethoxy-5'-(3- (fluoromethyl)tetrahydro furan-3-yl)-2-methyl- [3,3'-bipyridin]-5-yl)-2- (2-fluoropropan-2- yl)isonicotinamide::US10167279, Example 165 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313541 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313541&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609662 383540439 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605899 CCOc1ncc(cc1C1(CF)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cnc1C InChI=1S/C28H30FN5O3/c1-5-37-26-23(28(15-29)7-9-36-17-28)10-20(13-33-26)22-12-21(14-32-18(22)2)34-25(35)19-6-8-31-24(11-19)27(3,4)16-30/h6,8,10-14H,5,7,9,15,17H2,1-4H3,(H,34,35) AGHVCOLHDMLFAL-UHFFFAOYSA-N 313542 2-(2-cyanopropan-2-yl)- N-(6'-ethoxy-5'-(3- (fluoromethyl)tetrahydro furan-3-yl)-2-methyl- [3,3'-bipyridin]-5- yl)isonicotinamide::US10167279, Example 166 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313542 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313542&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609692 383540440 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605900 CCOc1ncc(cc1C1(CF)CCOC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C26H25F4N3O3/c1-3-36-24-22(25(14-27)7-8-35-15-25)10-18(12-32-24)21-11-20(13-31-16(21)2)33-23(34)17-5-4-6-19(9-17)26(28,29)30/h4-6,9-13H,3,7-8,14-15H2,1-2H3,(H,33,34) VYDQGCDLANAUHN-UHFFFAOYSA-N 313543 N-(6'-ethoxy-5'-(3- (fluoromethyl)tetrahydro furan-3-yl)-2-methyl- [3,3'-bipyridin]-5-yl)-3- (trifluoromethyl) benzamide::US10167279, Example 167 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313543 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313543&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609469 383540441 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605901 CCOc1ncc(cc1C1(CCOC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C26H23F3N4O3/c1-3-36-24-21(25(14-30)7-9-35-15-25)10-18(13-32-24)20-12-19(5-4-16(20)2)33-23(34)17-6-8-31-22(11-17)26(27,28)29/h4-6,8,10-13H,3,7,9,15H2,1-2H3,(H,33,34) LIKXKYXCAJBYQO-UHFFFAOYSA-N 313544 N-(3-(5-(3- cyanotetrahydrofuran-3- yl)-6-ethoxypyridin-3- yl)-4-methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 168 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313544 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313544&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609515 383540442 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605902 CCOc1ncc(cc1C1(CCOC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C29H29N5O3/c1-5-37-27-24(29(17-31)9-11-36-18-29)12-21(15-33-27)23-14-22(7-6-19(23)2)34-26(35)20-8-10-32-25(13-20)28(3,4)16-30/h6-8,10,12-15H,5,9,11,18H2,1-4H3,(H,34,35) VUUQQSSODBMHNV-UHFFFAOYSA-N 313545 2-(2-cyanopropan-2-yl)- N-(3-(5-(3- cyanotetrahydrofuran-3- yl)-6-ethoxypyridin-3- yl)-4-methylphenyl) isonicotinamide::US10167279, Example 169 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313545 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313545&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609486 383540443 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605903 CCOc1ncc(cc1C1(CCOC1)C#N)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C27H28FN5O3/c1-5-36-25-22(27(15-29)7-9-35-16-27)10-19(13-32-25)21-12-20(14-31-17(21)2)33-24(34)18-6-8-30-23(11-18)26(3,4)28/h6,8,10-14H,5,7,9,16H2,1-4H3,(H,33,34) IFNFBFJANFJMJX-UHFFFAOYSA-N 313546 N-(5'-(3- cyanotetrahydrofuran-3- yl)-6'-ethoxy-2-methyl- [3,3'-bipyridin]-5-yl)-2- (2-fluoropropan-2-yl) isonicotinamide::US10167279, Example 170 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313546 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313546&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609526 383540444 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605904 CCOc1ncc(cc1C1(CCOC1)C#N)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C26H23F3N4O3/c1-3-36-24-22(25(14-30)7-8-35-15-25)10-18(12-32-24)21-11-20(13-31-16(21)2)33-23(34)17-5-4-6-19(9-17)26(27,28)29/h4-6,9-13H,3,7-8,15H2,1-2H3,(H,33,34) NGZHIYQXRADWED-UHFFFAOYSA-N 313547 N-(5'-(3- cyanotetrahydrofuran-3- yl)-6'-ethoxy-2-methyl- [3,3'-bipyridin]-5-yl)-3- (trifluoromethyl) benzamide::US10167279, Example 171 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313547 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313547&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609472 383540445 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605905 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C26H27F3N4O3/c1-16-2-3-20(32-25(35)18-4-7-30-23(13-18)26(27,28)29)15-21(16)19-12-22(17-5-10-36-11-6-17)33-24(14-19)31-8-9-34/h2-4,7,12-15,17,34H,5-6,8-11H2,1H3,(H,31,33)(H,32,35) CUHGCVUHMAWPCM-UHFFFAOYSA-N 313548 N-(3-(2-((2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 172 RAF proto-oncogene serine/threonine-protein kinase Human 1992 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313548 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313548&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609592 383540446 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605906 CCC(F)(F)c1cc(ccn1)C(=O)Nc1ccc(C)c(c1)-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C28H32F2N4O3/c1-3-28(29,30)25-15-20(6-9-31-25)27(36)33-22-5-4-18(2)23(17-22)21-14-24(19-7-12-37-13-8-19)34-26(16-21)32-10-11-35/h4-6,9,14-17,19,35H,3,7-8,10-13H2,1-2H3,(H,32,34)(H,33,36) XVXJQQMXFFMSFX-UHFFFAOYSA-N 313549 2-(1,1-difluoropropyl)- N-(3-(2-((2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl-4- methylphenyl) isonicotinamide::US10167279, Example 173 RAF proto-oncogene serine/threonine-protein kinase Human 383 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313549 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313549&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133631 383540447 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605907 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C27H28F3N3O3/c1-17-5-6-22(32-26(35)19-3-2-4-21(13-19)27(28,29)30)16-23(17)20-14-24(18-7-11-36-12-8-18)33-25(15-20)31-9-10-34/h2-6,13-16,18,34H,7-12H2,1H3,(H,31,33)(H,32,35) QQKXKFGXJFXNAE-UHFFFAOYSA-N 313550 N-(3-(2-((2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl-4- methylphenyl)-3- (trifluoromethyl) benzamide::US10167279, Example 174 RAF proto-oncogene serine/threonine-protein kinase Human 331 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313550 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313550&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133665 383540448 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605908 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C29H33N5O3/c1-19-4-5-23(33-28(36)21-6-9-31-26(15-21)29(2,3)18-30)17-24(19)22-14-25(20-7-12-37-13-8-20)34-27(16-22)32-10-11-35/h4-6,9,14-17,20,35H,7-8,10-13H2,1-3H3,(H,32,34)(H,33,36) UZOCTXYRHFUYRR-UHFFFAOYSA-N 313551 2-(2-cyanopropan-2-yl)- N-(3-(2-((2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 175 RAF proto-oncogene serine/threonine-protein kinase Human 830 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313551 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313551&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609393 383540449 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605909 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N(CCO)CCO)C1CCOCC1 InChI=1S/C28H31F3N4O4/c1-18-2-3-22(33-27(38)20-4-7-32-25(15-20)28(29,30)31)17-23(18)21-14-24(19-5-12-39-13-6-19)34-26(16-21)35(8-10-36)9-11-37/h2-4,7,14-17,19,36-37H,5-6,8-13H2,1H3,(H,33,38) BBABBTASQGCUCI-UHFFFAOYSA-N 313552 N-(3-(2-(bis(2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 176 RAF proto-oncogene serine/threonine-protein kinase Human 684 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313552 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313552&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133585 383540450 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605910 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(nc(c1)N(CCO)CCO)C1CCOCC1 InChI=1S/C29H34F2N4O4/c1-19-3-4-23(33-28(38)21-5-8-32-26(16-21)29(2,30)31)18-24(19)22-15-25(20-6-13-39-14-7-20)34-27(17-22)35(9-11-36)10-12-37/h3-5,8,15-18,20,36-37H,6-7,9-14H2,1-2H3,(H,33,38) VKXYATMSQGRBHS-UHFFFAOYSA-N 313553 N-(3-(2-(bis(2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-(1,1- difluoroethyl) isonicotinamide::US10167279, Example 177 RAF proto-oncogene serine/threonine-protein kinase Human 621 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313553 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313553&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609649 383540451 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605911 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N(CCO)CCO)C1CCOCC1 InChI=1S/C29H32F3N3O4/c1-19-5-6-24(33-28(38)21-3-2-4-23(15-21)29(30,31)32)18-25(19)22-16-26(20-7-13-39-14-8-20)34-27(17-22)35(9-11-36)10-12-37/h2-6,15-18,20,36-37H,7-14H2,1H3,(H,33,38) KDARLYRUYXHESF-UHFFFAOYSA-N 313554 N-(3-(2-(bis(2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-3- trifluoromethyl) benzamide::US10167279, Example 178 RAF proto-oncogene serine/threonine-protein kinase Human 136 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313554 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313554&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133459 383540452 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605912 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(nc(c1)N(CCO)CCO)C1CCOCC1 InChI=1S/C31H37N5O4/c1-21-4-5-25(34-30(39)23-6-9-33-28(17-23)31(2,3)20-32)19-26(21)24-16-27(22-7-14-40-15-8-22)35-29(18-24)36(10-12-37)11-13-38/h4-6,9,16-19,22,37-38H,7-8,10-15H2,1-3H3,(H,34,39) LFIQSUXPNFFECE-UHFFFAOYSA-N 313555 N-(3-(2-(bis(2- hydroxyethyl)amino)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-(2- cyanopropan-2-yl) isonicotinamide::US10167279, Example 179 RAF proto-oncogene serine/threonine-protein kinase Human 795 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313555 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313555&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609653 383540453 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605913 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C26H27F3N4O3/c1-16-22(19-12-23(17-5-9-36-10-6-17)33-24(13-19)30-7-8-34)14-21(15-31-16)32-25(35)18-3-2-4-20(11-18)26(27,28)29/h2-4,11-15,17,34H,5-10H2,1H3,(H,30,33)(H,32,35) GTKHIKTZPNHVCJ-UHFFFAOYSA-N 313556 N-(2'-((2- hydroxyethyl)amino)-2- methyl-6'-(tetrahydro- 2H-pyran-4-yl)-[3,4'- bipyridin]-5-yl)-3- (trifluoromethyl) benzamide::US10167279, Example 180 RAF proto-oncogene serine/threonine-protein kinase Human 297 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313556 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313556&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609599 383540454 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605914 Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C25H26F3N5O3/c1-15-20(18-10-21(16-3-8-36-9-4-16)33-23(12-18)30-6-7-34)13-19(14-31-15)32-24(35)17-2-5-29-22(11-17)25(26,27)28/h2,5,10-14,16,34H,3-4,6-9H2,1H3,(H,30,33)(H,32,35) XXWCQOFTRCJSPN-UHFFFAOYSA-N 313557 N-(2'-((2- hydroxyethyl)amino)-2- methyl-6'-(tetrahydro- 2H-pyran-4-yl)-[3,4'- bipyridin]-5-yl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 181 RAF proto-oncogene serine/threonine-protein kinase Human 393 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313557 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313557&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609720 383540455 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605915 CCC(F)(F)c1cc(ccn1)C(=O)Nc1cnc(C)c(c1)-c1cc(NCCO)nc(c1)C1CCOCC1 InChI=1S/C27H31F2N5O3/c1-3-27(28,29)24-13-19(4-7-30-24)26(36)33-21-15-22(17(2)32-16-21)20-12-23(18-5-10-37-11-6-18)34-25(14-20)31-8-9-35/h4,7,12-16,18,35H,3,5-6,8-11H2,1-2H3,(H,31,34)(H,33,36) HMBWCHRXEYRESX-UHFFFAOYSA-N 313558 2-(1,1-difluoropropyl)- N-(2'-((2- hydroxyethyl)amino)-2- methyl-6'-(tetrahydro- 2H-pyran-4-yl)-[3,4'- bipyridin]-5-yl) isonicotinamide::US10167279, Example 182 RAF proto-oncogene serine/threonine-protein kinase Human 951 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313558 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313558&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609593 383540456 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605916 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N1CCC(O)CC1)C1CCOCC1 InChI=1S/C29H31F3N4O3/c1-18-25(16-23(17-33-18)34-28(38)20-3-2-4-22(13-20)29(30,31)32)21-14-26(19-7-11-39-12-8-19)35-27(15-21)36-9-5-24(37)6-10-36/h2-4,13-17,19,24,37H,5-12H2,1H3,(H,34,38) BOBJEMUPXHNUGZ-UHFFFAOYSA-N 313559 N-(2'-(4- hydroxypiperidin-1-yl)- 2-methyl-6'-(tetrahydro- 2H-pyran-4-yl)-[3,4'- bipyridin]-5-yl)-3- (trifluoromethyl) benzamide::US10167279, Example 183 RAF proto-oncogene serine/threonine-protein kinase Human 1992 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313559 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313559&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609571 383540457 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605917 Cc1ncc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N1CCC(O)CC1)C1CCOCC1 InChI=1S/C28H30F3N5O3/c1-17-23(15-21(16-33-17)34-27(38)19-2-7-32-25(13-19)28(29,30)31)20-12-24(18-5-10-39-11-6-18)35-26(14-20)36-8-3-22(37)4-9-36/h2,7,12-16,18,22,37H,3-6,8-11H2,1H3,(H,34,38) RNCXZGGSSNOHCF-UHFFFAOYSA-N 313560 N-(2'-(4- hydroxypiperidin-1-yl)- 2-methyl-6'-(tetrahydro- 2H-pyran-4-yl)-[3,4'- bipyridin]-5-yl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 184 RAF proto-oncogene serine/threonine-protein kinase Human 383 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313560 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313560&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609555 383540458 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605918 CCC(F)(F)c1cc(ccn1)C(=O)Nc1cnc(C)c(c1)-c1cc(nc(c1)N1CCC(O)CC1)C1CCOCC1 InChI=1S/C30H35F2N5O3/c1-3-30(31,32)27-15-21(4-9-33-27)29(39)35-23-17-25(19(2)34-18-23)22-14-26(20-7-12-40-13-8-20)36-28(16-22)37-10-5-24(38)6-11-37/h4,9,14-18,20,24,38H,3,5-8,10-13H2,1-2H3,(H,35,39) CICBFOYFWKEYGW-UHFFFAOYSA-N 313561 2-(1,1-difluoropropyl)- N-(2'-(4- hydroxypiperidin-1-yl)- 2-methyl-6'-(tetrahydro- 2H-pyran-4-yl)-[3,4'- bipyridin]-5-yl) isonicotinamide::US10167279, Example 185 RAF proto-oncogene serine/threonine-protein kinase Human 331 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313561 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313561&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609656 383540459 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605919 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N1CCC(O)CC1)C1CCOCC1 InChI=1S/C30H32F3N3O3/c1-19-5-6-24(34-29(38)21-3-2-4-23(15-21)30(31,32)33)18-26(19)22-16-27(20-9-13-39-14-10-20)35-28(17-22)36-11-7-25(37)8-12-36/h2-6,15-18,20,25,37H,7-14H2,1H3,(H,34,38) UJFRNIUGWVOJQM-UHFFFAOYSA-N 313562 N-(3-(2-(4- hydroxypiperidin-1-yl)- 6-(tetrahydro-2H-pyran- 4-yl)pyridin-4-yl)-4- methylphenyl)-3- (trifluoromethyl) benzamide::US10167279, Example 186 RAF proto-oncogene serine/threonine-protein kinase Human 830 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313562 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313562&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609566 383540460 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605920 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N1CCC(O)CC1)C1CCOCC1 InChI=1S/C29H31F3N4O3/c1-18-2-3-22(34-28(38)20-4-9-33-26(15-20)29(30,31)32)17-24(18)21-14-25(19-7-12-39-13-8-19)35-27(16-21)36-10-5-23(37)6-11-36/h2-4,9,14-17,19,23,37H,5-8,10-13H2,1H3,(H,34,38) JDFVZTXJXZDOQV-UHFFFAOYSA-N 313563 N-(3-(2-(4- hydroxypiperidin-1-yl)- 6-(tetrahydro-2H-pyran- 4-yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 187 RAF proto-oncogene serine/threonine-protein kinase Human 684 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313563 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313563&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609717 383540461 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605921 CCC(F)(F)c1cc(ccn1)C(=O)Nc1ccc(C)c(c1)-c1cc(nc(c1)N1CCC(O)CC1)C1CCOCC1 InChI=1S/C31H36F2N4O3/c1-3-31(32,33)28-17-22(6-11-34-28)30(39)35-24-5-4-20(2)26(19-24)23-16-27(21-9-14-40-15-10-21)36-29(18-23)37-12-7-25(38)8-13-37/h4-6,11,16-19,21,25,38H,3,7-10,12-15H2,1-2H3,(H,35,39) OMRUALSQGYUQNU-UHFFFAOYSA-N 313564 2-(1,1-difluoropropyl)- N-(3-(2-(4- hydroxypiperidin-1-yl)- 6-(tetrahydro-2H-pyran- 4-yl)pyridin-4-yl)-4- methylphenyl)-2- isonicotinamide::US10167279, Example 188 RAF proto-oncogene serine/threonine-protein kinase Human 621 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313564 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313564&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133632 383540462 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605922 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C27H27F3N2O4/c1-17-5-6-22(31-26(34)19-3-2-4-21(13-19)27(28,29)30)16-23(17)20-14-24(18-7-10-35-11-8-18)32-25(15-20)36-12-9-33/h2-6,13-16,18,33H,7-12H2,1H3,(H,31,34) NVYVXZVKYCIBMK-UHFFFAOYSA-N 313565 N-(3-(2-(2- hydroxyethoxy)- 6-(tetrahydro-2H-pyran- 4-yl)pyridin-4-yl)-4- methylphenyl)-3- (trifluoromethyl) benzamide::US10167279, Example 189 RAF proto-oncogene serine/threonine-protein kinase Human 136 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313565 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313565&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609614 383540463 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605923 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H26F3N3O4/c1-16-2-3-20(31-25(34)18-4-7-30-23(13-18)26(27,28)29)15-21(16)19-12-22(17-5-9-35-10-6-17)32-24(14-19)36-11-8-33/h2-4,7,12-15,17,33H,5-6,8-11H2,1H3,(H,31,34) ATDUIKGIHAEWJZ-UHFFFAOYSA-N 313566 N-(3-(2-(2- hydroxyethoxy)- 6-(tetrahydro-2H-pyran- 4-yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 190 RAF proto-oncogene serine/threonine-protein kinase Human 795 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313566 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313566&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609352 383540464 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605924 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc2OC(C)(CO)C(=O)Nc2c(c1)C1CCOCC1 InChI=1S/C30H31F2N3O5/c1-17-4-5-21(34-27(37)19-6-9-33-25(14-19)30(3,31)32)15-22(17)20-12-23(18-7-10-39-11-8-18)26-24(13-20)40-29(2,16-36)28(38)35-26/h4-6,9,12-15,18,36H,7-8,10-11,16H2,1-3H3,(H,34,37)(H,35,38) BFHRGTMSCLFCFJ-UHFFFAOYSA-N 313567 2-(1,1-difluoroethyl)-N- (3-(2-(hydroxymethyl)- 2-methyl-3-oxo-5- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-7-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 191 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313567 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313567&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609554 383540465 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605925 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc2OC(C)(CO)C(=O)Nc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O5/c1-16-3-4-20(34-26(37)23-13-19(5-8-33-23)29(30,31)32)14-21(16)18-11-22(17-6-9-39-10-7-17)25-24(12-18)40-28(2,15-36)27(38)35-25/h3-5,8,11-14,17,36H,6-7,9-10,15H2,1-2H3,(H,34,37)(H,35,38) CVCWPOXZQKWUDE-UHFFFAOYSA-N 313568 US10167279, Example 194::US10167279, Example 193::N-(3-(2- (hydroxymethyl)- 2-methyl-3-oxo-5- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-7-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 192 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313568&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609468 383540466 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605926 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc2OC(C)(CO)C(=O)Nc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O5/c1-16-3-4-20(34-26(37)23-13-19(5-8-33-23)29(30,31)32)14-21(16)18-11-22(17-6-9-39-10-7-17)25-24(12-18)40-28(2,15-36)27(38)35-25/h3-5,8,11-14,17,36H,6-7,9-10,15H2,1-2H3,(H,34,37)(H,35,38) CVCWPOXZQKWUDE-UHFFFAOYSA-N 313568 US10167279, Example 194::US10167279, Example 193::N-(3-(2- (hydroxymethyl)- 2-methyl-3-oxo-5- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-7-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 192 RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313568&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609468 383540466 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605927 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc2OC(C)(CO)C(=O)Nc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O5/c1-16-3-4-20(34-26(37)23-13-19(5-8-33-23)29(30,31)32)14-21(16)18-11-22(17-6-9-39-10-7-17)25-24(12-18)40-28(2,15-36)27(38)35-25/h3-5,8,11-14,17,36H,6-7,9-10,15H2,1-2H3,(H,34,37)(H,35,38) CVCWPOXZQKWUDE-UHFFFAOYSA-N 313568 US10167279, Example 194::US10167279, Example 193::N-(3-(2- (hydroxymethyl)- 2-methyl-3-oxo-5- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-7-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 192 RAF proto-oncogene serine/threonine-protein kinase Human 70.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313568 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313568&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609468 383540466 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605928 Cc1ccc(NC(=O)c2cc(cnn2)C(F)(F)F)cc1-c1cc2OC(C)(CO)C(=O)Nc2c(c1)C1CCOCC1 InChI=1S/C28H27F3N4O5/c1-15-3-4-19(33-25(37)22-11-18(13-32-35-22)28(29,30)31)12-20(15)17-9-21(16-5-7-39-8-6-16)24-23(10-17)40-27(2,14-36)26(38)34-24/h3-4,9-13,16,36H,5-8,14H2,1-2H3,(H,33,37)(H,34,38) TWLVHIUKTDMFSD-UHFFFAOYSA-N 313571 N-(3-(2- (hydroxymethyl)- 2-methyl-3-oxo-5- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-7-yl)-4- methylphenyl)-5- (trifluoromethyl) pyridazine-3-carboxamide::US10167279, Example 195 RAF proto-oncogene serine/threonine-protein kinase Human 30.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313571 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313571&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609422 383540467 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605929 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(C)Oc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O4/c1-16-4-5-20(34-26(36)18-6-9-33-24(14-18)29(30,31)32)15-21(16)19-12-22(17-7-10-38-11-8-17)25-23(13-19)35-27(37)28(2,3)39-25/h4-6,9,12-15,17H,7-8,10-11H2,1-3H3,(H,34,36)(H,35,37) FEUHFBJSWSMHCZ-UHFFFAOYSA-N 313572 N-(3-(2,2-dimethyl-3- oxo-8-(tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin- 6-yl)-4-methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 196 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313572 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313572&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609385 383540468 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605930 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc2NC(=O)C(C)(C)Oc2c(c1)C1CCOCC1 InChI=1S/C30H31F2N3O4/c1-17-5-6-21(34-27(36)19-7-10-33-25(15-19)30(4,31)32)16-22(17)20-13-23(18-8-11-38-12-9-18)26-24(14-20)35-28(37)29(2,3)39-26/h5-7,10,13-16,18H,8-9,11-12H2,1-4H3,(H,34,36)(H,35,37) JVBZFQRUJXQOAP-UHFFFAOYSA-N 313573 2-(1,1-difluoroethyl)-N- (3-(2,2-dimethyl-3-oxo- 8-(tetrahydro-2H-pyran- 4-yl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl) isonicotinamide::US10167279, Example 197 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313573 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313573&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609436 383540469 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605931 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(C)Oc2c(c1)C1CCOCC1 InChI=1S/C28H27F3N4O4/c1-15-4-5-19(33-25(36)18-12-23(28(29,30)31)35-32-14-18)13-20(15)17-10-21(16-6-8-38-9-7-16)24-22(11-17)34-26(37)27(2,3)39-24/h4-5,10-14,16H,6-9H2,1-3H3,(H,33,36)(H,34,37) SUHMZPJTJZZOJI-UHFFFAOYSA-N 313574 N-(3-(2,2-dimethyl-3- oxo-8-(tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 198 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313574 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313574&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609543 383540470 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605932 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(C)Oc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O4/c1-16-4-5-20(34-26(36)24-14-19(6-9-33-24)29(30,31)32)15-21(16)18-12-22(17-7-10-38-11-8-17)25-23(13-18)35-27(37)28(2,3)39-25/h4-6,9,12-15,17H,7-8,10-11H2,1-3H3,(H,34,36)(H,35,37) JHYANUJDBGGKOJ-UHFFFAOYSA-N 313575 N-(3-(2,2-dimethyl-3- oxo-8-(tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 199 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313575 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313575&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609545 383540471 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605933 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(CO)Oc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O5/c1-16-3-4-20(34-26(37)18-5-8-33-24(13-18)29(30,31)32)14-21(16)19-11-22(17-6-9-39-10-7-17)25-23(12-19)35-27(38)28(2,15-36)40-25/h3-5,8,11-14,17,36H,6-7,9-10,15H2,1-2H3,(H,34,37)(H,35,38) HKDHYGXPCCCNFO-UHFFFAOYSA-N 313576 N-(3-(2- (hydroxymethyl)-2- methyl-3-oxo-8- (tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 200 RAF proto-oncogene serine/threonine-protein kinase Human 500 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313576 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313576&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609679 383540472 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605934 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(CO)Oc2c(c1)C1CCOCC1 InChI=1S/C28H27F3N4O5/c1-15-3-4-19(33-25(37)18-11-23(28(29,30)31)35-32-13-18)12-20(15)17-9-21(16-5-7-39-8-6-16)24-22(10-17)34-26(38)27(2,14-36)40-24/h3-4,9-13,16,36H,5-8,14H2,1-2H3,(H,33,37)(H,34,38) YOASTUSUWIAGNG-UHFFFAOYSA-N 313577 N-(3-(2- (hydroxymethyl)-2- methyl-3-oxo-8- (tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 201 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313577 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313577&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609412 383540473 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605935 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(CO)Oc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O5/c1-16-3-4-20(34-26(37)24-13-19(5-8-33-24)29(30,31)32)14-21(16)18-11-22(17-6-9-39-10-7-17)25-23(12-18)35-27(38)28(2,15-36)40-25/h3-5,8,11-14,17,36H,6-7,9-10,15H2,1-2H3,(H,34,37)(H,35,38) GFWURJJGOGWYKL-UHFFFAOYSA-N 313578 N-(3-(2- (hydroxymethyl)-2- methyl-3-oxo-8- (tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 202 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313578 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313578&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609722 383540474 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605936 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc2NC(=O)C(C)(CO)Oc2c(c1)C1CCOCC1 InChI=1S/C30H31F2N3O5/c1-17-4-5-21(34-27(37)19-6-9-33-25(14-19)30(3,31)32)15-22(17)20-12-23(18-7-10-39-11-8-18)26-24(13-20)35-28(38)29(2,16-36)40-26/h4-6,9,12-15,18,36H,7-8,10-11,16H2,1-3H3,(H,34,37)(H,35,38) IXCUZYXUHWEJJF-UHFFFAOYSA-N 313579 2-(1,1-difluoroethyl)-N- (3-(2-(hydroxymethyl)- 2-methyl-3-oxo-8- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-6-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 203 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313579 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313579&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609502 383540475 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605937 Cc1ccc(NC(=O)c2cc(cnn2)C(F)(F)F)cc1-c1cc2NC(=O)C(C)(CO)Oc2c(c1)C1CCOCC1 InChI=1S/C28H27F3N4O5/c1-15-3-4-19(33-25(37)23-11-18(13-32-35-23)28(29,30)31)12-20(15)17-9-21(16-5-7-39-8-6-16)24-22(10-17)34-26(38)27(2,14-36)40-24/h3-4,9-13,16,36H,5-8,14H2,1-2H3,(H,33,37)(H,34,38) FJKDWRMOEUEOSF-UHFFFAOYSA-N 313580 N-(3-(2- (hydroxymethyl)-2- methyl-3-oxo-8- (tetrahydro-2H- pyran-4-yl)-3,4-dihydro- 2H- benzo[b][1,4]oxazin-6- yl)-4-methylphenyl)-5- (trifluoromethyl) pyridazine-3-carboxamide::US10167279, Example 204 RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313580 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313580&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609707 383540476 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605938 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(C)CCOCC1 InChI=1S/C27H28F3N3O4/c1-17-3-4-20(32-25(35)18-5-8-31-23(13-18)27(28,29)30)16-21(17)19-14-22(26(2)6-10-36-11-7-26)33-24(15-19)37-12-9-34/h3-5,8,13-16,34H,6-7,9-12H2,1-2H3,(H,32,35) QGBCILMHDQIELA-UHFFFAOYSA-N 313581 N-(3-(2-(2- hydroxyethoxy)-6-(4- methyltetrahydro-2H- pyran-4-yl)pyridin-4- yl)-4-methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 205 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313581 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313581&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609726 383540477 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605939 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1(C)CCOCC1 InChI=1S/C28H31F2N3O4/c1-18-4-5-21(32-26(35)19-6-9-31-24(14-19)28(3,29)30)17-22(18)20-15-23(27(2)7-11-36-12-8-27)33-25(16-20)37-13-10-34/h4-6,9,14-17,34H,7-8,10-13H2,1-3H3,(H,32,35) WDSNOUKCIYVWCG-UHFFFAOYSA-N 313582 2-(1,1-difluoroethyl)-N- (3-(2-(2- hydroxyethoxy)-6-(4- methyltetrahydro-2H- pyran-4-yl)pyridin-4- yl)-4-methylphenyl) isonicotinamide::US10167279, Example 206 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313582 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313582&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609463 383540478 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605940 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(C)CCOCC1 InChI=1S/C26H27F3N4O4/c1-16-3-4-19(31-24(35)18-12-22(26(27,28)29)33-30-15-18)14-20(16)17-11-21(25(2)5-8-36-9-6-25)32-23(13-17)37-10-7-34/h3-4,11-15,34H,5-10H2,1-2H3,(H,31,35) DBNCHPWCAHXMNS-UHFFFAOYSA-N 313583 N-(3-(2-(2- hydroxyethoxy)-6-(4- methyltetrahydro-2H- pyran-4-yl)pyridin-4- yl)-4-methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 207 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313583 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313583&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609559 383540479 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605941 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(OCCO)nc(c1)C1(C)CCOCC1 InChI=1S/C30H34N4O4/c1-20-5-6-23(33-28(36)21-7-10-32-25(15-21)29(2,3)19-31)18-24(20)22-16-26(30(4)8-12-37-13-9-30)34-27(17-22)38-14-11-35/h5-7,10,15-18,35H,8-9,11-14H2,1-4H3,(H,33,36) WJCCYJYZHUENFP-UHFFFAOYSA-N 313584 2-(2-cyanopropan-2-yl)- N-(3-(2-(2- hydroxyethoxy)-6-(4- methyltetrahydro-2H- pyran-4-yl)pyridin-4- yl)-4-methylphenyl) isonicotinamide::US10167279, Example 208 RAF proto-oncogene serine/threonine-protein kinase Human 500 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313584 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313584&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609560 383540480 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605942 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(C)CCOCC1 InChI=1S/C27H28F3N3O4/c1-17-3-4-20(32-25(35)22-15-19(5-8-31-22)27(28,29)30)16-21(17)18-13-23(26(2)6-10-36-11-7-26)33-24(14-18)37-12-9-34/h3-5,8,13-16,34H,6-7,9-12H2,1-2H3,(H,32,35) MSEDRPGTPQVXGJ-UHFFFAOYSA-N 313585 N-(3-(2-(2- hydroxyethoxy)-6-(4- methyltetrahydro-2H- pyran-4-yl)pyridin-4- yl)-4-methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 209 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313585 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313585&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609618 383540481 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605943 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)CCOCC1 InChI=1S/C27H27F4N3O4/c1-17-2-3-20(33-25(36)18-4-7-32-23(12-18)27(29,30)31)15-21(17)19-13-22(34-24(14-19)38-11-8-35)26(16-28)5-9-37-10-6-26/h2-4,7,12-15,35H,5-6,8-11,16H2,1H3,(H,33,36) QOZDCUXMOHXMHD-UHFFFAOYSA-N 313586 N-(3'-(2- hydroxyethoxy)-6- methyl-5'-(4- methyltetrahydro-2H- pyran-4-yl)-[1,1'- biphenyl]-3-yl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 210 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313586 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313586&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133301 383540482 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605944 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)CCOCC1 InChI=1S/C28H30F3N3O4/c1-18-3-4-21(33-26(36)19-5-8-32-23(13-19)27(2,30)31)16-22(18)20-14-24(34-25(15-20)38-12-9-35)28(17-29)6-10-37-11-7-28/h3-5,8,13-16,35H,6-7,9-12,17H2,1-2H3,(H,33,36) FWCRDIDARBEOIS-UHFFFAOYSA-N 313587 2-(1,1-difluoroethyl)-N- (3-(2-(4-(fluoromethyl) tetrahydro-2H-pyran-4- yl)-6-(2-hydroxyethoxy) pyridin-4-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 211 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313587 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313587&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609473 383540483 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605945 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)CCOCC1 InChI=1S/C26H26F4N4O4/c1-16-2-3-19(32-24(36)18-11-22(26(28,29)30)34-31-14-18)13-20(16)17-10-21(33-23(12-17)38-9-6-35)25(15-27)4-7-37-8-5-25/h2-3,10-14,35H,4-9,15H2,1H3,(H,32,36) ALCKIOZIGSOBTE-UHFFFAOYSA-N 313588 N-(3-(2-(4- (fluoromethyl)tetrahydro- 2H-pyran-4-yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4-methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 212 RAF proto-oncogene serine/threonine-protein kinase Human 80.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313588 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313588&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609569 383540484 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605946 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(OCCO)nc(c1)C1(CF)CCOCC1 InChI=1S/C30H33FN4O4/c1-20-4-5-23(34-28(37)21-6-9-33-25(14-21)29(2,3)19-32)17-24(20)22-15-26(35-27(16-22)39-13-10-36)30(18-31)7-11-38-12-8-30/h4-6,9,14-17,36H,7-8,10-13,18H2,1-3H3,(H,34,37) RPXDSMWOTXRAMM-UHFFFAOYSA-N 313589 2-(2-cyanopropan-2-yl)- N-(3-(2-(4- (fluoromethyl)tetrahydro- 2H-pyran-4-yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4-methylphenyl) isonicotinamide::US10167279, Example 213 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313589 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313589&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609694 383540485 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605947 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CF)CCOCC1 InChI=1S/C27H27F4N3O4/c1-17-2-3-20(33-25(36)22-14-19(4-7-32-22)27(29,30)31)15-21(17)18-12-23(34-24(13-18)38-11-8-35)26(16-28)5-9-37-10-6-26/h2-4,7,12-15,35H,5-6,8-11,16H2,1H3,(H,33,36) OVYWUDPPZFIWDA-UHFFFAOYSA-N 313590 N-(3-(2-(4- (fluoromethyl)tetrahydro- 2H-pyran-4-yl)-6-(2- hydroxyethoxy)pyridin- 4-yl)-4-methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 214 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313590 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313590&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609579 383540486 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605948 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CO)CCOCC1 InChI=1S/C27H28F3N3O5/c1-17-2-3-20(32-25(36)18-4-7-31-23(12-18)27(28,29)30)15-21(17)19-13-22(33-24(14-19)38-11-8-34)26(16-35)5-9-37-10-6-26/h2-4,7,12-15,34-35H,5-6,8-11,16H2,1H3,(H,32,36) OHVVCHZDLZISSA-UHFFFAOYSA-N 313591 N-(3'-(2- hydroxyethoxy)-6- methyl-5'-(4- methyltetrahydro-2H- pyran-4-yl)-[1,1'- biphenyl]-3-yl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 215 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313591 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313591&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133303 383540487 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605949 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CO)CCOCC1 InChI=1S/C28H31F2N3O5/c1-18-3-4-21(32-26(36)19-5-8-31-23(13-19)27(2,29)30)16-22(18)20-14-24(33-25(15-20)38-12-9-34)28(17-35)6-10-37-11-7-28/h3-5,8,13-16,34-35H,6-7,9-12,17H2,1-2H3,(H,32,36) XMHHXHXIHPJJAE-UHFFFAOYSA-N 313592 2-(1,1-difluoroethyl)-N- (3-(2-(2- hydroxyethoxy)-6-(4- (hydroxymethyl) tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 216 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313592 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313592&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609410 383540488 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605950 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CO)CCOCC1 InChI=1S/C26H27F3N4O5/c1-16-2-3-19(31-24(36)18-11-22(26(27,28)29)33-30-14-18)13-20(16)17-10-21(32-23(12-17)38-9-6-34)25(15-35)4-7-37-8-5-25/h2-3,10-14,34-35H,4-9,15H2,1H3,(H,31,36) VHNYMWYNJQXKST-UHFFFAOYSA-N 313593 N-(3-(2-(2- hydroxyethoxy)-6-(4- (hydroxymethyl) tetrahydro- 2H-pyran-4-yl)-4- methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 217 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313593 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313593&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133443 383540489 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605951 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(OCCO)nc(c1)C1(CO)CCOCC1 InChI=1S/C30H34N4O5/c1-20-4-5-23(33-28(37)21-6-9-32-25(14-21)29(2,3)18-31)17-24(20)22-15-26(34-27(16-22)39-13-10-35)30(19-36)7-11-38-12-8-30/h4-6,9,14-17,35-36H,7-8,10-13,19H2,1-3H3,(H,33,37) YSIIJLQFCVDKDY-UHFFFAOYSA-N 313594 2-(2-cyanopropan-2-yl)- N-(3-(2-(2- hydroxyethoxy)-6-(4- (hydroxymethyl) tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 218 RAF proto-oncogene serine/threonine-protein kinase Human 800 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313594 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313594&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609399 383540490 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605952 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(CO)CCOCC1 InChI=1S/C27H28F3N3O5/c1-17-2-3-20(32-25(36)22-14-19(4-7-31-22)27(28,29)30)15-21(17)18-12-23(33-24(13-18)38-11-8-34)26(16-35)5-9-37-10-6-26/h2-4,7,12-15,34-35H,5-6,8-11,16H2,1H3,(H,32,36) ZHOLVJIIDMFLGB-UHFFFAOYSA-N 313595 N-(3-(2-(2- hydroxyethoxy)-6-(4- (hydroxymethyl) tetrahydro- 2H-pyran-4-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 219 RAF proto-oncogene serine/threonine-protein kinase Human 500 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313595 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313595&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133715 383540491 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605953 Cc1nc2cc(cc(-c3cc(NC(=O)c4ccnc(c4)C(F)(F)F)ccc3C)c2[nH]1)C1CCOCC1 InChI=1S/C27H25F3N4O2/c1-15-3-4-20(34-26(35)18-5-8-31-24(13-18)27(28,29)30)14-21(15)22-11-19(17-6-9-36-10-7-17)12-23-25(22)33-16(2)32-23/h3-5,8,11-14,17H,6-7,9-10H2,1-2H3,(H,32,33)(H,34,35) IDRZUGZVTGJZEB-UHFFFAOYSA-N 313596 N-(4-methyl-3-(2- methyl-5-(tetrahydro- 2H-pyran-4-yl)-1H- benzo[d]imidazol-7-yl) phenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 220 RAF proto-oncogene serine/threonine-protein kinase Human 700 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313596 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313596&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609496 383540492 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605954 Cc1nc2cc(cc(-c3cc(NC(=O)c4cnnc(c4)C(F)(F)F)ccc3C)c2[nH]1)C1CCOCC1 InChI=1S/C26H24F3N5O2/c1-14-3-4-19(33-25(35)18-11-23(26(27,28)29)34-30-13-18)12-20(14)21-9-17(16-5-7-36-8-6-16)10-22-24(21)32-15(2)31-22/h3-4,9-13,16H,5-8H2,1-2H3,(H,31,32)(H,33,35) SHGPIERYDKGZDU-UHFFFAOYSA-N 313597 N-(4-methyl-3-(2- methyl-5-(tetrahydro- 2H-pyran-4-yl)-1H- benzo[d]imidazol-7-yl) phenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 221 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313597 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313597&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609697 383540493 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605955 Cc1nc2cc(cc(-c3cc(NC(=O)c4ccnc(c4)C(C)(F)F)ccc3C)c2[nH]1)C1CCOCC1 InChI=1S/C28H28F2N4O2/c1-16-4-5-21(34-27(35)19-6-9-31-25(14-19)28(3,29)30)15-22(16)23-12-20(18-7-10-36-11-8-18)13-24-26(23)33-17(2)32-24/h4-6,9,12-15,18H,7-8,10-11H2,1-3H3,(H,32,33)(H,34,35) CWARZIOLUQRWCS-UHFFFAOYSA-N 313598 2-(1,1-difluoroethyl)-N- (4-methyl-3-(2-methyl-5- (tetrahydro-2H-pyran-4- yl)-1H-benzo[d]imidazol- 7-yl)phenyl) isonicotinamide::US10167279, Example 222 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313598 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313598&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609419 383540494 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605956 Cc1nc2cc(cc(-c3cc(NC(=O)c4ccnc(c4)C(C)(C)C#N)ccc3C)c2[nH]1)C1CCOCC1 InChI=1S/C30H31N5O2/c1-18-5-6-23(35-29(36)21-7-10-32-27(15-21)30(3,4)17-31)16-24(18)25-13-22(20-8-11-37-12-9-20)14-26-28(25)34-19(2)33-26/h5-7,10,13-16,20H,8-9,11-12H2,1-4H3,(H,33,34)(H,35,36) GXXARGGVUKJQTD-UHFFFAOYSA-N 313599 2-(2-cyanopropan-2-yl)- N-(4-methyl-3-(2-methyl- 5-(tetrahydro-2H-pyran- 4-yl)-1H-benzo[d] imidazol-7-yl)phenyl) isonicotinamide::US10167279, Example 223 RAF proto-oncogene serine/threonine-protein kinase Human 600 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313599 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313599&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609494 383540495 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605957 Cc1nc2cc(cc(-c3cc(NC(=O)c4cc(ccn4)C(F)(F)F)ccc3C)c2[nH]1)C1CCOCC1 InChI=1S/C27H25F3N4O2/c1-15-3-4-20(34-26(35)24-13-19(5-8-31-24)27(28,29)30)14-21(15)22-11-18(17-6-9-36-10-7-17)12-23-25(22)33-16(2)32-23/h3-5,8,11-14,17H,6-7,9-10H2,1-2H3,(H,32,33)(H,34,35) LZABLTNRMAEOSS-UHFFFAOYSA-N 313600 N-(4-methyl-3-(2- methyl-5-(tetrahydro- 2H-pyran-4-yl)-1H- benzo[d]imidazol-7-yl) penyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 224 RAF proto-oncogene serine/threonine-protein kinase Human 5000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313600 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313600&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133626 383540496 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605958 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(F)F)ccc1C InChI=1S/C26H28F2N4O3/c1-4-35-25-21(17-8-11-34-12-9-17)15-22(31-32-25)20-14-19(6-5-16(20)2)30-24(33)18-7-10-29-23(13-18)26(3,27)28/h5-7,10,13-15,17H,4,8-9,11-12H2,1-3H3,(H,30,33) PSZRMDFZYQWUMK-UHFFFAOYSA-N 313601 2-(1,1-difluoroethyl)-N- (3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl) isonicotinamide::US10167279, Example 225 RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313601 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313601&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609713 383540497 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605959 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cc(c[nH]c2=O)C(F)(F)F)ccc1C InChI=1S/C25H25F3N4O4/c1-3-36-24-19(15-6-8-35-9-7-15)12-21(31-32-24)18-11-17(5-4-14(18)2)30-23(34)20-10-16(25(26,27)28)13-29-22(20)33/h4-5,10-13,15H,3,6-9H2,1-2H3,(H,29,33)(H,30,34) MZCADQYVKKJPEU-UHFFFAOYSA-N 313602 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2-oxo-5- (trifluoromethyl)-1,2- dihydropyridine-3- carboxamide::US10167279, Example 226 RAF proto-oncogene serine/threonine-protein kinase Human 4000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313602 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313602&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 138106772 383540498 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605960 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C2(CC2)C(F)(F)F)ccc1C InChI=1S/C28H29F3N4O3/c1-3-38-26-22(18-7-12-37-13-8-18)16-23(34-35-26)21-15-20(5-4-17(21)2)33-25(36)19-6-11-32-24(14-19)27(9-10-27)28(29,30)31/h4-6,11,14-16,18H,3,7-10,12-13H2,1-2H3,(H,33,36) NUQSULHMZAQCBR-UHFFFAOYSA-N 313603 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2-(1- (trifluoromethyl) cyclopropyl) isonicotinamide::US10167279, Example 227 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313603 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313603&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609641 383540499 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605961 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cc(c(Cl)cn2)C(F)(F)F)ccc1C InChI=1S/C25H24ClF3N4O3/c1-3-36-24-18(15-6-8-35-9-7-15)11-21(32-33-24)17-10-16(5-4-14(17)2)31-23(34)22-12-19(25(27,28)29)20(26)13-30-22/h4-5,10-13,15H,3,6-9H2,1-2H3,(H,31,34) UORSDJKSEPMQEF-UHFFFAOYSA-N 313604 5-chloro-N-(3-(6- ethoxy-5-(tetrahydro- 2H-pyran-4-yl) pyridazin-3-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 228 RAF proto-oncogene serine/threonine-protein kinase Human 60.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313604 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313604&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609426 383540500 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605962 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C#N)ccc1C InChI=1S/C25H25N5O3/c1-3-33-25-22(17-7-10-32-11-8-17)14-23(29-30-25)21-13-19(5-4-16(21)2)28-24(31)18-6-9-27-20(12-18)15-26/h4-6,9,12-14,17H,3,7-8,10-11H2,1-2H3,(H,28,31) XOMFFKHQNKROSH-UHFFFAOYSA-N 313605 2-cyano-N-(3-(6-ethoxy- 5-(tetrahydro-2H-pyran- 4-yl)pyridazin-3-yl)-4- methylphenyl)::US10167279, Example 229 RAF proto-oncogene serine/threonine-protein kinase Human 700 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313605 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313605&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133645 383540501 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605963 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cnc(cn2)C(F)(F)F)ccc1C InChI=1S/C24H24F3N5O3/c1-3-35-23-18(15-6-8-34-9-7-15)11-19(31-32-23)17-10-16(5-4-14(17)2)30-22(33)20-12-29-21(13-28-20)24(25,26)27/h4-5,10-13,15H,3,6-9H2,1-2H3,(H,30,33) NJDCDMZVQMDVST-UHFFFAOYSA-N 313606 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-5- (trifluoromethyl) pyrazine-2-carboxamide::US10167279, Example 230 RAF proto-oncogene serine/threonine-protein kinase Human 11000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313606 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313606&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609657 383540502 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605964 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cncc(c2)C(F)(F)F)ccc1C InChI=1S/C25H25F3N4O3/c1-3-35-24-21(16-6-8-34-9-7-16)12-22(31-32-24)20-11-19(5-4-15(20)2)30-23(33)17-10-18(14-29-13-17)25(26,27)28/h4-5,10-14,16H,3,6-9H2,1-2H3,(H,30,33) MJWBETFMQMTLTH-UHFFFAOYSA-N 313607 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-5- (trifluoromethyl) nicotinamide::US10167279, Example 231 RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313607 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313607&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609668 383540503 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605965 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cc(ncn2)C(F)(F)F)ccc1C InChI=1S/C24H24F3N5O3/c1-3-35-23-18(15-6-8-34-9-7-15)11-19(31-32-23)17-10-16(5-4-14(17)2)30-22(33)20-12-21(24(25,26)27)29-13-28-20/h4-5,10-13,15H,3,6-9H2,1-2H3,(H,30,33) PCULKHIWACIBFE-UHFFFAOYSA-N 313608 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-5- (trifluoromethyl) pyrazine-2-carboxamide::US10167279, Example 232 RAF proto-oncogene serine/threonine-protein kinase Human 30.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313608 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313608&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133445 383540504 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605966 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H30FN5O3/c1-5-35-25-21(17-7-10-34-11-8-17)14-22(31-32-25)20-13-19(15-29-16(20)2)30-24(33)18-6-9-28-23(12-18)26(3,4)27/h6,9,12-15,17H,5,7-8,10-11H2,1-4H3,(H,30,33) JTTHAGVONQLBFE-UHFFFAOYSA-N 313609 N-(5-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-2- (2-fluoropropan-2-yl) isonicotinamide::US10167279, Example 233 RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313609 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313609&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609617 383540505 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605967 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C25H25F3N4O3/c1-3-35-24-21(16-7-9-34-10-8-16)13-22(31-32-24)20-12-19(14-29-15(20)2)30-23(33)17-5-4-6-18(11-17)25(26,27)28/h4-6,11-14,16H,3,7-10H2,1-2H3,(H,30,33) XYTVFLHAYRVGSQ-UHFFFAOYSA-N 313610 N-(5-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-3- (trifluoromethyl) benzamide::US10167279, Example 234 RAF proto-oncogene serine/threonine-protein kinase Human 80.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313610 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313610&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609632 383540506 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605968 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)cnc1C InChI=1S/C24H24F3N5O3/c1-3-35-23-19(15-5-8-34-9-6-15)12-20(31-32-23)18-11-17(13-29-14(18)2)30-22(33)16-4-7-28-21(10-16)24(25,26)27/h4,7,10-13,15H,3,5-6,8-9H2,1-2H3,(H,30,33) LPDBIAJTOKEMKK-UHFFFAOYSA-N 313611 N-(5-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-6- methylpyridin-3-yl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 236 RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313611 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313611&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609387 383540507 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605969 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cnnc(c2)C(F)(F)F)ccc1C InChI=1S/C24H24F3N5O3/c1-3-35-23-19(15-6-8-34-9-7-15)12-20(30-32-23)18-11-17(5-4-14(18)2)29-22(33)16-10-21(24(25,26)27)31-28-13-16/h4-5,10-13,15H,3,6-9H2,1-2H3,(H,29,33) WGSGBMHEAJWXLX-UHFFFAOYSA-N 313612 N-(5-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 237 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313612 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313612&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609660 383540508 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605970 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C27H31FN4O3/c1-5-35-26-22(18-9-12-34-13-10-18)16-23(31-32-26)21-15-20(7-6-17(21)2)30-25(33)19-8-11-29-24(14-19)27(3,4)28/h6-8,11,14-16,18H,5,9-10,12-13H2,1-4H3,(H,30,33) VTIVWBKXOXDVJB-UHFFFAOYSA-N 313613 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2- (2-fluoropropan-2-yl) isonicotinamide::US10167279, Example 238 RAF proto-oncogene serine/threonine-protein kinase Human 70.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313613 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313613&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609587 383540509 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605971 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C25H25F3N4O3/c1-3-35-24-20(16-7-10-34-11-8-16)14-21(31-32-24)19-13-18(5-4-15(19)2)30-23(33)17-6-9-29-22(12-17)25(26,27)28/h4-6,9,12-14,16H,3,7-8,10-11H2,1-2H3,(H,30,33) CYFMPOZTYGDTCV-UHFFFAOYSA-N 313614 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 239 RAF proto-oncogene serine/threonine-protein kinase Human 40.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313614 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313614&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609610 383540510 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605972 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cc(cnn2)C(F)(F)F)ccc1C InChI=1S/C24H24F3N5O3/c1-3-35-23-19(15-6-8-34-9-7-15)12-20(31-32-23)18-11-17(5-4-14(18)2)29-22(33)21-10-16(13-28-30-21)24(25,26)27/h4-5,10-13,15H,3,6-9H2,1-2H3,(H,29,33) FHVJGIOJDOFRJS-UHFFFAOYSA-N 313615 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-5- (trifluoromethyl) pyridazine-3-carboxamide::US10167279, Example 240 RAF proto-oncogene serine/threonine-protein kinase Human 40.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313615 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313615&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609349 383540511 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605973 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cnc(N3CCN(CC)CC3)c(c2)C(F)(F)F)ccc1C InChI=1S/C31H37F3N6O3/c1-4-39-10-12-40(13-11-39)28-26(31(32,33)34)16-22(19-35-28)29(41)36-23-7-6-20(3)24(17-23)27-18-25(21-8-14-42-15-9-21)30(38-37-27)43-5-2/h6-7,16-19,21H,4-5,8-15H2,1-3H3,(H,36,41) CNGODCYMBQBZGT-UHFFFAOYSA-N 313616 N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-6-(4- ethylpiperazin-1-yl)-5- (trifluoromethyl) nicotinamide::US10167279, Example 241 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313616 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313616&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609530 383540512 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605974 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc2OC(C)(CO)C(=O)Nc2c(c1)C1CCOCC1 InChI=1S/C29H28F3N3O5/c1-16-3-4-20(34-26(37)18-5-8-33-24(13-18)29(30,31)32)14-21(16)19-11-22(17-6-9-39-10-7-17)25-23(12-19)40-28(2,15-36)27(38)35-25/h3-5,8,11-14,17,36H,6-7,9-10,15H2,1-2H3,(H,34,37)(H,35,38) XDVYBOBMEVIMHP-UHFFFAOYSA-N 313617 N-(3-(2-(hydroxymethyl)- 2-methyl-3-oxo-5- (tetrahydro-2H-pyran-4- yl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-7- yl)-4-methylphenyl)-2- (trifluoromethyl) isonicotinamide::US10167279, Example 242 RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313617 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313617&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609732 383540513 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605975 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C27H29F2N3O5/c1-16-3-4-19(31-26(35)17-5-7-30-24(12-17)27(2,28)29)14-21(16)18-11-22(20-6-9-36-15-23(20)34)32-25(13-18)37-10-8-33/h3-5,7,11-14,20,23,33-34H,6,8-10,15H2,1-2H3,(H,31,35) MOCDYSOJMQNHFV-UHFFFAOYSA-N 313618 2-(1,1-difluoroethyl)-N- (3-(2-(2-hydroxyethoxy)- 6-(3-hydroxytetrahydro- 2H-pyran-4-yl)pyridin-4- yl)-4-methylphenyl) isonicotinamide::US10167279, Example 243 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313618 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313618&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609577 383540514 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605976 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C28H32FN3O5/c1-17-4-5-20(31-27(35)18-6-8-30-25(13-18)28(2,3)29)15-22(17)19-12-23(21-7-10-36-16-24(21)34)32-26(14-19)37-11-9-33/h4-6,8,12-15,21,24,33-34H,7,9-11,16H2,1-3H3,(H,31,35) AHXGWAAMWDBTEX-UHFFFAOYSA-N 313619 2-(2-fluoropropan-2-yl)- N-(3-(2-(2- hydroxyethoxy)-6-(3- hydroxytetrahydro-2H- pyran-4-yl)pyridin-4-yl)- 4-methylphenyl) isonicotinamide::US10167279, Example 244 RAF proto-oncogene serine/threonine-protein kinase Human 3000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313619 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313619&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609373 383540515 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605977 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C25H25F3N4O5/c1-14-2-3-17(30-24(35)16-9-22(25(26,27)28)32-29-12-16)11-19(14)15-8-20(18-4-6-36-13-21(18)34)31-23(10-15)37-7-5-33/h2-3,8-12,18,21,33-34H,4-7,13H2,1H3,(H,30,35) SHXLXFOCOAMUAT-UHFFFAOYSA-N 313620 N-(3-(2-(2- hydroxyethoxy)-6-(3- (hydroxytetrahydro- 2H-pyran-4-yl)pyridin-4- yl)-4-methylphenyl)-6- (trifluoromethyl) pyridazine-4-carboxamide::US10167279, Example 245 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313620 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313620&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133628 383540516 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605978 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C29H32N4O5/c1-18-4-5-21(32-28(36)19-6-8-31-26(13-19)29(2,3)17-30)15-23(18)20-12-24(22-7-10-37-16-25(22)35)33-27(14-20)38-11-9-34/h4-6,8,12-15,22,25,34-35H,7,9-11,16H2,1-3H3,(H,32,36) SABFGDFZYOLMBY-UHFFFAOYSA-N 313621 2-(2-cyanopropan-2-yl)- N-(3-(2-(2- hydroxyethoxy)-6-(3- (hydroxytetrahydro- 2H-pyran-4-yl)pyridin-4- yl)-4-methylphenyl) isonicotinamide::US10167279, Example 246 RAF proto-oncogene serine/threonine-protein kinase Human 6000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313621 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313621&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133714 383540517 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605979 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C26H26F3N3O5/c1-15-2-3-18(31-25(35)22-12-17(4-6-30-22)26(27,28)29)13-20(15)16-10-21(19-5-8-36-14-23(19)34)32-24(11-16)37-9-7-33/h2-4,6,10-13,19,23,33-34H,5,7-9,14H2,1H3,(H,31,35) XPUKUTBYZDFHBI-UHFFFAOYSA-N 313622 N-(3-(2-(2- hydroxyethoxy)-6-(3- (hydroxytetrahydro- 2H-pyran-4-yl)pyridin-4- yl)-4-methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 248::US10167279, Example 247 RAF proto-oncogene serine/threonine-protein kinase Human 400 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313622 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313622&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133415 383540518 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605980 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C26H26F3N3O5/c1-15-2-3-18(31-25(35)22-12-17(4-6-30-22)26(27,28)29)13-20(15)16-10-21(19-5-8-36-14-23(19)34)32-24(11-16)37-9-7-33/h2-4,6,10-13,19,23,33-34H,5,7-9,14H2,1H3,(H,31,35) XPUKUTBYZDFHBI-UHFFFAOYSA-N 313622 N-(3-(2-(2- hydroxyethoxy)-6-(3- (hydroxytetrahydro- 2H-pyran-4-yl)pyridin-4- yl)-4-methylphenyl)-4- (trifluoromethyl) picolinamide::US10167279, Example 248::US10167279, Example 247 RAF proto-oncogene serine/threonine-protein kinase Human 700 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313622 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313622&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133415 383540518 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605981 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C26H26F3N3O5/c1-15-2-3-18(31-25(35)16-4-6-30-23(11-16)26(27,28)29)13-20(15)17-10-21(19-5-8-36-14-22(19)34)32-24(12-17)37-9-7-33/h2-4,6,10-13,19,22,33-34H,5,7-9,14H2,1H3,(H,31,35) FWJIIHAZGHCLGJ-UHFFFAOYSA-N 313538 US10167279, Example 251::US10167279, Example 250::N-(3-(2-(2-hydroxyethoxy)-6-(3-hydroxytetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide::US10167279, Example 162 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313538&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609482 383540436 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605982 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1O InChI=1S/C26H26F3N3O5/c1-15-2-3-18(31-25(35)16-4-6-30-23(11-16)26(27,28)29)13-20(15)17-10-21(19-5-8-36-14-22(19)34)32-24(12-17)37-9-7-33/h2-4,6,10-13,19,22,33-34H,5,7-9,14H2,1H3,(H,31,35) FWJIIHAZGHCLGJ-UHFFFAOYSA-N 313538 US10167279, Example 251::US10167279, Example 250::N-(3-(2-(2-hydroxyethoxy)-6-(3-hydroxytetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide::US10167279, Example 162 RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313538 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313538&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609482 383540436 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605983 Cc1ccc(NC(=O)c2cc(c[nH]c2=O)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H26F3N3O5/c1-15-2-3-19(31-25(35)21-12-18(26(27,28)29)14-30-24(21)34)13-20(15)17-10-22(16-4-7-36-8-5-16)32-23(11-17)37-9-6-33/h2-3,10-14,16,33H,4-9H2,1H3,(H,30,34)(H,31,35) CTROUHYNUQHONM-UHFFFAOYSA-N 313626 US10167279, Example 252::N-(3-(2-(2- hydroxyethoxy)-6- (terahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-oxo-5- (trifluoromethyl)-1,2- dihydropyridine-3- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 4000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313626 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313626&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 138106773 383540519 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605984 Cc1ccc(NC(=O)c2cc(cn(C)c2=O)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C27H28F3N3O5/c1-16-3-4-20(31-25(35)22-13-19(27(28,29)30)15-33(2)26(22)36)14-21(16)18-11-23(17-5-8-37-9-6-17)32-24(12-18)38-10-7-34/h3-4,11-15,17,34H,5-10H2,1-2H3,(H,31,35) GWHPTBUZZCQFCD-UHFFFAOYSA-N 313627 US10167279, Example 253::N-(3-(2-(2- hydroxyethoxy)-6- (terahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-1- methyl-2-oxo-5- (trifluoromethyl)-1,2- dihydropyridine-3- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313627 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313627&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609464 383540520 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605985 Cc1ccc(NC(=O)c2ccnc(n2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H25F3N4O4/c1-15-2-3-18(30-23(34)20-4-7-29-24(32-20)25(26,27)28)14-19(15)17-12-21(16-5-9-35-10-6-16)31-22(13-17)36-11-8-33/h2-4,7,12-14,16,33H,5-6,8-11H2,1H3,(H,30,34) HKIYUOLLCWIPOR-UHFFFAOYSA-N 313628 US10167279, Example 254::N-(3-(2-(2- hydroxyethoxy)-6- (terahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl) pyrimidine-4- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313628 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313628&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609716 383540521 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605986 Cc1ccc(NC(=O)c2cc3cnccc3nc2C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C29H27F3N4O4/c1-17-2-3-21(34-28(38)23-12-20-16-33-7-4-24(20)36-27(23)29(30,31)32)15-22(17)19-13-25(18-5-9-39-10-6-18)35-26(14-19)40-11-8-37/h2-4,7,12-16,18,37H,5-6,8-11H2,1H3,(H,34,38) PVGZRCINHSTDLC-UHFFFAOYSA-N 313629 US10167279, Example 255::N-(3-(2-(2- hydroxyethoxy)-6- (terahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl)-1,6- naphthyridine-3- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313629 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313629&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609729 383540522 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605987 Cc1ccc(NC(=O)c2cc(nc(O)n2)C(C)(C)C)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C28H34N4O5/c1-17-5-6-20(29-26(34)23-16-24(28(2,3)4)32-27(35)31-23)15-21(17)19-13-22(18-7-10-36-11-8-18)30-25(14-19)37-12-9-33/h5-6,13-16,18,33H,7-12H2,1-4H3,(H,29,34)(H,31,32,35) JFRFCXCIYGZNJG-UHFFFAOYSA-N 313630 US10167279, Example 256::6-(tert-butyl)-2- hydroxy-N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)pyrimidine- 4-carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313630 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313630&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609508 383540523 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605988 CN(C)c1nc(cc(n1)C(F)(F)F)C(=O)Nc1ccc(C)c(c1)-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C27H30F3N5O4/c1-16-4-5-19(31-25(37)22-15-23(27(28,29)30)34-26(33-22)35(2)3)14-20(16)18-12-21(17-6-9-38-10-7-17)32-24(13-18)39-11-8-36/h4-5,12-15,17,36H,6-11H2,1-3H3,(H,31,37) DRBQNSYDUBCNGU-UHFFFAOYSA-N 313631 US10167279, Example 257::2-(dimethylamino)-N- (3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-6- (trifluoromethyl) pyrimidine- 4-carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313631 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313631&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609651 383540524 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605989 Cc1ccc(NC(=O)c2cc(cnn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H25F3N4O4/c1-15-2-3-19(30-24(34)22-12-18(14-29-32-22)25(26,27)28)13-20(15)17-10-21(16-4-7-35-8-5-16)31-23(11-17)36-9-6-33/h2-3,10-14,16,33H,4-9H2,1H3,(H,30,34) ZRNFFEWARCYPIS-UHFFFAOYSA-N 313632 US10167279, Example 258::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-5- (trifluoromethyl) pyridazine- 3-carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313632 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313632&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609431 383540525 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605990 Cc1ccc(NC(=O)c2ccnc(c2)C2(CC2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C29H30F3N3O4/c1-18-2-3-22(34-27(37)20-4-9-33-25(15-20)28(7-8-28)29(30,31)32)17-23(18)21-14-24(19-5-11-38-12-6-19)35-26(16-21)39-13-10-36/h2-4,9,14-17,19,36H,5-8,10-13H2,1H3,(H,34,37) XIPDXUIVFHOFTM-UHFFFAOYSA-N 313633 US10167279, Example 259::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-(1- (trifluoromethyl) cyclopropyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313633 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313633&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609343 383540526 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605991 Cc1ccc(NC(=O)c2cc(ncn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H25F3N4O4/c1-15-2-3-18(31-24(34)21-13-22(25(26,27)28)30-14-29-21)12-19(15)17-10-20(16-4-7-35-8-5-16)32-23(11-17)36-9-6-33/h2-3,10-14,16,33H,4-9H2,1H3,(H,31,34) UXPKTFMUGCDRBD-UHFFFAOYSA-N 313634 US10167279, Example 260::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-6- (trifluoromethyl) pyrimidine-4- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 80.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313634 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313634&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609466 383540527 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605992 Cc1ccc(NC(=O)c2cc(Cl)ccn2)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H26ClN3O4/c1-16-2-3-20(28-25(31)23-14-19(26)4-7-27-23)15-21(16)18-12-22(17-5-9-32-10-6-17)29-24(13-18)33-11-8-30/h2-4,7,12-15,17,30H,5-6,8-11H2,1H3,(H,28,31) OCVKILSSZJRMLN-UHFFFAOYSA-N 313635 US10167279, Example 261::4-chloro-N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 30.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313635 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313635&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609646 383540528 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605993 Cc1ccc(NC(=O)c2cnc(cn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H25F3N4O4/c1-15-2-3-18(31-24(34)21-13-30-22(14-29-21)25(26,27)28)12-19(15)17-10-20(16-4-7-35-8-5-16)32-23(11-17)36-9-6-33/h2-3,10-14,16,33H,4-9H2,1H3,(H,31,34) KMUADBSAVIBQDZ-UHFFFAOYSA-N 313636 US10167279, Example 262::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-5- (trifluoromethyl) pyrazine-2-carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313636 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313636&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609681 383540529 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605994 Cc1ccc(NC(=O)c2ccnc(c2)C#N)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H26N4O4/c1-17-2-3-21(29-26(32)19-4-7-28-22(12-19)16-27)15-23(17)20-13-24(18-5-9-33-10-6-18)30-25(14-20)34-11-8-31/h2-4,7,12-15,18,31H,5-6,8-11H2,1H3,(H,29,32) IVUGYPGUVQXSPO-UHFFFAOYSA-N 313637 US10167279, Example 263::2-cyano-N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313637 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313637&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609686 383540530 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605995 Cc1ccc(NC(=O)c2ccnc(Cl)c2)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H26ClN3O4/c1-16-2-3-20(28-25(31)18-4-7-27-23(26)13-18)15-21(16)19-12-22(17-5-9-32-10-6-17)29-24(14-19)33-11-8-30/h2-4,7,12-15,17,30H,5-6,8-11H2,1H3,(H,28,31) DHQDRGFMIXDNGE-UHFFFAOYSA-N 313638 US10167279, Example 264::2-chloro-N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313638 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313638&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609673 383540531 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605996 Cc1ccc(NC(=O)c2cncc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H26F3N3O4/c1-16-2-3-21(31-25(34)19-10-20(15-30-14-19)26(27,28)29)13-22(16)18-11-23(17-4-7-35-8-5-17)32-24(12-18)36-9-6-33/h2-3,10-15,17,33H,4-9H2,1H3,(H,31,34) VBTIQTLWWXLJFC-UHFFFAOYSA-N 313639 US10167279, Example 265::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-5- (trifluoromethyl) nicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313639 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313639&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609367 383540532 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605997 Cc1ccc(NC(=O)c2cc(c(Cl)cn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H25ClF3N3O4/c1-15-2-3-18(32-25(35)23-13-20(26(28,29)30)21(27)14-31-23)12-19(15)17-10-22(16-4-7-36-8-5-16)33-24(11-17)37-9-6-34/h2-3,10-14,16,34H,4-9H2,1H3,(H,32,35) IPGBGGBYGMSHCH-UHFFFAOYSA-N 313640 US10167279, Example 266::5-chloro-N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313640 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313640&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609667 383540533 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605998 COc1cc(ncn1)C(=O)Nc1ccc(C)c(c1)-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H28N4O5/c1-16-3-4-19(28-25(31)22-14-23(32-2)27-15-26-22)13-20(16)18-11-21(17-5-8-33-9-6-17)29-24(12-18)34-10-7-30/h3-4,11-15,17,30H,5-10H2,1-2H3,(H,28,31) BACNATHAVYDHLC-UHFFFAOYSA-N 313641 US10167279, Example 267::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-6- methoxypyrimidine-4- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 5.00 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313641 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313641&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609683 383540534 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 605999 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)CF)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C27H28F3N3O4/c1-17-2-3-21(32-26(35)19-4-7-31-24(13-19)27(29,30)16-28)15-22(17)20-12-23(18-5-9-36-10-6-18)33-25(14-20)37-11-8-34/h2-4,7,12-15,18,34H,5-6,8-11,16H2,1H3,(H,32,35) MMDOOTGKNIUMTA-UHFFFAOYSA-N 313642 US10167279, Example 268::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-(1,1,2- trifluoroethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313642 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313642&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609573 383540535 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606000 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C27H29F2N3O4/c1-17-3-4-21(31-26(34)19-5-8-30-24(14-19)27(2,28)29)16-22(17)20-13-23(18-6-10-35-11-7-18)32-25(15-20)36-12-9-33/h3-5,8,13-16,18,33H,6-7,9-12H2,1-2H3,(H,31,34) YHQYFZLOKGCSQT-UHFFFAOYSA-N 313643 US10167279, Example 269::2-(1,1-difluoroethyl)-N- (3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 30.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313643 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313643&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609706 383540536 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606001 Cc1ccc(NC(=O)c2ccnc(c2)C(C)(C)C#N)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C29H32N4O4/c1-19-4-5-23(32-28(35)21-6-9-31-26(15-21)29(2,3)18-30)17-24(19)22-14-25(20-7-11-36-12-8-20)33-27(16-22)37-13-10-34/h4-6,9,14-17,20,34H,7-8,10-13H2,1-3H3,(H,32,35) WWVVPXRLAMVCBA-UHFFFAOYSA-N 313644 US10167279, Example 270::2-(2-cyanopropan-2-yl)- N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 90.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313644 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313644&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609420 383540537 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606002 Cc1ccc(NC(=O)c2cnnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C25H25F3N4O4/c1-15-2-3-19(30-24(34)18-11-22(25(26,27)28)32-29-14-18)13-20(15)17-10-21(16-4-7-35-8-5-16)31-23(12-17)36-9-6-33/h2-3,10-14,16,33H,4-9H2,1H3,(H,30,34) VSOMYJMPJLQLAG-UHFFFAOYSA-N 313645 US10167279, Example 271::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-6- (trifluoromethyl) pyridazine-4- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313645 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313645&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609347 383540538 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606003 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H26F3N3O4/c1-16-2-3-20(31-25(34)23-14-19(4-7-30-23)26(27,28)29)15-21(16)18-12-22(17-5-9-35-10-6-17)32-24(13-18)36-11-8-33/h2-4,7,12-15,17,33H,5-6,8-11H2,1H3,(H,31,34) FIZUKPFAYVRXQL-UHFFFAOYSA-N 313646 US10167279, Example 272::N-(3-(2-(2- hydroxyethoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 50.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313646 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313646&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609636 383540539 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606004 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)CF)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C28H30F3N3O5/c1-17-2-3-21(33-27(37)19-4-7-32-25(11-19)28(30,31)16-29)13-23(17)20-10-24(18-5-8-38-9-6-18)34-26(12-20)39-15-22(36)14-35/h2-4,7,10-13,18,22,35-36H,5-6,8-9,14-16H2,1H3,(H,33,37) AFKDEOHDIDNWJK-UHFFFAOYSA-N 313647 US10167279, Example 273::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-(1,1,2- trifluoroethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 10.00 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313647 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313647&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609483 383540540 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606005 Cc1ccc(NC(=O)c2cc(cnn2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C26H27F3N4O5/c1-15-2-3-19(31-25(36)23-10-18(12-30-33-23)26(27,28)29)11-21(15)17-8-22(16-4-6-37-7-5-16)32-24(9-17)38-14-20(35)13-34/h2-3,8-12,16,20,34-35H,4-7,13-14H2,1H3,(H,31,36) HLAXESBPHWXKFC-UHFFFAOYSA-N 313648 US10167279, Example 274::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-5-trifluoromethyl) pyridazine-3-carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 30.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313648 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313648&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133446 383540541 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606006 Cc1ccc(NC(=O)c2ccnc(c2)C2(CC2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C30H32F3N3O5/c1-18-2-3-22(35-28(39)20-4-9-34-26(13-20)29(7-8-29)30(31,32)33)15-24(18)21-12-25(19-5-10-40-11-6-19)36-27(14-21)41-17-23(38)16-37/h2-4,9,12-15,19,23,37-38H,5-8,10-11,16-17H2,1H3,(H,35,39) GPGRTTBVHRSFPB-UHFFFAOYSA-N 313649 US10167279, Example 275::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2-(1- (trifluoromethyl) cyclopropyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313649 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313649&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609642 383540542 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606007 Cc1ccc(NC(=O)c2cc(ncn2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C26H27F3N4O5/c1-15-2-3-18(32-25(36)22-11-23(26(27,28)29)31-14-30-22)10-20(15)17-8-21(16-4-6-37-7-5-16)33-24(9-17)38-13-19(35)12-34/h2-3,8-11,14,16,19,34-35H,4-7,12-13H2,1H3,(H,32,36) CLBAVQUKLIDHCF-UHFFFAOYSA-N 313650 US10167279, Example 276::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-6- (trifluoromethyl) pyrimidine-4- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 60.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313650 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313650&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609353 383540543 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606008 Cc1ccc(NC(=O)c2cnc(cn2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C26H27F3N4O5/c1-15-2-3-18(32-25(36)22-11-31-23(12-30-22)26(27,28)29)10-20(15)17-8-21(16-4-6-37-7-5-16)33-24(9-17)38-14-19(35)13-34/h2-3,8-12,16,19,34-35H,4-7,13-14H2,1H3,(H,32,36) LNRKQCSTWVTDDU-UHFFFAOYSA-N 313651 US10167279, Example 277::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-5- (trifluoromethyl) pyrazine-2- carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313651 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313651&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609511 383540544 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606009 Cc1ccc(NC(=O)c2cc(Cl)ccn2)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C26H28ClN3O5/c1-16-2-3-20(29-26(33)24-12-19(27)4-7-28-24)13-22(16)18-10-23(17-5-8-34-9-6-17)30-25(11-18)35-15-21(32)14-31/h2-4,7,10-13,17,21,31-32H,5-6,8-9,14-15H2,1H3,(H,29,33) ZLQQYYIUWZJNGZ-UHFFFAOYSA-N 313652 US10167279, Example 278::(R)-4-chloro-N-(3-(2- (2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 50.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313652 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313652&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609503 383540545 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606010 Cc1ccc(NC(=O)c2ccnc(c2)C#N)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C27H28N4O5/c1-17-2-3-21(30-27(34)19-4-7-29-22(10-19)14-28)13-24(17)20-11-25(18-5-8-35-9-6-18)31-26(12-20)36-16-23(33)15-32/h2-4,7,10-13,18,23,32-33H,5-6,8-9,15-16H2,1H3,(H,30,34) NRMZZCUAZLNBRP-UHFFFAOYSA-N 313653 US10167279, Example 279::(R)-2-cyano-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 70.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313653 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313653&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609356 383540546 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606011 Cc1ccc(NC(=O)c2ccnc(Cl)c2)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C26H28ClN3O5/c1-16-2-3-20(29-26(33)18-4-7-28-24(27)11-18)13-22(16)19-10-23(17-5-8-34-9-6-17)30-25(12-19)35-15-21(32)14-31/h2-4,7,10-13,17,21,31-32H,5-6,8-9,14-15H2,1H3,(H,29,33) HLLXAEFJZGBUKW-UHFFFAOYSA-N 313654 US10167279, Example 280::(R)-2-chloro-N-(3-(2- (2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 70.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313654 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313654&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609603 383540547 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606012 Cc1ccc(NC(=O)c2cncc(c2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C27H28F3N3O5/c1-16-2-3-21(32-26(36)19-8-20(13-31-12-19)27(28,29)30)11-23(16)18-9-24(17-4-6-37-7-5-17)33-25(10-18)38-15-22(35)14-34/h2-3,8-13,17,22,34-35H,4-7,14-15H2,1H3,(H,32,36) ZDCWZMLYGOAMLZ-UHFFFAOYSA-N 313655 US10167279, Example 281::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-5- (trifluoromethyl) nicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 50.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313655 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313655&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609416 383540548 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606013 Cc1ccc(NC(=O)c2cc(c(Cl)cn2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C27H27ClF3N3O5/c1-15-2-3-18(33-26(37)24-11-21(27(29,30)31)22(28)12-32-24)10-20(15)17-8-23(16-4-6-38-7-5-16)34-25(9-17)39-14-19(36)13-35/h2-3,8-12,16,19,35-36H,4-7,13-14H2,1H3,(H,33,37) BZXHFPBJGXIJCT-UHFFFAOYSA-N 313656 US10167279, Example 282::(R)-5-chloro-N-(3-(2- (2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 300 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313656 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313656&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609407 383540549 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606014 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OC[C@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C27H28F3N3O5/c1-16-2-3-20(32-26(36)24-12-19(4-7-31-24)27(28,29)30)13-22(16)18-10-23(17-5-8-37-9-6-17)33-25(11-18)38-15-21(35)14-34/h2-4,7,10-13,17,21,34-35H,5-6,8-9,14-15H2,1H3,(H,32,36) LZLWKZRADXPBIE-UHFFFAOYSA-N 313657 US10167279, Example 283::(R)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 70.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313657 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313657&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609401 383540550 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606015 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(OC[C@@H](O)CO)nc(c1)C1CCOCC1 |r| InChI=1S/C27H28F3N3O5/c1-16-2-3-20(32-26(36)24-12-19(4-7-31-24)27(28,29)30)13-22(16)18-10-23(17-5-8-37-9-6-17)33-25(11-18)38-15-21(35)14-34/h2-4,7,10-13,17,21,34-35H,5-6,8-9,14-15H2,1H3,(H,32,36) LZLWKZRADXPBIE-UHFFFAOYSA-N 313658 US10167279, Example 284::(S)-N-(3-(2-(2,3- dihydroxypropoxy)-6- (tetrahydro-2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 200 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313658 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313658&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133701 383540551 C02773 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606016 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccc3CNCc3c2)ccc1C InChI=1S/C27H30N4O3/c1-3-34-27-24(18-8-10-33-11-9-18)14-25(30-31-27)23-13-22(7-4-17(23)2)29-26(32)19-5-6-20-15-28-16-21(20)12-19/h4-7,12-14,18,28H,3,8-11,15-16H2,1-2H3,(H,29,32) IYJPVGYEGMUFPU-UHFFFAOYSA-N 313659 US10167279, Example 285::N-(3-(6-ethoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl) isoindoline-5-carboxamid RAF proto-oncogene serine/threonine-protein kinase Human 900 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313659 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313659&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609685 383540552 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606017 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(nc(c1)C1(O)CCOCC1)N1CCOC1=O InChI=1S/C27H25F3N4O5/c1-16-2-3-19(32-24(35)17-4-7-31-22(12-17)27(28,29)30)15-20(16)18-13-21(26(37)5-9-38-10-6-26)33-23(14-18)34-8-11-39-25(34)36/h2-4,7,12-15,37H,5-6,8-11H2,1H3,(H,32,35) JVXVMCHLVVZREG-UHFFFAOYSA-N 313660 US10167279, Example 286::N-(3-(2-(4-hydroxytetrahydro-2H-pyran-4-yl)-6-(2-oxooxazolidin-3-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide and N-(3-(2-((2-hydroxyethyl)amino)-6-(4-hydroxytetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide::US10167279, Example 287 RAF proto-oncogene serine/threonine-protein kinase Human 297 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313660&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609666 383540553 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606018 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(nc(c1)C1(O)CCOCC1)N1CCOC1=O InChI=1S/C27H25F3N4O5/c1-16-2-3-19(32-24(35)17-4-7-31-22(12-17)27(28,29)30)15-20(16)18-13-21(26(37)5-9-38-10-6-26)33-23(14-18)34-8-11-39-25(34)36/h2-4,7,12-15,37H,5-6,8-11H2,1H3,(H,32,35) JVXVMCHLVVZREG-UHFFFAOYSA-N 313660 US10167279, Example 286::N-(3-(2-(4-hydroxytetrahydro-2H-pyran-4-yl)-6-(2-oxooxazolidin-3-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide and N-(3-(2-((2-hydroxyethyl)amino)-6-(4-hydroxytetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide::US10167279, Example 287 RAF proto-oncogene serine/threonine-protein kinase Human 393 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313660 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313660&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609666 383540553 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606019 CCOc1ncc(cc1C1(CF)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C29H31FN4O3/c1-5-37-27-24(29(16-30)9-11-36-18-29)12-21(15-33-27)23-14-22(7-6-19(23)2)34-26(35)20-8-10-32-25(13-20)28(3,4)17-31/h6-8,10,12-15H,5,9,11,16,18H2,1-4H3,(H,34,35) MLXSGWNLNPEOPD-UHFFFAOYSA-N 313662 US10167279, Example 288::2-(2-cyanopropan-2-yl)-N-(3-(6-ethoxy-5-(3-(fluoromethyl)tetrahydrofuran-3-yl)pyridin-3-yl)-4-methylphenyl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 600 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313662 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313662&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609451 383540554 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606020 CCOc1ncc(cc1C1(CO)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C29H32N4O4/c1-5-37-27-24(29(17-34)9-11-36-18-29)12-21(15-32-27)23-14-22(7-6-19(23)2)33-26(35)20-8-10-31-25(13-20)28(3,4)16-30/h6-8,10,12-15,34H,5,9,11,17-18H2,1-4H3,(H,33,35) FXBNKARFXIZURO-UHFFFAOYSA-N 313663 US10167279, Example 289::2-(2-cyanopropan-2- yl)-N-(3-(6-ethoxy- 5-(3- (hydroxymethyl) tetrahydrofuran-3- yl)pyridin-3-yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313663 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313663&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609425 383540555 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606021 CCOc1ncc(cc1C1(CO)CCOC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C26H26F3N3O4/c1-3-36-24-22(25(14-33)7-8-35-15-25)10-18(12-31-24)21-11-20(13-30-16(21)2)32-23(34)17-5-4-6-19(9-17)26(27,28)29/h4-6,9-13,33H,3,7-8,14-15H2,1-2H3,(H,32,34) GPYRSFDCXBSKKZ-UHFFFAOYSA-N 313664 US10167279, Example 290::N-(6'-ethoxy-5'-(3- (hydroxymethyl) tetrahydrofuran-3- yl)-2-methyl-[3,3'- bipyridin]-5-yl)-3- (trifluoromethyl) benzamide RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313664 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313664&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609455 383540556 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606022 CCOc1ncc(cc1C1(CO)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C28H32FN3O4/c1-5-36-26-23(28(16-33)9-11-35-17-28)12-20(15-31-26)22-14-21(7-6-18(22)2)32-25(34)19-8-10-30-24(13-19)27(3,4)29/h6-8,10,12-15,33H,5,9,11,16-17H2,1-4H3,(H,32,34) VUWCRJJWWYPOOH-UHFFFAOYSA-N 313665 US10167279, Example 291::N-(3-(6-ethoxy-5-(3- (hydroxymethyl) tetrahydrofuran-3- yl)pyridin-3-yl)-4- methylphenyl)-2-(2- fluoropropan-2- yl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313665 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313665&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609467 383540557 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606023 CCOc1ncc(cc1C1(CO)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C27H31FN4O4/c1-5-36-25-22(27(15-33)7-9-35-16-27)10-19(13-31-25)21-12-20(14-30-17(21)2)32-24(34)18-6-8-29-23(11-18)26(3,4)28/h6,8,10-14,33H,5,7,9,15-16H2,1-4H3,(H,32,34) IQWPXTCAIAPPED-UHFFFAOYSA-N 313666 US10167279, Example 292::N-(6'-ethoxy-5'-(3- (hydroxymethyl) tetrahydrofuran-3- yl)-2-methyl-[3,3'- bipyridin]-5-yl)-2- (2-fluoropropan-2- yl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 9000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313666 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313666&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609589 383540558 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606024 CCOc1ncc(cc1C1(O)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)C#N)ccc1C InChI=1S/C28H30N4O4/c1-5-36-26-23(28(34)9-11-35-17-28)12-20(15-31-26)22-14-21(7-6-18(22)2)32-25(33)19-8-10-30-24(13-19)27(3,4)16-29/h6-8,10,12-15,34H,5,9,11,17H2,1-4H3,(H,32,33) NFACLWQKSUEDLE-UHFFFAOYSA-N 313667 US10167279, Example 293::2-(2-cyanopropan-2- yl)-N-(3-(6-ethoxy- 5-(3- hydroxytetrahydro- furan-3-yl)pyridin-3- yl)-4- methylphenyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313667 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313667&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609678 383540559 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606025 CCOc1ncc(cc1C1(O)CCOC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C25H24F3N3O4/c1-3-35-23-21(24(33)7-8-34-14-24)10-17(12-30-23)20-11-19(13-29-15(20)2)31-22(32)16-5-4-6-18(9-16)25(26,27)28/h4-6,9-13,33H,3,7-8,14H2,1-2H3,(H,31,32) ACOPMFAFMFBCBV-UHFFFAOYSA-N 313668 US10167279, Example 294::N-(6'-ethoxy-5'-(3- hydroxytetrahydro- furan-3-yl)-2- methyl-[3,3'- bipyridin]-5-yl)-3- (trifluoromethyl) benzamide RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313668 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313668&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609500 383540560 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606026 CCOc1ncc(cc1C1(O)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)ccc1C InChI=1S/C27H30FN3O4/c1-5-35-25-22(27(33)9-11-34-16-27)12-19(15-30-25)21-14-20(7-6-17(21)2)31-24(32)18-8-10-29-23(13-18)26(3,4)28/h6-8,10,12-15,33H,5,9,11,16H2,1-4H3,(H,31,32) VCMSTJFOYCZQFP-UHFFFAOYSA-N 313669 US10167279, Example 295::N-(3-(6-ethoxy-5- (3-hydroxytetra- hydrofuran-3-yl) pyridin-3-yl)-4- methylphenyl)-2-(2- fluoropropan-2- yl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313669 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313669&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609575 383540561 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606027 CCOc1ncc(cc1C1(O)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H29FN4O4/c1-5-35-24-21(26(33)7-9-34-15-26)10-18(13-30-24)20-12-19(14-29-16(20)2)31-23(32)17-6-8-28-22(11-17)25(3,4)27/h6,8,10-14,33H,5,7,9,15H2,1-4H3,(H,31,32) JKIRHAVIYFTWKT-UHFFFAOYSA-N 313670 US10167279, Example 296::N-(6'-ethoxy-5'-(3- hydroxytetrahydro- furan-3-yl)-2- methyl-[3,3'- bipyridin]-5- yl)-2-(2- fluoropropan-2- yl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 4000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313670 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313670&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609670 383540562 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606028 CCOc1ncc(cc1C1(F)CCOC1)-c1cc(NC(=O)c2cccc(c2)C(F)(F)F)cnc1C InChI=1S/C25H23F4N3O3/c1-3-35-23-21(24(26)7-8-34-14-24)10-17(12-31-23)20-11-19(13-30-15(20)2)32-22(33)16-5-4-6-18(9-16)25(27,28)29/h4-6,9-13H,3,7-8,14H2,1-2H3,(H,32,33) RCMRONACPGPIAQ-UHFFFAOYSA-N 313671 US10167279, Example 297::N-(6'-ethoxy-5'-(3- fluorotetrahydro- furan-3-yl)-2- methyl-[3,3'- bipyridin]-5- yl)-3-(trifluoro- methyl)benzamide RAF proto-oncogene serine/threonine-protein kinase Human 1000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313671 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313671&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609510 383540563 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606029 CCOc1ncc(cc1C1(F)CCOC1)-c1cc(NC(=O)c2ccnc(c2)C(C)(C)F)cnc1C InChI=1S/C26H28F2N4O3/c1-5-35-24-21(26(28)7-9-34-15-26)10-18(13-31-24)20-12-19(14-30-16(20)2)32-23(33)17-6-8-29-22(11-17)25(3,4)27/h6,8,10-14H,5,7,9,15H2,1-4H3,(H,32,33) XGNXPSIBBLDIBL-UHFFFAOYSA-N 313672 US10167279, Example 298::N-(6'-ethoxy-5'-(3- fluorotetrahydro- furan-3-yl)-2- methyl-[3,3'- bipyridin]-5-yl)-2- (2-fluoropropan-2- yl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 2000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313672 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313672&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609547 383540564 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606030 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1(O)COC1 InChI=1S/C24H23F3N4O4/c1-14-2-3-17(30-22(33)15-4-5-28-20(8-15)24(25,26)27)11-18(14)16-9-19(23(34)12-35-13-23)31-21(10-16)29-6-7-32/h2-5,8-11,32,34H,6-7,12-13H2,1H3,(H,29,31)(H,30,33) ICXJXKUEHBEYBG-UHFFFAOYSA-N 313673 US10167279, Example 299::N-(3-(2-((2- hydroxyethyl) amino)-6-(3- hydroxyoxetan-3- yl)pyridin-4-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313673 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313673&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609623 383540565 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606031 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1(O)COC1 InChI=1S/C25H24F3N3O4/c1-15-5-6-19(30-23(33)16-3-2-4-18(9-16)25(26,27)28)12-20(15)17-10-21(24(34)13-35-14-24)31-22(11-17)29-7-8-32/h2-6,9-12,32,34H,7-8,13-14H2,1H3,(H,29,31)(H,30,33) BDVMXUDSQHURFK-UHFFFAOYSA-N 313674 US10167279, Example 300::N-(3-(2-((2- hydroxyethyl) amino)-6-(3- hydroxyoxetan-3- yl)pyridin-4-yl)-4- methylphenyl)-3- (trifluoromethyl) benzamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313674 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313674&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609345 383540566 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606032 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(nc(c1)C1(O)CCOCC1)N1CCOC1=O InChI=1S/C27H25F3N4O5/c1-16-21(14-20(15-31-16)32-24(35)17-3-2-4-19(11-17)27(28,29)30)18-12-22(26(37)5-8-38-9-6-26)33-23(13-18)34-7-10-39-25(34)36/h2-4,11-15,37H,5-10H2,1H3,(H,32,35) AMARCPVTOGSMMO-UHFFFAOYSA-N 313675 US10167279, Example 301::N-(2'-(4- hydroxytetrahydro- 2H-pyran-4-yl)-2- methyl-6'-(2- oxooxazolidin-3- yl)-[3,4'-bipyridin]- 5-yl)-3- (trifluoromethyl) benzamide RAF proto-oncogene serine/threonine-protein kinase Human 951 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313675 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313675&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609704 383540567 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606033 Cc1ncc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1(O)CCOCC1 InChI=1S/C26H27F3N4O4/c1-16-21(14-20(15-31-16)32-24(35)17-3-2-4-19(11-17)26(27,28)29)18-12-22(25(36)5-9-37-10-6-25)33-23(13-18)30-7-8-34/h2-4,11-15,34,36H,5-10H2,1H3,(H,30,33)(H,32,35) HWMIXQLMBMUUDN-UHFFFAOYSA-N 313676 US10167279, Example 302::N-(2'-((2- hydroxyethyl) amino)-6'-(4- hydroxytetrahydro- 2H-pyran-4-yl)-2- methyl-[3,4'- bipyridin]-5-yl)-3- (trifluoromethyl) benzamide RAF proto-oncogene serine/threonine-protein kinase Human 1528 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313676 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313676&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609383 383540568 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606034 Cc1ccc(NC(=O)c2cc(ccn2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1(O)CCOCC1 InChI=1S/C26H27F3N4O4/c1-16-2-3-19(32-24(35)21-14-18(4-7-30-21)26(27,28)29)15-20(16)17-12-22(25(36)5-10-37-11-6-25)33-23(13-17)31-8-9-34/h2-4,7,12-15,34,36H,5-6,8-11H2,1H3,(H,31,33)(H,32,35) MDZPRWYSFIBBHB-UHFFFAOYSA-N 313677 US10167279, Example 303::N-(3-(2-((2- hydroxyethyl) amino)-6-(4- hydroxytetrahydro- 2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-4- (trifluoromethyl) picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 1992 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313677 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313677&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609429 383540569 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606035 Cc1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1-c1cc(NCCO)nc(c1)C1(O)CCOCC1 InChI=1S/C27H28F3N3O4/c1-17-5-6-21(32-25(35)18-3-2-4-20(13-18)27(28,29)30)16-22(17)19-14-23(26(36)7-11-37-12-8-26)33-24(15-19)31-9-10-34/h2-6,13-16,34,36H,7-12H2,1H3,(H,31,33)(H,32,35) DKCVTJBBGDEEMG-UHFFFAOYSA-N 313678 US10167279, Example 304::N-(3-(2-((2- hydroxyethyl) amino)-6-(4- hydroxytetrahydro- 2H-pyran-4- yl)pyridin-4-yl)-4- methylphenyl)-3- (trifluoromethyl) benzamide RAF proto-oncogene serine/threonine-protein kinase Human 383 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313678 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313678&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609501 383540570 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606036 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(O)CCOCC1 InChI=1S/C26H26F3N3O5/c1-16-2-3-19(31-24(34)17-4-7-30-22(12-17)26(27,28)29)15-20(16)18-13-21(25(35)5-9-36-10-6-25)32-23(14-18)37-11-8-33/h2-4,7,12-15,33,35H,5-6,8-11H2,1H3,(H,31,34) VKJOSCAQEWNNDD-UHFFFAOYSA-N 313679 US10167279, Example 305::N-(3-(2-(2- hydroxyethoxy)-6- (4-hydroxytetra- hydro-2H-pyran- 4-yl)pyridin-4-yl)- 4-methylphenyl)- 2-(trifluoro- methyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 331 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313679 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313679&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609359 383540571 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606037 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(OCCO)nc(c1)C1(F)CCOCC1 InChI=1S/C26H25F4N3O4/c1-16-2-3-19(32-24(35)17-4-7-31-22(12-17)26(28,29)30)15-20(16)18-13-21(25(27)5-9-36-10-6-25)33-23(14-18)37-11-8-34/h2-4,7,12-15,34H,5-6,8-11H2,1H3,(H,32,35) PZFXOYGXKDDNOK-UHFFFAOYSA-N 313680 US10167279, Example 306::N-(3-(2-(4- fluorotetrahydro- 2H-pyran-4-yl)-6- (2-hydroxy- ethoxy)pyridin-4- yl)-4-methyl- phenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 830 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313680 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313680&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609497 383540572 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606038 COCCNc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C26H28F3N5O3/c1-16-3-4-19(32-25(35)18-5-8-30-23(13-18)26(27,28)29)14-20(16)22-15-21(17-6-10-37-11-7-17)24(34-33-22)31-9-12-36-2/h3-5,8,13-15,17H,6-7,9-12H2,1-2H3,(H,31,34)(H,32,35) OWFDORFLXBEOGL-UHFFFAOYSA-N 313681 US10167279, Example 307::N-(3-(6-((2-methoxyethyl)amino)-5-(tetrahydro-2H-pyran-4-yl)pyridazin-3-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 80.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313681 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313681&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118949139 383540573 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606039 CN(CCO)c1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C26H28F3N5O3/c1-16-3-4-19(31-25(36)18-5-8-30-23(13-18)26(27,28)29)14-20(16)22-15-21(17-6-11-37-12-7-17)24(33-32-22)34(2)9-10-35/h3-5,8,13-15,17,35H,6-7,9-12H2,1-2H3,(H,31,36) CFRJZEVNKADQII-UHFFFAOYSA-N 313682 US10167279, Example 308::N-(3-(6-((2-hydroxyethyl(methyl)amino)-5-(tetrahydro-2H-pyran-4-yl)pyridazin-3-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 500 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313682 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313682&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609687 383540574 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606040 C[C@@H](CO)Nc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C |r| InChI=1S/C26H28F3N5O3/c1-15-3-4-19(32-25(36)18-5-8-30-23(11-18)26(27,28)29)12-20(15)22-13-21(17-6-9-37-10-7-17)24(34-33-22)31-16(2)14-35/h3-5,8,11-13,16-17,35H,6-7,9-10,14H2,1-2H3,(H,31,34)(H,32,36) DRXPHSQWLAZFIV-UHFFFAOYSA-N 313683 US10167279, Example 309::(S)-N-(3-(6-((1- hydroxypropan-2- yl)amino)-5-(tetrahydro- 2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 20.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313683 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313683&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609444 383540575 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606041 C[C@H](CO)Nc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C |r| InChI=1S/C26H28F3N5O3/c1-15-3-4-19(32-25(36)18-5-8-30-23(11-18)26(27,28)29)12-20(15)22-13-21(17-6-9-37-10-7-17)24(34-33-22)31-16(2)14-35/h3-5,8,11-13,16-17,35H,6-7,9-10,14H2,1-2H3,(H,31,34)(H,32,36) DRXPHSQWLAZFIV-UHFFFAOYSA-N 313684 US10167279, Example 310::(R)-N-(3-(6-((1- hydroxypropan-2- yl)amino)-5-(tetrahydro- 2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 40.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313684 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313684&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609581 383540576 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606042 C[C@H](O)CNc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C |r| InChI=1S/C26H28F3N5O3/c1-15-3-4-19(32-25(36)18-5-8-30-23(11-18)26(27,28)29)12-20(15)22-13-21(17-6-9-37-10-7-17)24(34-33-22)31-14-16(2)35/h3-5,8,11-13,16-17,35H,6-7,9-10,14H2,1-2H3,(H,31,34)(H,32,36) RORGLLVNFZEJNG-UHFFFAOYSA-N 313685 US10167279, Example 311::(S)-N-(3-(6-((2- hydroxypropyl)amino)- 5-(tetrahydro-2H-pyran- 4-yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 50.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313685 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313685&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609478 383540577 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606043 C[C@@H](O)CNc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C |r| InChI=1S/C26H28F3N5O3/c1-15-3-4-19(32-25(36)18-5-8-30-23(11-18)26(27,28)29)12-20(15)22-13-21(17-6-9-37-10-7-17)24(34-33-22)31-14-16(2)35/h3-5,8,11-13,16-17,35H,6-7,9-10,14H2,1-2H3,(H,31,34)(H,32,36) RORGLLVNFZEJNG-UHFFFAOYSA-N 313686 US10167279, Example 312::(R)-N-(3-(6-((2- hydroxypropyl)amino)- 5-(tetrahydro-2H-pyran- 4-yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313686 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313686&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609521 383540578 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606044 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(C2CCOCC2)c(OC2CCOCC2)nn1 InChI=1S/C28H29F3N4O4/c1-17-2-3-20(33-26(36)19-4-9-32-25(14-19)28(29,30)31)15-22(17)24-16-23(18-5-10-37-11-6-18)27(35-34-24)39-21-7-12-38-13-8-21/h2-4,9,14-16,18,21H,5-8,10-13H2,1H3,(H,33,36) OBJXEZQUWRAXFQ-UHFFFAOYSA-N 313687 US10167279, Example 313::N-(4-methyl-3-(5-tetrahydro-2H-pyran-4-yl-6-((tetrahydro-2H-pyran-4-yl)oxy)pyridazin-3-yl)phenyl)-2-(trifluoromethyl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 70.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313687 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313687&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609487 383540579 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606045 CCN1CCC(CC1)Oc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C30H34F3N5O3/c1-3-38-12-7-23(8-13-38)41-29-25(20-9-14-40-15-10-20)18-26(36-37-29)24-17-22(5-4-19(24)2)35-28(39)21-6-11-34-27(16-21)30(31,32)33/h4-6,11,16-18,20,23H,3,7-10,12-15H2,1-2H3,(H,35,39) KOACOQKHCPGWQR-UHFFFAOYSA-N 313688 US10167279, Example 314::N-(3-(6-((1- ethylpiperidin-4- yl)oxy)-5-(tetrahydro- 2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 60.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313688 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313688&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609728 383540580 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606046 COCCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C26H27F3N4O4/c1-16-3-4-19(31-24(34)18-5-8-30-23(13-18)26(27,28)29)14-20(16)22-15-21(17-6-9-36-10-7-17)25(33-32-22)37-12-11-35-2/h3-5,8,13-15,17H,6-7,9-12H2,1-2H3,(H,31,34) KERGCEOLYNWQEL-UHFFFAOYSA-N 313689 US10167279, Example 315::N-(3-(6-(2- methoxyethoxy)-5- (tetrahydro-2H-pyran- 4-yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313689 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313689&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609528 383540581 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606047 CC(C)Oc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2ccnc(c2)C(F)(F)F)ccc1C InChI=1S/C26H27F3N4O3/c1-15(2)36-25-21(17-7-10-35-11-8-17)14-22(32-33-25)20-13-19(5-4-16(20)3)31-24(34)18-6-9-30-23(12-18)26(27,28)29/h4-6,9,12-15,17H,7-8,10-11H2,1-3H3,(H,31,34) OJVGGCWFMKJETA-UHFFFAOYSA-N 313690 US10167279, Example 316::N-(3-(6-isopropoxy-5- (tetrahydro-2H-pyran-4- yl)pyridazin-3-yl)-4- methylphenyl)-2- (trifluoromethyl) isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313690 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313690&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609538 383540582 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606048 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)c2cc(ccn2)C(F)(F)F)ccc1C InChI=1S/C25H25F3N4O3/c1-3-35-24-20(16-7-10-34-11-8-16)14-21(31-32-24)19-13-18(5-4-15(19)2)30-23(33)22-12-17(6-9-29-22)25(26,27)28/h4-6,9,12-14,16H,3,7-8,10-11H2,1-2H3,(H,30,33) VNCRJWNJNAPPJN-UHFFFAOYSA-N 313691 US10167279, Example 317::N-(3-(6-ethoxy-5-(tetrahydro-2H-pyran-4-yl)pyridazin-3-yl)-4-methylphenyl)-4-(trifluoromethyl)picolinamide RAF proto-oncogene serine/threonine-protein kinase Human 600 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313691 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313691&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609457 383540583 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606049 CCOc1nnc(cc1C1CCOCC1)-c1cc(NC(=O)NCCC(C)(C)C)ccc1C InChI=1S/C25H36N4O3/c1-6-32-23-21(18-9-13-31-14-10-18)16-22(28-29-23)20-15-19(8-7-17(20)2)27-24(30)26-12-11-25(3,4)5/h7-8,15-16,18H,6,9-14H2,1-5H3,(H2,26,27,30) MRXLBNKLMVWUOB-UHFFFAOYSA-N 313692 US10167279, Example 318::1-(3,3-dimethylbutyl)-3-(3-(6-ethoxy-5-(tetrahydro-2H-pyran-4-yl)pyridazin-3-yl)-4-methylphenyl)urea RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313692 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313692&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 118948933 383540584 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606050 Cc1ccc(NC(=O)NCCC(C)(C)C)cc1-c1cc(OCCO)nc(c1)C1CCOCC1 InChI=1S/C26H37N3O4/c1-18-5-6-21(28-25(31)27-10-9-26(2,3)4)17-22(18)20-15-23(19-7-12-32-13-8-19)29-24(16-20)33-14-11-30/h5-6,15-17,19,30H,7-14H2,1-4H3,(H2,27,28,31) GOOMLLXVDCHYJL-UHFFFAOYSA-N 313693 US10167279, Example 319::1-(3,3-dimethylbutyl)-3-(3-(2-(2-hydroxyethoxy)-6-(tetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)urea RAF proto-oncogene serine/threonine-protein kinase Human 100.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313693 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313693&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 134609565 383540585 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606051 Cc1ccc(NC(=O)C2CCNC(C2)C(F)(F)F)cc1-c1cc(nc(c1)N1CCC(C)(CC1)NC(=O)OC(C)(C)C)C1CCOCC1 InChI=1S/C35H48F3N5O4/c1-22-6-7-26(40-31(44)24-8-13-39-29(19-24)35(36,37)38)21-27(22)25-18-28(23-9-16-46-17-10-23)41-30(20-25)43-14-11-34(5,12-15-43)42-32(45)47-33(2,3)4/h6-7,18,20-21,23-24,29,39H,8-17,19H2,1-5H3,(H,40,44)(H,42,45) BFBAPFFQFBKBIP-UHFFFAOYSA-N 313694 US10167279, Example 320::N-(3-(2-(4-amino-4-methylpiperidin-1-yl)-6-(tetrahydro-2H-pyran-4-yl)pyridin-4-yl-4-methylphenyl)-2-(trifluoromethyl)piperidine-4-carboxamide RAF proto-oncogene serine/threonine-protein kinase Human 350000 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313694&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133647 383540586 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5 606052 Cc1ccc(NC(=O)c2ccnc(c2)C(F)(F)F)cc1-c1cc(nc(c1)N1CCC(C)(CC1)NC(=O)OC(C)(C)C)C1CCOCC1 InChI=1S/C35H42F3N5O4/c1-22-6-7-26(40-31(44)24-8-13-39-29(19-24)35(36,37)38)21-27(22)25-18-28(23-9-16-46-17-10-23)41-30(20-25)43-14-11-34(5,12-15-43)42-32(45)47-33(2,3)4/h6-8,13,18-21,23H,9-12,14-17H2,1-5H3,(H,40,44)(H,42,45) PXXSMUPFTDZXSL-UHFFFAOYSA-N 313695 US10167279, Example 321::N-(3-(2-(4-amino-4-methylpiperidin-1-yl)-6-(tetrahydro-2H-pyran-4-yl)pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide RAF proto-oncogene serine/threonine-protein kinase Human 90.0 US Patent 10.7270/Q2W0981V aid1796438 US10167279 Aversa, RJ; Burger, MT; Dillon, MP; Dineen, Jr., TA; Lou, Y; Nishiguchi, GA; Ramurthy, S; Rico, AC; Rauniyar, V; Sendzik, M; Subramanian, S; Setti, LQ; Taft, BR; Tanner, HR; Wan, L 1/1/2019 4/24/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=313695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2939&target=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=313695&enzyme=RAF+proto-oncogene+serine%2Fthreonine-protein+kinase&column=ki&startPg=0&Increment=50&submit=Search 135133702 383540587 1 MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF 7Z38,7Z37,8U1L,9MMQ,9MMP,3OMV,8GAE,7JHP,8T75,6XI7,6XHB,6XHA,6XGV,6XGU,6PTW,6PTS,1GUA,8T74,8EPW,6VJJ,1RFA,4G0N,4G3X,1C1Y RAF proto-oncogene serine/threonine-protein kinase RAF1_HUMAN P04049 B0LPH8 B2R5N3 Q15278 Q9UC20 RAF proto-oncogene serine/threonine-protein kinase L7RRS6_HUMAN L7RRS6 A0A024R2G5